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Abstract 
 
 
 
 
 
There is a delicate evolutionary balance between viruses and their hosts. The 
host has evolved the intrinsic, innate and adaptive immunity to fight viral 
infections. However, viruses have acquired several counteracting measures to 
evade host defences. Ovine Betaretroviruses, including the exogenous and 
pathogenic Jaagsiekte sheep retrovirus (JSRV) and the highly related endogenous 
enJSRVs are a unique model system to investigate virus-host interaction over 
long evolutionary periods. Sheep have co-opted some defective enJSRV loci to (i) 
counteract infection by exogenous viruses and likely (ii) to cope with the 
continuous retroviral invasion of their genome. In addition, various genes of the 
innate and intrinsic immunity of the host have evolved to block viral replication. 
The work presented in this thesis focuses on the ovine bone marrow stromal cell 
antigen 2 (Bst-2)/ tetherin, a recently identified cellular restriction factor with a 
broad antiviral activity, and its interaction with sheep Betaretroviruses. In 
sheep, the BST-2 gene is duplicated into two paralogs termed oBST-2A and -2B. 
Studies presented in this thesis show that oBST-2B possesses several biological 
properties distinct from the paralog oBST-2A and from all the other BST-2 
orthologs. oBST-2A prevents the release of JSRV/enJSRV viral particles by 
‘tethering’ them at the cell membrane similarly to what observed by human 
BST-2. On the other hand, oBST-2B, does not reach the cell membrane but 
remains within the Golgi stacks and the trans-Golgi network. Several lines of 
evidence obtained in this thesis suggest that oBST-2B reduces significantly Env 
incorporation into viral particles. Therefore, oBST-2B possesses a unique 
antiviral activity that complements the classical tethering restriction provided 
by oBST-2A. 
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1.1 Overview of retroviruses 
1.1.1  Taxonomy  
Retroviruses are positive-sense single-stranded RNA viruses, which infect a wide 
range of vertebrates (Coffin, Hughes et al. 1997). The defining feature common 
to all retroviruses is their ability to reverse-transcribe their RNA genome into 
double stranded DNA (“provirus”) that is then inserted into the host genome 
(Vogt 1997). The family Retroviridae encompasses a large number of diverse 
retroviruses divided into two sub-families (Orthoretrovirinae and 
Spumaretrovirinae) (Fauquet, Mayo et al. 2010). The majority of retroviruses are 
included in the Orthoretrovirinae, which is the further divided into six genera 
(Alpharetroviruses, Betaretroviruses, Gammaretroviruses, Deltaretroviruses, 
Epsilonretroviruses, Lentiviruses) based upon genome divergence (defined by 
reverse transcriptase sequence similarity and genome complexity), virion site of 
assembly, and morphology, as detailed in Figure 1 (Coffin, Hughes et al. 1997) 
(Vogt 1997).  
Retroviruses were also classified as one of four groups (A-D) based on the 
appearance of virion morphology by electron microscopy. Type A retroviral 
particles are used to describe the intracisternal particles of rodent endogenous 
retroviruses. These particles are non-enveloped virions with a structure similar 
to that of immature virions with an electron-lucent centre (Vogt 1997).  
In contrast, type B, C and D group retroviruses demonstrate morphology similar 
to that of mature particles, with differences observed within their core region. 
Type B and type D retroviruses, such as the Betaretrovirus Jaagsiekte Sheep 
Retrovirus (JSRV) and Mason-Pfizer Monkey Virus (M-PMV), assemble in the 
cytoplasm and are distinguishable by their round, eccentrically positioned or bar 
shaped cores respectively (Payne, Verwoerd et al. 1983; Sfakianos, LaCasse et 
al. 2003; Murcia, Arnaud et al. 2007). Type C retroviruses, such as the 
Lentiviruses or Gammaretroviruses, assemble at the plasma membrane and 
possess a central spherical inner core (Yeger, Kalnins et al. 1978; Coffin, Hughes 
et al. 1997; Swanstrom and Wills 1997).  
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Figure 1. Overview of the taxonomy of the Retroviridae 
 
 
1.1.2 Genomic Structure 
The retroviral genome consists of two identical copies of single stranded positive 
sense RNA molecules of approximately 7-10 kb in length. The two molecules of 
RNA are held together by hydrogen bonds and are similar to the cellular 
messenger RNA as they possess a cap structure at the 5’ end and are 
polyadenylated at the 3’ end (Beemon, Duesberg et al. 1974; Vogt 1997).  
All retroviruses possess the same genomic arrangement with at least the 
canonical gag, pro, pol and env genes flanked by the R (“repeated”) and U5 
(“unique region at the 5’ end) region at the 5’ end and by a U3- R region at the 
3’ end (see 1.2.2.2 Reverse Transcription for details) (Wang, Galehouse et al. 
1976; Wang, Duesberg et al. 1976; Wang, Duesberg et al. 1976; Vogt 1997). Upon 
entry the RNA genome is reverse transcribed into double-stranded DNA following 
entry into the host cell (Baltimore 1970; Temin and Mizutani 1970). The end of 
the RNA viral genome is duplicated during reverse transcription into two LTRs 
(“long terminal repeats”) arranged invariable as U3 – R – U5. The DNA copy of 
the viral genome (termed “provirus”) is stably integrated into the host 
chromosomal DNA (Hughes, Shank et al. 1978). The site for transcription 
initiation, known as the primer binding site (PBS), is found immediately after the 
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5’ LTR, whereas the site for polyadenylation is found within the U5-R region of 
the 3’ LTR (Vogt 1997).  
Retroviruses can be also defined as either ‘simple’ or ‘complex’ viruses based 
upon their genomic structure. Simple retroviruses rely upon the minimal number 
of genes sufficient for viral replication (gag, pro, pol and env). Jaagsiekte Sheep 
retrovirus (JSRV) and the endogenous enJSRVs, the viruses studied in this thesis, 
are “simple” Betaretroviruses (Palmarini and Fan 2003). However, complex 
retroviruses, such as the HIV, encode a number of additional “accessory” and 
“regulatory” genes which play roles in supporting replication and evading host 
immune responses, as summarised in Figure 2 (see 1.5 Host vs. Virus) (Coffin, 
Hughes et al. 1997) 
 
1.1.3 Viral Proteins 
Retroviruses possess a lipidic envelope that surrounds the viral particle and 
incorporates the Env glycoproteins (Swanstrom and Wills 1997). Env mediates 
retroviral infection and contributes to virion structure and stability. The Env 
glycoprotein is translated from the env gene as a single polyprotein. Env forms a 
trimer in the ER (Chan, Fass et al. 1997) before passing into the Golgi for further 
post-translational modifications such as glycosylation. Env eventually enters the 
Trans Golgi Network (TGN) where it is cleaved (processed) into the 
transmembrane (TM) and the surface (SU) domains (Henderson, Sowder et al. 
1984; Coffin, Hughes et al. 1997; Swanstrom and Wills 1997). SU is the external, 
hydrophilic region of Env that mediates the interaction with the host receptor/s, 
whereas TM is the membrane spanning portion of Env that anchors the SU to the 
lipid membrane. This cleavage is essential both for the arrangement and 
stabilisation of virions as well as the functional aspect of retroviral entry. For 
most retroviruses Env must be transported to the surface where it is incorporate 
into virions as they bud from the cell. Mutational analysis of MLV, which 
assembles at the plasma membrane suggests that cleavage plays an important 
role in the intracellular trafficking of the protein. Uncleaved Env will not traffic 
to the cell surface and is retained within the Golgi. Therefore it is not 
incorporated into viral particles which in turn reduce the infectivity of VLPs 
assembled void of Env (Apte and Sanders 2010). The necessity of correct 
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cleavage has been shown for other retroviruses including HIV (Bosch and Pawlita 
1990) as well as Betaretrovirus MMTV (Goodman, Kain et al. 1993).  
Env is critical in mediating viral entry and it is under strong immune pressure 
from the host as it is targeted by neutralizing antibodies. Consequently, the Env 
glycoproteins are highly divergent between different retroviruses and contain 
the most variable regions within different strains of the same virus. TM also 
undergoes conformational changes in order to assist the fusion of the cellular 
receptor and viral proteins during cell entry. Env is arranged as an oligomeric 
complex on the cell surface and in this way is thought to increase Env stability 
(Coffin, Hughes et al. 1997). 
All of the structural proteins required to drive the process of virion assembly and 
encapsidate the viral genomic RNA, are derived from the gag gene product. Gag 
is regarded as the determinant of virion size and morphology (Ako-Adjei, 
Johnson et al. 2005). Gag is cleaved by the viral protease (PR, encoded by pro) 
during maturation to form the matrix (MA), the major capsid protein (CA) and 
the nucleocapsid (NC) (Swanstrom and Wills 1997). All of the proteins derived 
from Gag provide similar structural functions among retroviruses although their 
sequence varies considerably between different genus. The major homology 
region (MHR) within CA is, like the name suggests, the region with the greater 
degree of homology between retroviruses (Strambio-de-Castillia and Hunter 
1992).  
The pol gene encodes both the reverse transcriptase (RT) and the integrase (IN) 
required for reverse transcription of the gRNA and integration of the proviral 
DNA into the host genome, respectively (Swanstrom and Wills 1997).  
 
1.1.4 Virion structure 
The structure of the virion after exit from the host cell is distinctly different 
from the structure of the virion during assembly. This difference is likely due to 
the different requirements of these two processes. Whereas the assembly 
process is largely focused upon gathering together all of the required 
components of the virion, the infectious virus released from the cell must be 
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competent to infect, reverse transcribe and finally integrate into a new host cell 
(see 1.2, Overview of the retroviral cycle). The difference in structure has been 
highlighted by HIV where the immature virions have an incomplete spherical 
shape with the N terminal of MA arranged adjacent to the virion surface. The 
inner layers comprise of the CA, NC and genomic RNA. Following budding, 
cleavage of viral proteins by the viral encoded protease allows NC and the 
genomic RNA to condense into the “mature” morphology observed in the 
extracellular virions by electron microscopy (de Marco, Muller et al. 2010) 
(Figure 2B).  
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Figure 2. Schematic diagram of the retroviral genomic organisation and virion morphology. 
The genomic organisation as both proviral DNA and viral RNA is shown (adapted from 
(Coffin, Hughes et al. 1997)). In addition, the distinction between immature and mature 
virions morphology is shown based upon HIV as an example (B, adapted from (de Marco, 
Muller et al. 2010)). This schematic diagram does not take into account the arrangement 
of the virion core that contributes to the A-D morphological classification. 
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1.2 Overview of the retroviral cycle  
The major steps of retroviral replication are common among all retroviruses. 
However, each retroviral genera, including the Betaretroviruses, possess unique 
aspects to their replication cycle (Vogt 1997; Vogt 1997).  
 
 
Figure 3. An illustration of the key steps of the retroviral replication cycle. 
Viral entry (1), reverse transcription (2), integration (3), transcription (4), translation (5), viral 
assembly (6) and exit (7). Note that, in contrast to the majority of retroviruses (which assemble at 
the cell membrane), Betaretroviruses assemble at the perinuclear region prior to exit (8 & 9). Note 
the exact stage at which Env incorporation occurs for Betaretroviruses is currently unknown. 
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1.2.1 Viral Entry 
Viral entry, the first phase of the retroviral lifecycle, is mediated by a direct 
interaction between the retroviral Env glycoprotein and the cellular receptor/s 
on the host cell (Hunter 1997). Virus-cell receptor interaction is a key point in 
the viral replication cycle and one of the primary determinants of host and 
tissue/cell tropism. Each retrovirus utilises a specific cellular receptor that may 
function independently or with the aid of a co-receptor (Hunter 1997).  
 
1.2.1.1 Receptor recognition and entry 
Virions must directly engage a specific host cellular receptor to gain access into 
the cell and initiate the replication cycle.  
The initial virion “attachment” or “adsorption” to the host plasma membrane is 
independent of the receptor and is mediated by surface molecules such as 
lectins and heparan sulphate proteoglycans (Roderiquez, Oravecz et al. 1995; 
Pizzato, Marlow et al. 1999). Following attachment of the virions to the cell 
membrane, there is evidence suggesting that virions ‘surf’ the membrane and 
filopodia in order to reach and interact with the target receptor that will 
ultimately allow proper “penetration” into the cell (Lehmann, Sherer et al. 
2005). The virion movement across the cell surface stimulates the underlying 
intracellular actin and initiates the oligomerisation of receptors which in turn 
primes the membrane for virus entry (Ewers, Smith et al. 2005; Lehmann, Sherer 
et al. 2005) 
The specificity of the receptor and viral Env interaction largely determines the 
cellular tropism of the virus. For example, ecotropic Murine Leukaemia Virus 
(MLV) only infects mouse cells while xenotropic MLV infects non mouse cells, 
whereas amphotropic viruses can infect both (Boeke and Stoye 1997). 
It is usual for the host cell receptor to be downregulated from the cell surface 
upon virus entry and replication within the cell. This mechanism prevents 
apoptosis of the cell following superinfection and inhibits the entry of newly 
assembled and released virions into the cell (Hunter 1997). For example, HIV-1 
utilises its Env and the viral accessory proteins Vpu and Nef to downregulate the 
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target receptor (CD4) from the host cell surface by a mechanism not yet fully 
understood (Wildum, Schindler et al. 2006). 
In many ways, environmental cues are necessary for the viral envelope fusion 
with the cell membrane and entry of the virus into the cell. In some cases virus 
entry may be driven simply by receptor recognition alone at the cell surface, as 
has been shown for HIV (Maddon, McDougal et al. 1988). Alternatively, a virus 
may initially be internalised by endocytosis and, following exposure to the low 
internal pH, be released from the endosome into the cell,  as is the case for 
both MMTV and JSRV (Redmond, Peters et al. 1984; Bertrand, Cote et al. 2008). 
However, different entry pathways are not always mutually exclusive. For 
example, a combination of both pH-dependent and pH-independent entry has 
been observed for HIV, although in this case only the direct entry route appears 
to result in a productive infection (Nisole and Saib 2004). Some viruses require 
additional co-factors to allow successful entry, for example HIV-1 engages both 
the receptor CD4 and in addition co-receptors CCR5 and/ or CXCR4, as reviewed 
by (Doms 2000). Alternative co-receptors such as CCR3 and FPRL1 have also been 
associated with HIV-1 infection (Nedellec, Coetzer et al. 2009). 
 
1.2.2 Reverse transcription and Integration 
 
The synthesis of proviral DNA and its integration into the host genome are key 
events in the retroviral replication cycle. Following entry, the incoming virion 
uncoats and utilises the microtubule network for particle progression towards 
the nucleus (Goff 2007). Reverse transcription occurs after entry and before 
provirus integration in a complex known as the “reverse transcriptase complex”, 
Following reverse transcription, the “preintegration complex” (PIC) which 
contains the proviral DNA ready for integration enters the nucleus and mediates 
successful integration within the host genome (Brown 1997), as illustrated in 
Figure 4.  
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1.2.2.1 Reverse transcriptase complex (RTC)  
 
The primary role of the RTC is the generation of proviral DNA. It consists of the 
retroviral RNA genome and co-packaged virion proteins necessary for reverse 
transcription, including reverse transcriptase and RNase H. A tRNA (carried 
within the virion core) initiates reverse transcription by binding to the primer 
binding site (PBS) of the 5’LTR. The RTC is a continually evolving nucleoprotein 
complex that varies in composition and activity as it progresses from the cell 
periphery to the nucleus and will also carry components of the downstream PIC 
into which it develops, such as integrase proteins (Telesnitsky and Goff 1997).  
Following successful viral entry of the virion, the capsid is gradually 
disassembled as the formation of the RTC is initiated. The speed and extent of 
the viral particle uncoating process is unique to specific retroviruses, but the 
capsid protein may not be completely removed during this process, as there is 
evidence of its presence further downstream at the nuclear import level (Risco, 
Menendez-Arias et al. 1995). There has been some debate as to whether reverse 
transcription is initiated prior to, or after, the uncoating process has begun and 
cDNA can be detected within newly produced viral particles of HIV and Moloney 
murine leukaemia virus (MoMLV) (Trono 1992). In addition, it has been observed 
that viral particles with HIV Capsid mutants are deficient in reverse transcriptase 
activity (Forshey, von Schwedler et al. 2002). Therefore, it is likely that the 
Capsid has a role in the reverse transcription process. An alternative explanation 
is that uncoating occurs directly at the nuclear pore prior to import (Arhel, 
Souquere-Besse et al. 2007). Extensive RT activity in mature viral particles is 
thought to be prevented by the presence of the nucleocapsid (NC), confirming 
the control it exerts over the timing of reverse transcription (Telesnitsky and 
Goff 1997).  
The RTC cannot simply diffuse from the cellular periphery to the nucleus. The 
“crowded” nature of the cytoplasm heavily restricts intracellular movements 
and provides many obstacles that hinder RTC progression (Luby-Phelps 2000). 
The RTC therefore utilises the host microtubule network (McDonald, Vodicka et 
al. 2002; Goff 2007) and, in the case of HIV, the Matrix protein is important for 
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recruitment onto the host cytoskeleton for transport to occur (Allain, Lapadat-
Tapolsky et al. 1994; Bukrinskaya, Brichacek et al. 1998). 
 
 
 
1.2.2.2 Reverse transcription (RT) 
 
Reverse transcription is the unique feature of the retroviral replication cycle and 
involves the conversion of the viral RNA genome into the double-stranded DNA 
provirus. Reverse transcription is a multi-step process mediated by the viral 
encoded enzyme reverse transcriptase, an RNA dependent DNA polymerase, and 
RNase H (Fig. 4) (Telesnitsky and Goff 1997).  
 
 
Figure 4.  Illustration highlighting the major steps of the process of reverse transcription. 
The reverse transcription complex generates proviral DNA for insertion into the host genome from 
a starting viral gRNA template (1). The first action involves the production of a short minus strand 
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DNA (-ssDNA) (2). This –ssDNA undergoes first strand transfer shifting from the 5’ end to the 3’ 
end (3). Elongation of the –ssDNA continues to generate the minus strand. This is accompanied by 
the degradation of the viral gRNA template by RNaseH (4). A short polypurine tract is non 
degradable by RNaseH and this primes synthesis of the corresponding plus strand (5 and 6).  
 
The first action (Figure 4, step 2) involves the production of the short minus 
strand DNA (–ssDNA). Reverse transcription is initiated by the recognition of the 
primer binding site (PBS) at the end of the U5 region contained within the 
flanking 5’ region of the genome by an approximately eighteen nucleotide 
stretch of a tRNA. Binding of the tRNA to the PBS results in elongation from the 
PBS to the 5’ cap.  Each viral genus utilises a distinct pattern of tRNAs to initiate 
RT. For example, M-PMV uses tRNALys1-2 (Sonigo, Barker et al. 1986) whereas  
MMTV and HIV exclusively utilise tRNA Lys3 as a primer for reverse transcription 
(Peters and Glover 1980; Ratner, Fisher et al. 1987). Production of HIV mutants 
with an altered PBS site that utilises a selection of other tRNAs results in the 
emergence of reverse mutants that use the preferred tRNA Lys3 (Ni and Morrow 
2007). However, MLV is more versatile and can use alternative tRNAs for priming 
reverse transcription although the maximum efficiency of the process is reached 
when using its preferred tRNA Pro (Palmer, McPherson et al. 2005). 
The –ssDNA undergoes first strand transfer (Figure 4 step 3), shifting from the 5’ 
end to the 3’ end which serves as a template for further transcription (in an 
intra or intermolecular fashion). The R region of the –ssDNA anneals with that of 
the 3’ end and elongation of the –ssDNA in the direction of the 5’LTR continues, 
generating the minus strand DNA. RNase H activity is essential for successful first 
strand transfer as it degrades the RNA from the -ssDNA:RNA complex and 
mutations within RNaseH have been shown to inhibit the process of reverse 
transcription (Figure 4 step 4) (Telesnitsky and Goff 1997). The RNA genome 
contains a short polypurine tract (PPT) resistant to degradation by RNaseH from 
which the +ssDNA is generated (Figure 4 step 5 & 6). Annealing of the PBS of the 
+ssDNA to that of the 5’ end of the minus strand DNA generates the second 
strand transferred where after the plus strand of DNA is synthesised and proviral 
DNA has been fully generated. During the process of reverse transcription both 
the 5’ and 3’LTRs of the proviral DNA generated are identical containing U3-R-U5 
arrangement, in contrast to the viral mRNA where the 5’ and 3’LTRs only contain 
the R-U5 and U3-R portions respectively (Telesnitsky and Goff 1997). 
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Whilst the process of reverse transcription is uniform the structure of the 
enzyme reverse transcriptase varies between retroviruses. For example, the 
Betaretrovirus MMTV has a reverse transcriptase (RT) protein which is a 
functional monomer (Taube, Loya et al. 1998) whilst the lentivirus HIV-1 RT is a 
dimer. Reverse transcription per se is an error prone process as the reverse 
transcriptase has no proof reading activity and therefore contributing to viral 
genetic diversity (Moya 1999). Far from being detrimental, the lack of proof 
reading activity by RT allows retroviruses the flexibility required to rapidly 
evolve and meet the requirements of their environment and also to evade host 
immune responses (see section 1.5 Host vs Virus ). 
 
1.2.2.3 The Preintegration complex (PIC) and nuclear import 
 
During the progression from the plasma membrane to the nucleus along the 
microtubule network, the properties of the RTC are modified allowing it to 
mature into the PIC. This is reflected in the change of viral particle density 
following infection (Fassati and Goff 1999; Fassati and Goff 2001). The PIC is 
defined as a complex containing proviral DNA ready for integration. The ends of 
the cDNA generated within the RTC are closely associated with integrase (IN) 
(Wei, Mizuuchi et al. 1998) which drives integration. The PIC must first cross the 
nuclear membrane to gain access to the genome. Generally, most retroviruses 
including Betaretroviruses require the host cells to be actively dividing (i.e. 
passing through M phase with the nuclear membrane disassembled) in order to 
successfully enter the nucleus and integrate. However, HIV and other 
lentiviruses are capable of infecting non dividing cells due to the presence of a 
nuclear localisation signal (NLS) (Brown 1997).  
 
1.2.2.4 Integration 
 
Following nuclear import it is essential that the proviral DNA is integrated into 
the host genome. Successful retroviral infection requires that the provirus is 
permanently integrated in the host cell genome, otherwise the DNA is unstable 
and decays within the nucleus. Stable integration of proviral DNA allows the 
virus to mimic host DNA thus allowing it to utilise the cell machinery for gene 
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expression. The physical process of integration involves DNA cleavage and 
ligation in two distinct stages. First, the 3’ end processing of proviral DNA to be 
integrated occurs with the removal of two nucleotides from the 3’ end by 
integrase, thus exposing the hydroxyl group that will join to the host DNA. The 
second step is called ‘DNA strand transfer’ whereby the exposed proviral 3’ end 
hydroxyl group joins the 5’ end of the host target genome and is repaired by 
cellular enzymes (Brown 1997).  
Generally, on a structural basis retroviruses may have a preference for the 
major groove of DNA rather than the minor groove that is curved along the 
nucleosomes. The major groove is more accessible, providing less steric 
inhibition from DNA binding proteins. Retroviral integrations can in many ways 
be considered a random event. However, there is evidence suggesting that 
different retroviruses tend to integrate in different areas of the genome 
(Mitchell, Beitzel et al. 2004). The site of integration by JSRV or enJSRVs within 
the genome has not yet been defined.  
A recent study of integration target site selection by a “reconstituted” human 
endogenous retrovirus (HERV)-K has shown that new integration sites were 
predominately found in active gene dense areas slightly enriched in transcription 
sites (Lee and Bieniasz 2007). This is in contrast to established HERV-K elements 
which are found mainly outside active gene rich areas. These data suggest that 
HERV-K integration that occurred in areas that negatively altered gene function 
were counter-selected during evolution. 
 
1.2.3 Transcription and viral mRNA processing and export 
 
1.2.3.1 Expression 
The successful integration of proviral DNA is essential as it provides a template 
for transcription (Rabson and Graves 1997). Non-integrated DNA produced during 
the process of reverse transcription can account for as much as 99% of 
intracellular viral DNA at the early stages of infection but it makes no 
contribution to viral expression. Unintegrated DNA can be found as 1-LTR, 2-LTR 
and linear DNA forms. In turn, viral transcription is influenced by the site of 
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proviral integration. Generally, successful and stable integration occurs in 
transcriptionally silent regions causing minimal disruption to the host. 
Therefore, successful translation often does not just depend upon the 
recruitment of transcription factors to the U3 of the 5’LTR, but in the depletion 
of those which are repressive and restricting access (Rabson and Graves 1997).  
The initiation site of transcription is defined within the 5’LTR at the beginning of 
the central short direct repeat “R” region. The U3, which precedes R, regulates 
transcription and contain the promoter and enhancer regions. The promoter 
contains the initiating TATA binding element and a range of positive binding 
regulatory sequences, while upstream the enhancer region contains positive 
acting transcription factor binding regulatory elements and negative regulatory 
elements. These positive binding regulatory transcription factors will often be 
related to the viral tropism (Rabson and Graves 1997). Cell type and 
differentiation status dictates the enhancing factors available to the provirus 
and obviously impacts its transcription levels. For example, the HIV LTR recruits 
the lymphocyte enhancer factor (LEF) to its promoter region which is commonly 
present in immature B cells and both immature and mature T cells (Waterman 
and Jones 1990; Waterman, Fischer et al. 1991). This also has the added 
advantage of assisting with promoter accessibility as it alters the promoter 
conformation (Giese, Cox et al. 1992). Related viruses might be expressed in 
different cells/tissues due to differences in their LTRs. For example, the 
exogenous JSRV transcription is promoted by the lung specific hepatocyte 
nuclear factor 3β (HNF-3β)  (Palmarini, Datta et al. 2000; McGee-Estrada and Fan 
2006; McGee-Estrada and Fan 2007) while enJSRVs are driven by hormone 
responsive elements (Palmarini, Gray et al. 2001). Similarly, MMTV has 
functional hormone responsive elements within its promoter region (Cato, 
Henderson et al. 1987). Retroviruses exploit the host RNA polymerase II to drive 
viral mRNA production.  
 
 
1.2.3.2 Viral mRNA processing 
The provirus exploits the host cell machinery for expression, viral mRNA 
processing, export and translation. All retroviral mRNAs are produced initially as 
Chapter 1  32 
full length transcripts that are initially processed in order to have a 5’ 7-methyl-
guanosine cap (which assist with translation initiation) combined with cleavage 
and polyadenylation of the 3’ end within the R-U5 region, giving all transcripts 
identical 3’ ends and stability during transcription. 
All retroviruses use a full length viral mRNA (organised in 5’cap-R-U5-gag-pol-
env-u3-R-polyA) for the translation of both Gag and Pol proteins and for the 
genome of the viral progeny. For some retroviruses like HIV-2, it has been shown 
that the template used during translation can also be packaged (Rabson and 
Graves 1997; Bolinger and Boris-Lawrie 2009).  
1.2.3.3 Splicing  
Splicing is an important general intracellular function. Env is instead translated 
from a single spliced mRNA while some accessory proteins of complex 
retroviruses derive from multiple spliced mRNAs (Rabson and Graves 1997). 
Through splicing, complex genomes can produce regulatory proteins that 
facilitate transcription to maximise successful viral particle production. For 
example HIV encodes Tat, which trans activates the viral LTRs and help to 
recruit various cellular proteins such as histone acetylase transferase which 
acetylates histones therefore promoting access by transcription factors to the 
viral LTRs (Benkirane, Chun et al. 1998).  
Simple retroviruses, which only produce one splice variant for the production of 
Env, utilise standard splicing donor and acceptor sites. Complex retroviruses 
produce multiple transcripts (e.g. HIV has been described to produce in excess 
of 40 splice mRNA variants) (Rabson and Graves 1997).  
1.2.3.4 Nuclear Export 
The full length unspliced mRNA must be exported from the nucleus in order to 
be available for translation and/or to be packaged in the virion genomic RNA. It 
is important that the correct proportions of both spliced and unspliced 
populations are maintained in order to optimise viral particle production. 
Complex retroviruses encode additional proteins to assist with this process. For 
example, the transport of full length HIV viral mRNA from the nucleus is 
mediated by the regulatory protein Rev (Yi, Bogerd et al. 2002). Rev is 
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synthesized in the cytoplasm and transported back to the nucleus for action by 
its nuclear localisation signal (Truant and Cullen 1999).  Within the nucleus, Rev 
acts by binding RRE (Rev responsive element), a cis acting sequence within env. 
Rev-RRE binding masks the NLS and reveals the nuclear export signal (NES) 
(Henderson and Percipalle 1997). Rev binds the cellular export factor Crm1 
(Izaurralde, Kutay et al. 1997; Bogerd, Echarri et al. 1998). Once successful 
export of RNA has occurred, Crm1 is dissociated from the Rev-RRE complex 
allowing Rev to interact with Importin B and cycle back into the nucleus. Rev-
like viral proteins are also found encoded for other retroviruses such as mouse 
mammary tumour virus (MMTV) (Mertz, Simper et al. 2005) and human 
endogenous retrovirus-K (HERV-K) (Ruggieri, Maldener et al. 2009). However, the 
simple retrovirus M-PMV encodes no Rev-like protein and utilises a cis acting RNA 
element (the constitutive transport element, CTE) which interacts with the 
cellular nuclear export factor Tap1/NFX1 to promote nuclear export (Braun, 
Rohrbach et al. 1999). Interestingly, JSRV is a simple retrovirus but the signal 
peptide of the glycoprotein Env (Rej/SP) functions as a Rev-like protein and 
promotes full length viral RNA export by interacting with a cis acting responsive 
element within the 3’ end of the genome (Caporale, Arnaud et al. 2009; Nitta, 
Hofacre et al. 2009, Hofacre, 2009 #25).  
 
1.2.4  Viral assembly, budding and virion maturation 
 
1.2.4.1 Viral Proteins and Virion assembly 
The Env glycoproteins are synthesized specifically on the ER polysomes before 
being modified and delivered via the secretory pathway to the plasma 
membrane. In contrast, Gag and Gag-Pol protein precursors are produced within 
the cytosol on free polysomes (Swanstrom and Wills 1997). It is Gag which 
supports virion assembly/release and the various subdomains of Gag serve 
different functions during this process. The nucleocapsid (NC) domain of Gag is 
particularly important during the initial process of encapsidation of the viral RNA 
genome (Berkowitz, Ohagen et al. 1995). Recently, the presence of retroviral 
Gag proteins has been detected in some cases within the nucleus and this 
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supports the idea that Gag has a key role in viral genomic RNA export (Parent 
2011).  
Viral gRNA has a packaging signal which drives the encapsidation process and 
likely gives viral RNA the selection specificity required in the presence of a large 
volume of cellular mRNAs (Adam and Miller 1988). The NC domain of Gag is 
capable of non-specifically binding RNA and DNA, however, it relies upon the 
encapsidation sequence to specifically associate with the viral gRNA. The viral 
gRNA is dimerized at the 5’ end providing an important evolutionary factor as 
this can aid the diversification of the genome (Onafuwa-Nuga and Telesnitsky 
2009). Furthermore, it is the contact between the NC and the viral gRNA, which 
leads to the formation of the virion inner core. The spontaneous assembly of Gag 
when contacted by a non-specific single stranded nucleic acid highlights its 
importance in driving virion assembly (Campbell and Vogt 1995). Mutations in 
both the NC and CA region demonstrate their importance during virion formation 
and release (Hansen, Jelinek et al. 1990, Dorfman, 1993 #510; Dorfman, Luban 
et al. 1993). Mutations in CA affect virion formation (Ganser-Pornillos, von 
Schwedler et al. 2004) and it is the oligomerisation and assembly of the CA 
which encloses the gRNA genome associated with NC. Those virions which are 
formed initially are immature in structure, spherical and defined by a distinctive 
layer under the lipid envelope (Kurth 2010) Retroviral assembly and budding is 
thought to occur predominantly at the plasma membrane (Yeger, Kalnins et al. 
1978) although there is also evidence of assembly within the cytosol. 
Interestingly, Betaretroviruses are unique among retroviruses as their assembly 
occurs within the cytoplasm in the vicinity of the mitochondrial organizing 
centre (MTOC) independently of plasma membrane association (Payne, Verwoerd 
et al. 1983).  
 
 
1.2.4.2 Viral Budding 
The matrix (MA) is considered important for Gag membrane targeting during 
assembly and budding. In particular, it is the post-translational modification of 
MA by myristoylation (the attachment of a myristoyl group to the N terminal of 
the Gag protein) which influences membrane association of Gag (Facke, 
Janetzko et al. 1993; Ono, Orenstein et al. 2000). This in turn affects Env 
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distribution as Gag – Env interaction is an important factor for the presence of 
Env within the lipid rafts of the plasma membrane and subsequent incorporation 
into the assembling virions as they exit the cell (Bhattacharya, Repik et al. 
2006).  
Mutational analysis of Gag revealed that there exists specific position-
independent domains in Gag, the late (L) domains, which are common to many 
retroviruses and plays crucial roles in recruiting host factors during viral exit 
(Parent, Bennett et al. 1995). Several different L domains have been indentified 
for various retroviruses. For example, the P(T/S)AP L domain is present in both 
HIV-1 (Gottlinger, Dorfman et al. 1991) and M-PMV (Gottwein, Bodem et al. 
2003) while the PPxY domain is found in Rous Sarcoma Virus (RSV) (Parent, 
Bennett et al. 1995) and M-PMV (Yasuda and Hunter 1998). Other late domains 
have been also identified within retroviruses (Morita and Sundquist 2004). Late 
domains allow assembling virions to engage with host cofactors in order to reach 
the cell membrane for viral exit. For example the P(T/S)AP domain recruits 
TSG101 (Garrus, von Schwedler et al. 2001) and similarly PPxY allows interaction 
with TSG101 and AIP1 both of which are part of the endosomal ESCRTs 
(endosomal sorting complex required for transport) machinery that normally 
function at the surface of the endosome to induce the budding of vesicles into 
the multivescular bodies (MVB). During infection, retroviruses redirect the ESCRT 
machinery to the cell membrane in order to bud out of the cell (Morita and 
Sundquist 2004). During exit from the cell, retroviruses also interact with 
cellular proteins that induce a curvature of the plasma membrane observed 
during exit (Strack, Calistri et al. 2003; Morita and Sundquist 2004).  
The virions which assemble at the plasma membrane for budding are still 
immature in morphology. The processing of Gag into MA, CA and NC domains and 
Gag-Pol cleavage by the viral protease occurs after viral budding from the cell 
and allows the morphological and functional maturation of the virion (see 1.1.4 
Figure 2B). Multiple interactions between Gag, the plasma membrane and gRNA 
are required for correct virion maturation (Datta, Heinrich et al. 2010).  
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Figure 5. Schematic diagram highlighting the two major routes of virion assembly. 
For the majority of retroviruses viral particle assembly occurs at the plasma membrane and virions 
acquire Env as they bud from lipid rafts. Betaretroviruses are unique as they appear to assemble at 
the centrosomal region prior to collecting the envelope as they exit via lipid rafts. 
 
 
 
1.2.4.3 Cell-to-cell vs. cell-free transmission  
Once successful replication has taken place, retroviruses must exit the cell in 
which infection is established and enter another uninfected cell in order to 
spread infection within the host. In theory, cell free virus spreading provides the 
widest potential range for propagation to ensure survival. Virus exits the 
infected cell and is free to diffuse within the host infecting both close and 
distant tissues and cells. However, cell free transmission of virus encounters 
physical and kinetic challenges during the process of viral entry (see viral entry). 
Steric hindrance is associated with cell-free infection. Similarly, the negative 
charge density at the cell surface affects the accessibility of binding sites to 
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invading virions. Indeed, the addition of polybrene is required in vitro to 
increase the likelihood of successful infections (as much as ten fold for 
retroviruses) by reducing electrostatic repulsion between the incoming virions 
and the host cell membrane (Coffin, Hughes et al. 1997). Virions also face an 
increasing repertoire of cell host factors which target unique features of the 
replication cycle both during exit and entry. In response to this, retroviruses and 
other enveloped viruses have developed a strategy to pass from an infected to 
an uninfected cell by cell-to-cell transmission. This mode of transmission has the 
advantage to avoid the physical barriers imposed by the host and the immune 
system, increasing viral kinetics and efficiency but it has the disadvantage of 
"travelling" only a short distance between infected and uninfected neighbouring 
cells. Documented retrovirus cell to cell transmission occurs via the plasma 
membrane, filopodial bridges, nanotubules and virological synapses (reviewed in 
(Sattentau 2008)). Plasma membrane based fusion may result in the formation of 
syncytia observed for both Human T cell leukaemia virus 1 (HTLV-1) and HIV-1 
although the ability of efficient cell to cell spread by this method is still 
debated. Filopodia, are projections of actin from both infected and uninfected 
cells which support the movement of virus from an infected to an uninfected 
cell. This movement is driven by the aggregation of viral Env and the 
corresponding host cell receptor (Lehmann, Sherer et al. 2005; Sherer, Lehmann 
et al. 2007), HIV-1 transport along the exterior of T cell nanotubules has also 
been observed. Nanotubules can be multiple actin membrane based projections 
linking infected and uninfected cells forming after the formation of the 
virological synapse. Virions migrate along the exterior of the tubule before the 
interacting with the cellular receptor and entering the cell. Virological synapses, 
similar to immunological synapses, are another example of how cell-to-cell 
transmission of retroviruses and have been observed for HIV-1 and HTLV 
transmission between immune cells. (HTLV-1) infected T cells produce very few 
cell-free virions (Derse, Hill et al. 2001) in vivo and the virus is spread directly 
between lymphocytes via virological synapses (Jolly and Sattentau 2004). The 
budding of HTLV-1 virions and their entry into surrounding uninfected cells 
occurs at cell contact zones enriched in microtubules and adhesion factors 
(Igakura, Stinchcombe et al. 2003).  
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The virological synapses are supermolecular complexes that are formed at the 
site of contact between an infected cell and a target cell expressing the viral 
receptor. The virological synapses require a functional actin cytoskeleton and 
the expression of viral receptor/s in the target cells (summarised by (Sattentau 
2008)).  
 
1.3 Exogenous retroviruses 
 
1.3.1  Overview of exogenous retroviruses and disease 
Retroviruses were first associated with the development of disease over a 
century ago when an infectious, filterable agent was found to cause chicken 
leukosis and sarcoma. The viral aetiology for these diseases was identified by 
Ellermann in 1908 and Rous in 1911 and the viruses they described were named 
avian leukosis virus (ALV) and Rous sarcoma virus (RSV), respectively (Vogt 
1997). Later, retroviruses were discovered to be the cause of cancers in many 
other animal species including mice, cats, sheep, cattle and humans. 
Retroviruses are differentiated in “exogenous” and “endogenous” viruses. 
Exogenous retroviruses are transmitted horizontally from an infected host to an 
uninfected host like any other virus (Rosenberg and Jolicoeur 1997). 
Oncogenic retroviruses can be divided into different groups based on the 
mechanism of transformation they follow: acutely transducing, cis-acting and 
trans-acting retroviruses (Rosenberg and Jolicoeur 1997; Kurth 2010).  
Acutely transducing retroviruses, carry a host derived oncogene, for example, 
the Alpharetrovirus RSV carries the host derived oncogene src (Duesberg and 
Vogt 1970; Martin 2004). Acutely transducing retroviruses are usually replication 
defective and they need a “helper” virus for replication. They are capable of 
rapidly transforming an infected cell, once they integrate their genome (carrying 
an oncogene) within the infected cell.  
Cis-acting retroviruses lack an oncogene and do not directly transform cells in 
culture. Instead, transformation occurs during a period of latency as a result of 
mutagenesis of the host genome by proviral insertion (a process also known as 
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“insertional activation”) (Rosenberg and Jolicoeur 1997). An example of a cis 
acting retroviruses is MMTV which induces mammary tumours in mice by 
insertional mutagenesis (Theodorou, Kimm et al. 2007). Tumours induced by 
insertional activation are monoclonal or oligoclonal. Different tumours induced 
by the same retroviruses acting by insertional activation are characterized by 
the presence of common integration sites (Rosenberg and Jolicoeur 1997; 
Cousens, Bishop et al. 2004; Philbey, Cousens et al. 2006). 
Trans-acting retroviruses are those which induce transformation by a viral gene 
product. The Betaretrovirus of interest for this thesis, JSRV, has a trans-
activating Env and this mechanism will be discussed in detail below. Retroviruses 
have also been linked with a wider range of diseases, including neurological 
(Ances and Ellis 2007), autoimmune (Ansari, Pattanapanyasat et al. 2007) and 
more notably immunodeficiency diseases (Moanna, Dunham et al. 2005) which 
affect a range of species including humans. 
1.3.2 Ovine pulmonary adenocarcinoma (OPA) 
 
Jaagsiekte sheep retrovirus (JSRV) is unique among retroviruses as it is the only 
virus to cause a naturally occurring lung cancer, Ovine pulmonary 
adenocarcinoma (OPA) (Palmarini, Fan et al. 1997; Palmarini, Sharp et al. 1999; 
Palmarini and Fan 2001).  
OPA is a fatal disease and involves the development of lung adenocarcinoma as a 
result of infection and transformation of type II pneumatocytes within the 
bronchial and alveolar epithelium (Palmarini, Dewar et al. 1995; Palmarini, Fan 
et al. 1997; Murgia, Caporale et al. 2011; Yu, Linnerth-Petrik et al. 2011). JSRV 
is an “exogenous” retrovirus and is classically transmitted horizontally from 
infected to uninfected sheep. More recently, an important natural transmission 
route assisting the spread of OPA has been identified from mothers to their 
young via colostrum, although the respiratory secretions of affected animals 
remain the main cause of the contagium (Voigt, Kramer et al. 2007; Grego, De 
Meneghi et al. 2008) OPA is a veterinary disease that poses significant economic 
problems to several sheep-rearing countries. However, it also provides a large 
animal model for human lung cancer as it bears resemblance to human 
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bronchioloalveolar adenocarcinoma (BAC), an unusual form of human 
adenocarcinoma (Platt, Kraipowich et al. 2002) thus making it an interesting 
model for investigation.  
OPA is clinically identified through progressive acute respiratory distress of the 
host due to the development of multifocal tumours. In addition, secondary 
pulmonary bacterial infections are also common in affected animals. The 
pulmonary cells from which the tumours originate are type II pneumocytes 
(Palmarini, Dewar et al. 1995; Palmarini, Fan et al. 1997). More recently, it has 
been shown that JSRV infects a population of proliferating type II pneumocytes 
which, whilst abundant in young lambs, are relatively rare in adult sheep 
(Murgia, Caporale et al. 2011).  
Histologically, OPA generally manifests itself as multifocal tumours which extend 
from the lung surface and may be grouped into two distinct patterns classified as 
either “typical” or “atypical” forms (Garcia-Goti, Gonzalez et al. 2000). The 
secondary bacterial infections which occur frequently in OPA can distort the 
pathology presented. Sheep affected by OPA generally produce an excess of 
pulmonary surfactant which is an essential functional and protective component 
of the respiratory tract (De las Heras, Gonzalez et al. 2003; Johnson and Fan 
2011). 
In vivo, JSRV is found to be expressed preferentially in the tumour cells of 
affected animals. Interestingly, in reporter assays in vitro, the JSRV LTRs 
(containing the viral promoter and enhancers) are expressed preferentially in 
type II pneumatocytes and in Clara cell derived MLE-15 and mtCCl-2 cell lines 
(Palmarini, Datta et al. 2000; McGee-Estrada, Palmarini et al. 2005). 
A major issue at present is the lack of a simple laboratory test to diagnose JSRV 
infection. Diagnosis is difficult at the preclinical stages due to the lack of an 
antibody response from the host against JSRV. This lack of immune response is 
explained in part by the expression of enJSRVs during ontogeny that likely 
tolerize sheep against JSRV (Ortin, Minguijon et al. 1998). Early detection prior 
to OPA development is possible by highly sensitive nested PCR assays which are 
not a cost effective diagnostic tool (Palmarini, Holland et al. 1996; Holland, 
Palmarini et al. 1999; Gonzalez, Garcia-Goti et al. 2001; De Las Heras, Ortin et 
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al. 2005). In general, only 2-5% of the animals within an affected flock develop 
OPA. This suggests that JSRV may be expressed at low level in the majority of 
infected hosts (Caporale, Centorame et al. 2005) and low concentrations of viral 
DNA within blood during this latent period are linked with difficulty in accurate 
diagnosis (Lewis, Brulisauer et al.). OPA is experimentally reproducible in lambs 
by intratracheal inoculation using the JSRV21 molecular clone (or by using virus 
purified from lung secretions of an affected animal). The rate of disease 
induction changes depending on the age of the infected animal. Lambs are most 
susceptible to experimental infection and may develop tumours in as little as ten 
days (Fan, Palmarini et al. 2003). 
 
1.3.3  JSRV taxonomy and genome 
JSRV is a member of the Betaretrovirus genus within the family of the 
Retroviridae, subfamily, Orthoretroviranae. JSRV has the classic genomic 
organization of a simple retrovirus with gag, pro, pol, and env genes flanked at 
either side by the 5’ and 3’ long terminal repeats (LTRs) (Palmarini and Fan 
2003). Within the JSRV genome there is an accessory open reading frame, orf-X, 
to which no function has yet been assigned. All strains of JSRV studied have 
maintained this open reading frame intact suggesting that it may have an 
essential role for virus replication, although by mutational analysis it has been 
determined that Orf-X is not required for the process of transformation (Rosati, 
Pittau et al. 2000; Maeda, Palmarini et al. 2001).  
JSRV can infect a wide variety of cells in vitro and in vivo (Palmarini, Dewar et 
al. 1995; Palmarini, Holland et al. 1996; Holland, Palmarini et al. 1999; 
Palmarini, Sharp et al. 1999). However, in OPA-affected animals, viral antigens 
have been detected mainly if not almost exclusively in the tumour cells 
(Palmarini, Dewar et al. 1995; Murgia, Caporale et al. 2011). Within the JSRV U3 
region there are enhancer-binding motifs for lung-specific transcription factors, 
such as HNF-3β  that drives the expression and transformation of the lung 
epithelial cells (McGee-Estrada, Palmarini et al. 2002). The U3 region also 
contains several sites that engage general transcription factors such as CEB/P, 
commonly required by most cell types (McGee-Estrada and Fan 2006; McGee-
Estrada and Fan 2007).  
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1.3.4 JSRV oncogenesis 
JSRV follows unique mechanisms to induce cell transformation. The JSRV Env is a 
dominant oncoprotein both in vitro and in vivo (Maeda, Palmarini et al. 2001; 
DeMartini, Platt et al. 2004; Wootton, Halbert et al. 2005; Caporale, Cousens et 
al. 2006). The JSRV envelope is a type 1 transmembrane protein approximately 
620 amino acids (aa) in length. Within the cytoplasmic tail of the TM domain 
there is an important SH2 binding motif (YXXM) that has been found to be 
critical for Env-induced cell transformation (Caporale, Cousens et al. 2006; Hull 
and Fan 2006; Cousens, Maeda et al. 2007). The JSRV Env induces the activation 
of cellular signalling pathways such as the Ras-MEK-MAP and PI3-kinase-Akt-
mTOR pathways, although the relative importance of these pathways for 
oncogenesis remains to be elucidated (Palmarini, Maeda et al. 2001; Liu, Duh et 
al. 2003; Liu, Lerman et al. 2003; Maeda, Inoshima et al. 2003; Zavala, Pretto et 
al. 2003; Liu and Miller 2005; Maeda, Fu et al. 2005; Liu and Miller 2007; Maeda 
and Fan 2008).  
 
1.3.5  Hyal2 mediates viral entry of both JSRV and related 
enJSRVs 
JSRV and the related enJSRVs utilize Hyaluronidase 2 (Hyal2) for cell entry (Rai, 
Duh et al. 2001). Hyaluronidases degrade hyaluronidin, a glycosaminoglycan 
critical to maintain the integrity of the extracellular matrix (Lepperdinger, 
Mullegger et al. 2001). Hyal2 is a glycophosphatidylinositol (GPI) anchored 
protein with a weak hyaluronidase activity and it is the only member of the 
hyaluronidase family that JSRV utilises for cell entry (Miller 2003), which 
suggests that the hyaluronidase activity per se is not a requirement for viral 
receptor function (Vigdorovich, Strong et al. 2005; Vigdorovich, Miller et al. 
2007). JSRV is believed to enter the infected cells via a caveolar-dependent 
receptor-mediated endocytosis. 
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Figure 6. Illustration outlining the proposed caveolae-mediated viral entry pathway. 
JSRV makes a non-specific interaction on the cell surface before surfing towards hotspots and 
entering via a caveolae mediated pathway (Bertrand, Cote et al. 2008). Caveolae are grooves on 
the plasma membrane associated with lipid rafts. The latter are regions of the plasma membrane 
high in sphingolipids and GPI anchored proteins. A prerequisite for caveolar-mediated entry of a 
virus is the cluster of lipid rafts on the cell plasma membrane. This may enhance infection by 
concentrating virions and their receptors at a site prior to entry. The attachment of JSRV to Hyal2 
(a GPI and lipid raft associated protein) may occur with a pre-existing cluster of lipid rafts, or 
alternatively clustering may be induced following virion binding to non-specific receptors, as 
described previously. Caveloae domains are very flexible regions of the plasma membrane and this 
clustering of lipid rafts combined with virus attachment to the host receptor distorts the membrane 
shape leading to its curvature. This curvature promotes cleavage of the forming caveolar vesicle 
from the plasma membrane via Dynamin to complete the internalisation of the virus.  
 
 
1.4  Endogenous retroviruses (ERVs) 
1.4.1  Overview of endogenous retroviruses 
 
Retroviruses must integrate their genomic DNA (“provirus”) into the host cell 
genome in order to carry out a successful replication cycle. Cell division 
increases the capacity to produce viral particles and indirectly maximises viral 
infection and virus “survival” within the host. In turn, survival during evolution is 
dependent on the ability of the virus to be successfully transmitted between 
infected and uninfected hosts. Retroviruses can be transmitted either 
horizontally or vertically. “Exogenous” retroviruses are transmitted horizontally 
like any other virus and include many common pathogens of humans and 
animals, such as human immunodeficiency virus (Chiu, Yaniv et al. 1985), Feline 
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leukemia virus (Hardy, Old et al. 1973), Jaagsiekte sheep retrovirus (Palmarini, 
Sharp et al. 1999) and several others. “Endogenous” retroviruses (ERVs) are 
instead transmitted from generation to generation like any other Mendelian gene 
(Boeke and Stoye 1997). Some ERVs are derived from the integration of ancient 
and now extinct exogenous retroviruses within the germline cells of the host, for 
example Human endogenous retrovirus (HML-2) (Lee and Bieniasz 2007). Others, 
such as enJSRV, are regarded as modern ERVs as they are found to be highly 
related to current exogenous retroviruses which are still infectious (Palmarini, 
Hallwirth et al. 2000; Palmarini, Mura et al. 2004; Arnaud, Caporale et al. 2007; 
Arnaud, Varela et al. 2008; Varela, Spencer et al. 2009; Black, Arnaud et al. 
2010). Once present in the germline, the proviral DNA establishes itself as a 
permanent fixture within the host genome and is then vertically transmitted to 
future generations (Coffin, Hughes et al. 1997). ERVs are clearly an integral part 
of the mammalian genome as they represent approximately 8% of the human 
genome (Lander, Linton et al. 2001). 
ERVs originate from germline integration. The germline is a population of highly 
demethlyated, undifferentiated and active cells which provides optimum 
conditions for successful retroviral integration with ample unrestricted 
integration sites and uninhibited expression patterns thus allowing the rapid 
expansion of integrated elements (Boeke and Stoye 1997). Due to the selection 
pressure the host exerts over non-self sequences, many ERVs are silenced as 
they accumulate mutations which render them replication incompetent. 
Generally, the majority of examples of replication competent genomes will be 
found to be recent integrations or transposition events. Several animal species, 
including mice and sheep, have active and intact ERVs capable of viral particle 
production while in higher species (primates) the majority are inactive (Kurth, 
Bannert 2010). It is fair to assume that the ERVs identified within host genomes 
represent a very small proportion of those which have challenged the germline 
during evolution. Proviruses that pose a deleterious effect to the host have been 
likely counter-selected during evolution. In many ways, ERVs provide clues as to 
the ancient and now extinct retroviruses which challenged the genome and the 
interplay between virus and host during co-evolution. Several attempts have 
been made to “resurrect” endogenous retroviral sequences in order to 
investigate their infectious properties (Lee and Bieniasz 2007). There are few 
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opportunities to study a genome that is instead currently under invasion by 
retroviruses and to date the koala and sheep represent good examples of these 
genomes (Tarlinton, Meers et al. 2006; Arnaud, Caporale et al. 2007). ERVs are 
not just “fossils” and redundant junk DNA (Bock and Stoye 2000) within the host 
genome, as several studies suggest that these elements play major roles in host 
physiology (see 1.4.5 Placental formation).  
Interestingly, until recently retroviruses were considered the only viruses 
present in vertebrate genomes. However, analysis of a variety of vertebrate 
genomes has revealed that both RNA (Bornaviruses and Filoviruses) viruses 
(Horie, Honda et al. 2010), (Belyi, Levine et al. 2011) and DNA viruses 
(Densoviruses and Parvoviruses) have been endogenised during evolution (Belyi, 
Levine et al. 2010; Liu, Fu et al. 2011). Thus, the contribution to genomic 
diversity provided by viruses is far greater than previously recognised.  
 
1.4.2  The discovery of endogenous retroviruses 
 
ERVs were first highlighted during studies in the 1960s which focused on 
maintaining Avian Sarcoma Leukaemia virus (ASLV)-free egg producing chickens. 
Uninfected chickens consistently yielded positive results for a serologic assay 
targeting the viral Gag (group specific antigen) (Dougherty and Di Stefano 1966). 
Additionally, Gag and retroviral like particles were identified within healthy 
chicken tissues (Dougherty, Di Stefano et al. 1967). These data were further 
validated when it was shown that Gag could be inherited following a Mendelian 
cross between Gag+ and negative breeds of chickens (Payne and Chubb 1968). 
However, at that time it was suspected that these data could be either due to a 
latent retroviral infection or cross reactivity with a host gene. It was later 
observed that the fibroblasts of chick embryos were capable of releasing Rous 
Sarcoma Virus (RSV) in the absence of helper virus (Weiss 1967). Until this point, 
RSV required complementation by the envelope of RSV in order to release viral 
particles from cells in culture (Hanafusa, Miyamoto et al. 1970). However, it was 
later identified that virus was released spontaneously following ionizing 
radiation of both embryo and somatic cells (Weiss, Friis et al. 1971). The data at 
that time therefore revealed two fundamental properties of endogenous 
retroviruses: firstly that retroviral sequences were integrated within the 
Chapter 1  46 
germline of the host and were inherited vertically by future generations, and 
secondly that, although they are predominately silent within the genome, they 
can be reactivated. The discovery of ERVs has been reviewed by Weiss (Weiss 
2006). 
 
1.4.3  Classification of ERVs 
 
Transposable elements are mobile DNA segments (McClintock 1956) which utilise 
cellular machinery to support replication. They constitute a large fraction of the 
mammalian genome and represent up to approximately 50% of the human 
genome in comparison to the 3% of protein encoding genes identified to date, as 
described by (Coffin, Hughes et al. 1997). Transposable elements may be further 
categorized into Class I and II based upon structure and movement patterns 
(Finnegan 1989). Class I are DNA transposons which cut and paste themselves 
within the genome, while Class II are retroelements which are capable of copy 
and paste movements within the genome. Furthermore, retroelements consist of 
either LTR based DNA sequences (ERVs) or non-LTR based DNA sequences (LINES, 
SINES) (Boeke and Stoye 1997).  
ERVs represent a subclass of transposable elements that are self sufficient and 
capable of efficiently copying and reinserting themselves into the genome. They 
are restricted to vertebrates and there are many examples. With the exception 
of deltaretroviruses, many endogenous retroviruses have closely related 
exogenous forms (Boeke and Stoye 1997). ERVs are further categorized into 
three classes. First those which resemble most exogenous gammaretrovirus like 
sequences, the second Betaretrovirus like sequences and the third and final 
those which share homology with spumaretrovirus-like elements. This 
classification is, however, now deemed insufficient with the addition of 
subgroups due to the discovery of endogenous lentiviral (Katzourakis, Tristem et 
al. 2007; Gifford, Katzourakis et al. 2008) and authenticated spumaretroviral 
sequences (Lagaye, Vexiau et al. 1992; Coffin, Hughes et al. 1997). The rapidly 
expanding abundance and knowledge of ERVs has lead to problems with 
nomenclature and classification, as highlighted in a recent review by (Blomberg, 
Benachenhou et al. 2009) 
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1.4.4  The effects of ERV expression on host function and 
genome plasticity 
 
Endogenous retroviruses have overcome several barriers in order to achieve 
successful fixation in the host genome. Any given ERV must be able to infect 
reproductive tissues in order to facilitate the infection of germline cells. In 
addition, it must also be able to evade any host restriction mechanisms (see 1.5 
Host vs Virus), successfully integrate and persist without any detriment to the 
host and, finally, transcend from an insertionally polymorphic trait to a fixed 
gene within the host species (Boeke and Stoye 1997).  
Most ERVs are defective and transcriptionally repressed but in rare occasions 
they are functional, providing useful and essential functions to the host. 
Recombination between related ERV loci present in different chromosomal 
locations can also result in chromosomal rearrangements (Hughes and Coffin 
2001). Thus, ERV integration can modulate gene function and provide more 
plasticity for the genome of the host species (Eiden 2008). Whenever functional, 
ERVs are capable of exerting significant transcriptional control over host genes 
residing either as integral elements of the promoter or as enhancers from distal 
intergenic regions. For example, the salivary amylase promoter region contains 
several structures derived from retrotransposons (one of which is an ERV) that 
exert transcriptional control resulting in tissue specific expression of this gene 
(Ting, Rosenberg et al. 1992). An example of long range function is provided by 
ERV-9 which regulates fetal γ and adult β globin genes from 40-70kB upstream. 
The ERV-9 LTR binds NF-Y and GATA2 and generates an LTR/RNA polymerase II 
complex modulating downstream globin promoters (Pi, Zhu et al. 2010). In 
addition, ERVs have been reported to regulate particular host splicing events, 
for example an ERV derived from a human teratocarcinoma cell line promotes 
human PLA2L gene expression in these cells (Feuchter-Murthy, Freeman et al. 
1993). ERVs also have a prominent role in placental morphogensis (see 1.4.5 
Placental formation) and host immunity (see 1.5 Host vs. Virus) which will be 
discussed in detail later. 
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1.4.5  Placental formation 
 
Despite the significant physiological differences in the reproductive biology of 
mammals, the placentas of various animal species have been found to express 
ERVs and in some cases viral particles. Electron microscopy (EM) studies as early 
as the 1970s indicated the presence of viral-like particles within the 
reproductive tract of humans and animals (Kalter, Helmke et al. 1973; Kalter, 
Heberling et al. 1975). Further EM studies of suspected retroviral particles from 
placental tissue confirmed associated RT-activity with a density and size relative 
to that of C-type retroviruses (Lyden, Johnson et al. 1994). The placenta and the 
syncytiotrophoblast in particular, is the central point of exchange of nutrients 
between mother and child. Extensive HERV expression is detected within the 
human placenta (de Parseval and Heidmann 2005). In particular, expression of 
HERV-W Env protein Syncytin-1 is credited as the driving force behind the fusion 
event that leads to the formation of the syncytiotrophoblast during placental 
formation (Frendo, Vidaud et al. 2000; Frendo, Olivier et al. 2003). Indeed, 
knockout of a similar protein in mice (Syncytin-A) is embryo lethal. 
Histopathology examination of embryos revealed a lack of trophoblast fusion to 
the maternal uterine epithelium (Dupressoir, Vernochet et al. 2009). In humans, 
abnormal expression of Syncytin has been linked to preeclampsia (Lee, Keith et 
al. 2001) highlighting the important role of ERVs during pregnancy. ERVs can also 
exhibit immunosuppressive properties and interfere with the replication cycle of 
exogenous related retroviruses, as will be discussed later (see 1.5 Host vs Virus). 
In summary, there is significant evidence which indicates that the continuous 
challenges posed by ERVs have shaped the evolution and development of several 
mammals in many different ways. Several ERV LTRs appear to exert control over 
host genes while viral proteins have been found to be involved in essential 
physiological processes.  
 
1.4.6  Endogenous JSRVs 
 
JSRV-related viruses also exist as inherent “endogenous” (enJSRV) viruses stably 
integrated and established within the host genome. When compared to their 
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exogenous counterpart, enJSRVs share 85-89% identity with JSRV along the 
entire genome (Arnaud, Varela et al. 2008). Major differences are found across 
the U3 region of the LTRs as well within three variable regions, two of which 
reside in gag (VR1/2) and in the other within env (Bai, Bishop et al. 1999; 
Palmarini, Hallwirth et al. 2000).  
There are at least 27 enJSRV loci in the sheep genome which have been 
identified, isolated and cloned from a bacterial artificial chromosome library 
which originates from a single Texel ram (Figure 8) (Arnaud, Caporale et al. 
2007). The 27 enJSRVs appear to be distributed across the sheep chromosomes 
(Carlson, Lyon et al. 2003; Armezzani, Arnaud et al. 2011) and first entered the 
genome approximately 5-7 million years ago. The invasion of the host genome by 
enJSRVs has continued throughout the evolution of the Caprinae (Fig. 7) as the 
youngest provirus is predicted to have entered the host genome less than 200 
years ago. Thus, enJSRV colonization of the ovine genome remains an ongoing 
process. The 27 enJSRVs identified to date were likely acquired during evolution 
from multiple infection events of the germline by JSRV-related exogenous 
viruses or by reinfection of an existing active enJSRV locus. Most of the oldest 
enJSRV proviruses have acquired mutations and deletions that render them 
replication deficient. However, several enJSRVs loci possess an intact genome 
and are indeed able to express intact viral particles (Arnaud, Caporale et al. 
2007).  
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                         Figure 7 – Distribution of the 27 enJSRVs within the Caprinae. 
The insertionally polymorphic nature of the more recent integration indicated in white within the 
Ovis aries. Reproduced with permission from PLoS Pathogens (Arnaud, Murcia et al. 2007). 
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Figure 8- The 27 enJSRV loci isolated from the sheep genome. 
Many of the enJSRVs have accumulated mutations and deletions across their genome which 
render them replication incompetent. Several more recent integrations have retained open reading 
frames and are capable of viral particle production. Reproduced with permission from PLoS 
Pathogens .(Arnaud, Murcia et al. 2007).  
 
 
 
 
1.4.7  Evolutionary history of enJSRVs  
 
The “age” of a provirus can initially be estimated by determining its presence in 
phylogenetically related species. If a provirus is present in exactly the same 
chromosomal location in two phylogenetically related animal species then it is 
safe to assume that the original infection occurred before the divergence during 
the evolution of the two animal species in question (Boeke and Stoye 1997). As 
mentioned above, the oldest of the enJSRV proviruses, such as enJSRV-10, 
integrated before the divergence of the Ovis and Capra genera (Arnaud, 
Caporale et al. 2007). Another way to determine the age of a proviral sequence 
is by correlating the divergence between the 5’ and 3’LTRs, with the mutation 
rate of non-coding sequences in mammals. Retroviral LTRs are identical upon 
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integration of the proviral sequence. Therefore, the greater the level of 
divergence between LTRs the older the provirus will likely be. Although these 
calculations are subject to a wide margin of error due to homologous and 
heterologous recombination of the LTRs of different proviruses, they are 
nevertheless a useful indication of the age of any given provirus (Arnaud, 
Caporale et al. 2007). 
The sheep genome contains several enJSRVs that are fixed within the domestic 
sheep population (i.e. every sheep contains these proviruses and their fixation 
within the genome occurred prior to the domestication of sheep) and others 
(enJSRV7, 8, 15, 16, 18, 26 and enJS5F16) that are insertionally polymorphic. In 
other words these proviruses are younger and present only in a proportion of the 
domestic sheep population. Five of the insertionally polymorphic enJSRV 
proviruses have, as expected, identical 5’ and 3’ LTRs sequences (Arnaud, 
Caporale et al. 2007).  
Older enJSRV loci such as enJS59A1, enJSRV25 and enJSRV17 contain large 
deletions within the env gene. Both enJSRV6 and enJSRV2 have evidence of 
recombination events with other proviruses and contain internal sequence in the 
opposite direction to the general 5’ to 3’ sequence (Arnaud, Caporale et al. 
2007). It is thought that enJSRV2 derives from a recombination event as the 
flanking genomic regions lack the 6bp duplication at the site of chromosomal 
entry common to all proviral insertions (Arnaud, Caporale et al. 2007). Many 
enJSRV proviruses also have premature termination codons that “litter” their 
genome (e.g. enJSRV10 contains a premature stop codon in pro, pol, env and 
orf-X). Five of the recent enJSRVs maintain an intact genomic organization. Two 
loci, enJSRV-16 and 18 are identical across their entire genome and are 
therefore only distinguishable by the location of their integration. The most 
recently integrated provirus, enJSRV-26, is believed to be a virus that has 
integrated in a single animal. All of the information derived from the genomic 
organization of enJSRVs is summarized (Arnaud, Murcia et al. 2007). The 
genomes of all 27 enJSRVs identified to date are summarised in Figure 8. All of 
the insertionally polymorphic enJSRV loci with an intact genomic organization 
are able to produce virus particles in vitro and in vivo (Black, Arnaud et al. 
2010). 
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1.4.8  enJSRVs play a critical role in the reproductive biology of 
the host 
 
Endogenous retroviruses are by definition non-pathogenic, otherwise they would 
be counter-selected during evolution. The exogenous JSRV is an oncogenic virus 
whose Env is a dominant oncoprotein. However, as expected, none of the 
enJSRV Env glycoproteins are oncogenic and they all lack the SH2 binding domain 
within the cytoplasmic tail that has been found to be a major determinant of 
oncogenicity (Palmarini, Gray et al. 2001). In addition, the enJSRVs LTR lack 
those enhancer binding regions that are essential to drive lung-specific 
expression of JSRV. Expression of enJSRVs is widespread throughout the 
reproductive tract and has been detected within the oviduct, uterus, cervix and 
vagina (Palmarini, Gray et al. 2001). Thus, it appears that the high degree of 
divergence between the LTRs of the enJSRVs and JSRV contribute to their 
different patterns of expression. Early studies of enJS56A1, enJS59A1 and 
enJS5F16 LTRs show that the HNF-3 and C/EBP binding sites (found important for 
JSRV lung-specific expression) are interrupted by an insertion of 13 and 15 
nucleotides respectively (Palmarini, Datta et al. 2000; McGee-Estrada and Fan 
2007). A comparison of the enJSRV LTRs with that of MMTV has also confirmed 
the presence of hormone responsive elements (HRE) (Lieberman, Bona et al. 
1993) within enJSRV LTRs. The enJSRVs HRE can be linked to their identified 
expression in vivo during pregnancy. In addition, another conserved transcription 
binding domain among the LTR of enJSRVs is Activator Protein 2 (AP2) which has 
been identified to regulate bovine binucleate trophoblast-specific genes during 
the placental development in pregnancy (Ushizawa, Takahashi et al. 2007). 
In vivo, enJSRV expression has been found to peak in correspondence to high 
levels of progesterone and progesterone receptor. In vitro, the LTR of various 
enJSRV loci have shown enhanced expression of the corresponding enJSRV 
following progesterone treatment (Palmarini, Hallwirth et al. 2000; Dunlap, 
Palmarini et al. 2006; Spencer, Sandra et al. 2008). enJSRVs are particularly 
abundant within the luminial epithelium and glandular epithelium cells of the 
ovine genital tract from day 12 -18, coinciding with an upregulation of 
progesterone. Expression of enJSRVs also coincides with that of Interferon-tau 
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(IFNtau), the pregnancy recognition signal in ruminants (Bazer, Burghardt et al. 
2008). IFN-tau expression is crucial in order to prevent luteolysis from occurring 
and allows establishment of the developing conceptus (Spencer, Burghardt et al. 
2004). The involvement of HERV-W Env protein Syncytin-1 expression in the 
fusion event that leads to the formation of the syncytiotrophoblast during 
placental formation has already been shown (Frendo, Vidaud et al. 2000; 
Frendo, Olivier et al. 2003). Although human and ruminant pregnancy differs 
significantly in anatomy (Barry and Anthony 2008) it appears that they share the 
presence of ERVs during placental morphogensis. Inhibition of enJSRV env 
transcription and translation from day 12 of pregnancy results in the incorrect 
expansion of the conceptus during pre-implantation development from a solid 
form to that of a filamentous. This results in no attachment to the uterine wall, 
(the correct process is summarised in Figure 9) demonstrating the essential role 
of enJSRVs in this process (Dunlap, Palmarini et al. 2006). In preparation for the 
implantation of the conceptus, mononuclear/binuclear cell fusion occurs leading 
to trinucleate cells which fuse in order to produce placentomes in support of 
conceptus development (see Figure 10 for summary). This occurs in the presence 
of enJSRV and HYAL2 expression and it is speculated that they play an important 
part in this process (Dunlap, Palmarini et al. 2005). How enJSRVs elicit their 
action is not yet fully understood, although fusion mediated solely by the 
enJSRVs Env and HYAL-2 receptor seems unlikely, as to date enJSRV Env has not 
been found capable of inducing syncytia in vitro.  
Together, JSRV-enJSRVs and the domestic sheep provide a rare opportunity to 
study the on-going co-evolution of retroviruses and their host. This is a rare 
opportunity and the only other species for which there is evidence of ongoing 
endogenisation is the koalas (Tarlinton, Meers et al. 2006).  
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Figure 9. Schematic diagram illustrating the pattern of enJSRVs expression during early 
pregnancy. 
The developing conceptus emits IFNtau as a signal for the endometrium to prepare for the 
implantation event. enJSRVs are found expressed in the luminal and glandular epithelium of the 
endometrium as indicated in red as well as in the conceptus. A crucial part of development is the 
elongation of the conceptus into a filamentous form for successful implantation mediated by 
enJSRVs. 
 
 
Figure 10. Schematic diagram illustrating the major phases of placental morphogenesis. 
Fusion of mononucelate and binucleate trophoblast cells of the conceptus leads to trinucleate 
hybrid cells which invade the endometrium. This is a prerequisite for placentome formation 
necessary to support conceptus development and occurs during the expression of enJSRV and its 
receptor HYAL2.  
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1.5  Host vs. Virus 
 
Host cells possess a complex array of antiviral mechanisms with which to 
respond to viral detection to fight virus infections. In addition to the constitutive 
expression of “intrinsic” antiviral factors, the recognition of a virus infection 
triggers intracellular signalling pathways that result in the induction of the 
“innate” immune response and subsequently an “adaptive” immune response. 
The continuous challenge to the host provided by pathogens results in a strong 
selective pressure to develop sophisticated barriers to infection which, in turn, 
has major evolutionary implications for viral populations. Thus, a key requisite 
for any successful virus is the ability to evade recognition by the host innate 
immune system (Bieniasz 2004). 
 
1.5.1  Intrinsic immunity 
 
Intrinsic viral restriction factors are constitutively expressed proteins which 
interfere with the viral lifecycle. ‘Viral interference’ is a form of intrinsic 
immunity mediated by intact or defective endogenous retroviruses. Viral 
interference has not been reported in humans but there is evidence of this 
process in both mice and sheep. In mice, Fv1 and Fv4 are two host genes which 
control susceptibility to the Friend strain of Murine Leukemia Virus (F-MLV). Fv1 
is derived from a resident endogenized retroviral Gag (Best, Le Tissier et al. 
1996). Fv1 has two alleles, Fv1n and Fv1b present in mice, which exert their 
action over specific subtypes of MLV (Hartley, Rowe et al. 1970) and block MLV 
infection at a stage after reverse transcription but before integration takes 
place by a mechanism that has not been entirely clarified (Bieniasz 2004). Fv4 
instead is closely related to the Env of MuLV and restricts viral infection by 
blocking access to and downregulating the F-MLV receptor from the cell surface, 
as reviewed by (Bieniasz 2004).  
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The enJSRVs of sheep also provide a ‘viral interference’ restriction mechanism 
by engaging the HYAL-2 receptor (Spencer, Mura et al. 2003). Furthermore, two 
of the 27 enJSRVs identified to date, enJSRV-20 and en56A1, provide an 
additional form of intrinsic viral restriction mediated by their Gag protein. 
Unique to both enJSRV-20 and en56A1 is a tryptophan in position 21 of Gag 
which results in a transdominant phenotype defective for exit (Mura, Murcia et 
al. 2004). The exogenous JSRV has an arginine in position 21 of Gag that is 
considered essential for directing the protein towards the centrosome for 
assembly. The presence of tryptophan at position 21 of Gag of the transdominant 
en56A1 results in a significantly different intracellular distribution to that of 
exogenous Gag. It is suspected that both of these transdominant enJSRVs 
entered the germline with a tryptophan at position 21 in two distinct events. 
They then became fixed within the species thereafter due to the positive host 
function they are associated with. In the presence of en56A1, exogenous JSRV 
Gag does not assemble at the centrosome region. Instead the JSRV Gag is found 
to colocalise with en56A1 Gag and, when the proteosomal machinery is 
inhibited, en56A1/JSRV Gag aggresomes are observed (Mura, Murcia et al. 2004). 
This restriction mechanism is independent of the Late domain and membrane 
binding domains of Gag and is called JSRV late restriction (JLR) in recognition of 
the effect it has over the late phase of the replication cycle (Arnaud, Murcia et 
al. 2007; Murcia, Arnaud et al. 2007). The most recent sheep ERV acquisition , 
enJSRV-26, , is capable of escaping the JLR and this is due to the substitution of 
a single amino acid in the signal peptide of its envelope protein (Armezzani, 
Arnaud et al. 2011). The JLR proves to be a mode of restriction unique to sheep 
which gives specific protection against the continuous challenge JSRV poses. The 
escape by enJSRV-26 is an excellent example of the continuous struggle between 
the host and virus for dominance. 
1.5.2  Innate Immunity  
 
Innate immunity is a mechanism with ancient origins established prior to the 
evolutionary division which formed the plant and animal kingdoms and, as such, 
it is represented in both. In its most concise definition, innate immunity is an 
immediate, uniform, potentially inducible response inherited from the germline 
which can efficiently discriminate between host DNA/RNA and virus/pathogen 
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DNA/RNA (Janeway 1989). Innate immunity is distinguishable from intrinsic viral 
restriction as it requires induction by Interferon (IFN) to elicit widespread 
expression and effects, unlike intrinsic factors which are constitutively 
expressed. Innate immunity is regulated predominately by plasmacytoid 
dendritic cells (pDC) which are a large source of IFN following viral infection 
(Barchet, Cella et al. 2002). The innate immune response bridges the gap 
between host detection of virus and the time taken for the adaptive immune 
system to respond (Tough 2004). IFN induces an antiviral state in nearby 
uninfected cells following viral detection, upregulating a range of restriction 
factors which target various aspects of the retroviral lifecycle. Many studies on 
innate immunity have been conducted in the fruit fly drosophila due to the 
absence of an adaptive immune response. Simple invertebrates, such as 
Drosophila melanogaster, rely on RNA interference (RNAi) as the major antiviral 
mechanism (Wang and Ligoxygakis 2006) 
In contrast to the adaptive immunity, the innate immune response is an 
inherited uniform response “embedded” within the germline. In many ways the 
IFN response is therefore a uniform response. However, the IFN induced genes 
are by no means a static population with both positive and negative selection 
acting upon IFN stimulated genes (ISGs) and with many examples of the recent 
acquisition of further ISGs. The addition of further downstream genes activated 
by the innate immune response provides further antiviral related activity (see 
1.5.8 IFN stimulated genes with antiretroviral activity). Innate immunity 
provides a first line of defence while the adaptive response generates the 
potential to evade new and emerging viruses faster than the selective process to 
establish an innate response within the germline.  
1.5.3  Interferon (IFN)  
 
Interferons (IFNs) are a family of secreted cytokines that induce an antiviral 
cellular state following viral infection as part of the innate immune response 
(Shirazi and Pitha 1993). IFNs can be distinguished into three classes: type I, II 
and III IFNs. The type I IFNs found within placental mammals include IFN-α, IFN-
β, IFN-ω, IFN−δ,  IFN −ε, IFN− τ , IFN−κ, IFN− ζ subtypes. The exact biological effect 
and signalling pathways utilised by IFNs varies and is dependent on their 
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expression pattern, local host environment and subtype cellular targets. IFN-α 
and IFN-β can be induced in most cell types as a direct response to viral 
infection. However, IFN−δ is unique to pigs and IFN- ζ  is unique to mice whilst 
IFN -τ is specific to ruminants. Within humans, IFN-α has expanded considerably 
during evolution leading to a family consisting of thirteen genes whilst IFN-β , 
IFN-ω,  IFN -ε,  IFN -κ subtypes maintain only one gene  {Pestka 2004 #558}.  
Amplification of the IFN-α gene suggests this gene is of pivotal importance 
during initiation of innate immunity. Type II IFNs typically display less antiviral 
activity than that of IFN type 1. 
Although the majority of cell types are capable of IFN production following 
antiviral detection, pDC cells are a specific subset of DCs (Fitzgerald-Bocarsly 
1993) which have a prominent role in IFN production. They produce large 
quantities of type I IFN which in turn regulates the induction of both innate and 
adaptive immunity. In addition to IFN, pDCs also produce other cytokines with 
antiviral function. IFN plus IL-12 induces the secretion of IFN-γ from natural 
killer (NK) cells, CD8+ T cells and CD4+ T helper cells (Avice, Demeure et al. 
1998; Berg, Cordes et al. 2002; Kamath, Sheasby et al. 2005), whereas memory B 
cells are stimulated to produce antibodies in the presence of IFN and IL-6 (Jego, 
Palucka et al. 2003). Furthermore, IFN leads to the stimulation of T cells as IFN 
promotes the development of pDCs to DCs (Grouard, Rissoan et al. 1997). In 
short pDCs have three major functions: the production of IFN, antigen 
presentation and T cell priming, as summarised by (Barchet, Blasius et al. 2005). 
 
1.5.4  Intracellular recognition of retroviruses via TLR and RIG-I  
 
Recognition of viral entry occurs via viral “pathogen associated molecular 
patterns” (PAMPs) detected by cellular host ‘pattern recognition receptors’ 
(PRRs). There are several groups of PRRs which are capable of recognizing 
different forms of viral DNA/RNA including Toll like receptors (TLRs), retinoic-
acid inducible gene (RIG-I) like receptors (RLR), nucleotide binding domain, 
leucine-rich repeat containing proteins (NLR) and cytoplasmic sensors 
(Yoneyama and Fujita 2010). Of particular significance to retroviruses is the 
recognition of RNA by TLRs and RLRs. Certain cells will preferentially utilise one 
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pathway over the other for activation of an antiviral response following viral 
detection. RIG-I is utilised by a wide range of host cells while pDCs preferentially 
use TLR signalling as reviewed by (Kato, Sato et al. 2005). 
 
1.5.5 Toll like receptors  
TLRs are found both at the plasma membrane and within intracellular 
endosomes. Those members of the TLR family which are most significantly 
involved in the detection of invading retroviruses are those found within 
endosomes (TLRs 3, 4, 7, 8 and 9) with TLR3 and 4 specific to DCs and TLR7, 8 
and 9 for pDCs. Double stranded RNA (dsRNA) is a hallmark of viral infection and 
is recognised by TLR3, which is linked as a factor for DC maturation (Matsumoto 
and Seya 2008). In contrast, TLR7/8 are crucial for the recognition of ssRNA and 
TLR7/9 are found to be specific to pDCs. TLRs stimulate cytokine and IFN 
production via the adaptor molecules TRIF for TLR3 and Myd88 for TLR7/8/9, 
which act upon the transcription factors IRF3/7 and NF-κB. It is specifically the 
expression of IRF-7 in pDCs which is linked with the rapid secretion of IFN-α/β, 
as reviewed by (Beutler, Eidenschenk et al. 2007) and summarised in Figure 11. 
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Figure 11. Schematic diagram illustrating intracellular recognition of retroviruses by TLRs. 
Reproduced with permission from Nature. 
 
 
 
 
1.5.6  Retinoic-acid inducible gene I (RIG-I) like receptors 
 
 
Unlike the endosome based TLRs, RIG-I like receptors (RLR) which include 
Retinoic-acid-inducible-protein 1 (RIG1) and Melanoma-differentiation-
associated gene 5 (MDA5) are cytosol based proteins. Similarly to TLRs, they are 
also involved in the recognition of RNA viruses leading to the upregulation of 
cytokines and induction of IFN. It has been proposed that RIG-I recognizes 
intracellular viral non-capped ds/ssRNA, that is distinguishable from host capped 
mRNA. In addition, the identification of uridine and adenosine rich regions 
within viral sequences, as well as RNAseL products, upregulates the RLR 
response. RIG-I binds short viral RNAs, whilst MDA5 binds those longer than 1Kb. 
Both RIG-I and MDA5 remain within the cytoplasm in an inactive state until RNA 
binding triggers a conformational change and exposure of the Caspase activation 
and recruitment domain (CARD) for downstream signalling. The initiation of the 
RLR response is best understood to date for RIG-1 while the activation of MDA5 
has yet to be fully characterised. The CARD and repressor domain (RD) of RIG-I 
are held in an inactive state until the recognition of viral infection. The RD 
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domain of RIG-I recognises and engages with PAMPs. This leads to K63 linked 
ubiquitination of RIG-I by TRIM-25 and RING finger protein which switches RIG-I 
to an active state by an alteration in conformation. The new conformation 
induces a signalling cascade involving oligomerisation of RIG-I and a CARD 
dependent interaction with IPS-1, resulting in IFN upregulation as summarized by 
(Loo and Gale 2011) in Figure 12. However, several studies with knockout mice 
have revealed that the requirement of RIG-I/MDA5 varies depending on the virus 
in question. Whether activation occurs by TLRs or by RLRs both pathways act on 
transcription factors NF-κB, IRF-3 and IRF-7 which in turn induces the expression 
of IFN-α/β, as reviewed by (Beutler, Eidenschenk et al. 2007).  
 
 
 
Figure 12. Schematic diagram illustrating the induction of IFN by RLR signalling via RIG-I. 
Reproduced with permission from Cell Press. 
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1.5.7  Propagation of the IFN response 
 
Upon upregulation, IFN-α/β is secreted and induces dimerization of the IFN-α/β 
receptor (IFNAR-1 and -2) of neighbouring cells. Ligand-induced dimerization 
initiates a signalling cascade via the JAK/STAT pathway activating ISGF-3 
(Interferon stimulated gene factor, a heterodimer of STAT1/2). ISGF-3 binds to 
the IFN-stimulated response element (ISRE), present in the promoters of most 
IFN stimulated genes (ISGs). IFN elicits a very broad regulation of gene response 
to viral infection.  There are hundreds of genes that are upregulated in response 
to IFN treatment that, in combination, determine the antiviral state. The 
INTERFEROME database (Samarajiwa, Forster et al. 2009) collects all the IFN 
regulated genes. There are 1996 human genes thought to be influenced by IFN 
(1581 upregulated, while 415 appear to be downregulated). These gene products 
are further divided as roughly 676 being nuclear, 626 cytoplasmic, 379 are 
membrane based, 151 mitochondrial, 64 are Golgi based, 34 ribosomal and 
finally 35 are lysosomal (Hertzog, Mansell et al. 2011). 
 
1.5.8  IFN-stimulated genes with antiretroviral activity 
 
Intrinsic and innate immunity have a significant impact on retroviral evolution. 
There are several examples of retroviruses which have refined their genome in 
order to overcome the action of restriction factors that threaten their existence. 
Similarly, there is evidence of the expansion of innate immune restriction 
factors in response to the pressure exerted on the host by the consistent 
challenge that retroviruses present. There are several IFN induced restriction 
factors which have a significant role in the antiviral response elicited by the host 
following the discovery of infection, including APOBEC, TRIM and BST-2 (Neil and 
Bieniasz 2009). 
 
1.5.8.1 APOBECs  
Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like proteins 
(APOBECs) are a group of RNA/DNA editing enzymes. Two proteins belonging to 
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this family have a significant role in the antiviral innate immune response, 
APOBEC3F(1-3) and 3G, are induced or maximised by IFNα signalling in T cells, 
macrophages and DCs, (Chen, Huang et al. 2006; Peng, Lei et al. 2006; Wang, 
Huang et al. 2008). APOBEC3F and 3G are cytosine deaminases that target the 
early stages of viral replication and are incorporated into viral particles exiting 
the cell (Figure 13). Upon infection of new cells APOBEC exerts its antiviral 
effect during reverse transcription by editing cytosine residues to uracil. This has 
a significant impact on reverse transcription, creating a disproportionate amount 
of uracil in minus strand DNA. This in turn creates G to A ‘hypermutations’ 
during second strand synthesis with a negative impact, eventually inducing a 
‘crash’ in the viral population as reviewed by (Harris and Liddament 2004). 
There is evidence of the restriction of ancient gammaretroviruses by APOBEC3G 
as significant G to A hypermutation of the endogenous retroviruses of 
chimpanzee ERV-1 and 2 has been observed. These data led to the speculation 
that APOBEC had an impact on the evolution of these viruses and limited their 
host range (Perez-Caballero, Soll et al. 2008). Multiple copies of APOBEC 
proteins are found within primate genomes, indicating the presence of antiviral 
genes under positive selection. 
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Figure 13.  Overview of the antiviral properties of APOBECs. 
Reproduced with permission from Nature. 
 
 
 
 
1.5.8.2 TRIMs  
Tripartite motif proteins (TRIMs) are a family of IFN-induced proteins with a 
potent antiretroviral activity (Figure 14). Of all the TRIM proteins the most 
notable is TRIM5α,  which acts soon after viral entry but before reverse 
transcription (Asaoka, Ikeda et al. 2005). TRIM5α is composed of four distinct 
domains necessary for its function: an N-terminal RING domain involved with 
protein-protein interactions, two central B box domains with unspecified 
function and a C terminal coiled-coil domain associated with protein 
oligomerization. This restriction factor interacts with the Capsid protein of viral 
particles following entry (Sebastian and Luban 2005), although the exact 
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mechanism by which TRIM5α ‘disarms’ the entering virus is not completely clear. 
Whilst premature Capsid disassembly of entering viral particles, inhibition of RT 
and inhibition of proteosome activity have all been associated with TRIM5α 
activity, none of them alone appear to be essential for the antiviral function, 
reviewed by (Neil and Bieniasz 2009).  
The effect exerted by TRIM19 is an example of a nuclear antiviral mechanism. It 
has several isoforms which differ in their C-terminal regions and it is based 
within the nuclear bodies. The presence of different TRIM19 isoforms is linked to 
the range of functions that has been associated with this protein, including 
transcription, translation and signalling for cellular functions, reviewed by 
(Nisole, Stoye et al. 2005). 
A rapid expansion of TRIM proteins among vertebrates has been observed to the 
extent that TRIM is believed to have originated primarily as an antiviral 
mechanism rather than by subfunctionalization of a normal host physiological 
function. TRIM5α in primates has been under positive selection likely driven by 
episodes of retroviral infection within the species (Si, Vandegraaff et al. 2006). 
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Figure 14. An outline of the antiviral mechanisms induced by TRIM proteins. 
Reproduced with permission from Nature Reviews. 
 
 
 
 
1.5.9 Viral evasion of the host immune response 
 
Retroviruses have evolved a set of viral proteins and tuned their replication 
cycle with unique characteristics that best equip them to counteract the host 
intrinsic, innate and adaptive immune response. Common to most retroviruses 
(especially lentiviruses) for example, is the intrinsic ability to rapidly evolve Env 
in order to evade the host humoral immune responses and HIV-1 shows high 
variability within VR1 and VR2 as a result of host immune selection (Rambaut, 
Posada et al. 2004; Curlin, Zioni et al. 2010). Retroviral populations have a high 
turnover that is coupled with the genomic variability introduced by the reverse 
transcriptase (approximately 1 every 10,000 bases). This, combined with the 
possibility of recombination events, results in poor immune recognition by the 
host.  
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Cell-to-cell transmission can also allow retroviruses to evade the host immune 
response. For example, cell-to-cell transmission increases viral transfer 
efficiency from infected to uninfected cells in the presence of host restriction 
factors (Jolly, Booth et al. 2010{Jolly, 2011 #706; Jolly 2011) and allows the 
virus to “escape” from neutralising antibodies. 
Retroviruses may also target the immune cells that are responsible for driving 
the host response. For example, a significant clinical feature of HIV-1 infection 
during disease progression is the loss of both CD8 + and CD4+ T cells, both of 
which form part of the adaptive immune response of the host. In addition, it is 
suspected that for simple retroviruses ERVs also offer a degree of immune 
evasion through tolerance offered by the mandatory expression of enJSRVs 
during physiological processes which is tolerated by the host. 
It is possible that viral proteins may evade host restriction mechanisms by 
directly antagonising host restriction factors. Retroviruses with a complex 
genome have evolved a variety of mechanisms in order to evade immune 
recognition. HIV is probably one of the best understood examples of a retrovirus 
that has evolved a variety of countermeasures that allows the evasion of 
recognition and elimination by the host immune system.  
The HIV accessory genes (nef, vif, vpu and vpr) have been acquired in order to 
evade the host restriction mechanisms. In particular, the HIV accessory protein 
Vif counteracts the antiviral action of APOBEC-3F and -3G by linking them with 
the ubiquitin dependent proteosomal degradation pathway (Conticello, Harris et 
al. 2003; Sheehy, Gaddis et al. 2003). Distinct domains of both APOBEC-3F and -
3G interact with separate regions of HIV Vif (Russell, Smith et al. 2009). SIV Vif 
mutants have demonstrated the impact of this protein in viral pathogenesis and 
its importance in evading G to A hypermutation induced by APOBEC (Schmidt, 
Fritz et al. 2011). In theory, the activity of APOBEC is damaging to viral 
replication, although it can also be considered an important factor in shaping 
viral adaptation and evolution following transmission (Wood, Bhattacharya et al. 
2009). 
Retroviruses can also modify global cellular transcription levels, not only for 
viral particle production but also for inhibiting signalling pathways that are 
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involved in the induction of the innate immune response (Taylor, Ghorbel et al. 
2009). Certainly the response of IFN following infection appears to be delayed by 
HIV (Abel, Rocke et al. 2005).  
 
1.6  BST-2 /Tetherin 
 
Bone marrow stromal cell antigen 2 (BST-2) is a type II transmembrane protein 
with unique properties and potent antiviral activity. During viral replication, 
BST-2 blocks viral particle release from cells by ‘tethering’ virions to the plasma 
membrane as they bud from it (Neil, Zang et al. 2008; Van Damme, Goff et al. 
2008). To date, one copy of the Bst-2 gene has been found in most vertebrates 
(splice variants have been identified in human and canines) with the exception 
of ruminants (see below). BST-2 has been termed over the past decade in several 
ways including CD317, HM124 and, more recently, tetherin. In light of its 
discovery in bone marrow stromal cells, the original term Bst-2 will be used 
throughout this thesis (Goto, Kennel et al. 1994). 
 
1.6.1 Identification of BST-2 
 
BST-2 was originally identified as a surface protein preferentially expressed 
during B cell development in humans (Goto, Kennel et al. 1994; Ishikawa, Kaisho 
et al. 1995). Overexpression of BST-2 on the surface of terminally differentiated 
B cells was a consistent feature of multiple myeloma. For this reason, BST-2 was 
considered as a potential target for antibody-based therapy and considerable 
efforts were spent by several groups towards this goal (Ozaki, Kosaka et al. 
1997; Ozaki, Kosaka et al. 1998; Ohtomo, Sugamata et al. 1999; Ono, Ohtomo et 
al. 1999). These early studies were conducted before it was understood that 
BST-2 is an IFN-inducible gene that possess antiviral activity. However, at that 
time there were clues which indicated that BST-2 was involved in more than B 
cell development. The BST-2 promoter contains tandem repeats that can bind 
STAT3, known also to regulate the expression of IL-6, a differentiation factor of 
B cells. The binding region for STAT3 is highly conserved in the promoter regions 
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of human, rhesus and murine BST-2 orthologs. IRF-1/2, ISGF3 and five potential 
AP2 binding sites are additional transcription factor binding regions identified for 
BST-2 (Ohtomo, Sugamata et al. 1999).  
 
1.6.2  BST-2 is an IFN induced restriction factor 
 
The identification of a link between IFN and BST-2 established the possibility 
that BST-2 acted as a viral restriction factor (Blasius, Giurisato et al. 2006). 
Interestingly, the idea of a cellular restriction factor blocking HIV-1 exit was 
proposed following the observation that the HIV accessory protein Vpu was 
necessary for viral particle release in some cell lines, but dispensable in others 
(Neil, Eastman et al. 2006). Viral exit of HIV-1∆Vpu mutants was blocked in    
IFN-α  induced T cells and macrophages to the plasma membrane (Smith, 
Thresher et al. 1991). Later, it was shown that BST-2 was an IFN induced 
restriction factor, capable of ‘tethering’ particles of HIV-1∆Vpu mutants to the 
plasma membrane (Neil, Zang et al. 2008; Van Damme, Goff et al. 2008). The 
restriction model proposed was that BST-2 restricted HIV-1 by forming a link 
between the plasma membrane and the virion envelope thus preventing viral 
exit. The release of restricted viral particles was obtained by proteolytic 
treatment of cell membranes, strongly suggesting that a protein tether was 
active in the restriction process (Ohtomo, Sugamata et al. 1999). There is some 
evidence suggesting that BST-2 is incorporated into virions (Fitzpatrick, Skasko 
et al. 2010), although data with opposing conclusions are also present in the 
literature (Miyagi, Andrew et al. 2009).  
 
1.6.3  BST-2 has a broad restriction activity 
 
Human BST-2 has been found to block not only HIV but also several other 
retroviruses belonging to different genera including alpharetrovirus, 
Betaretrovirus, deltaretrovirus and spumaviruses (Jouvenet, Neil et al. 2009). In 
addition, BST-2 has been shown to restrict several other enveloped viruses 
including Arenaviruses (Sakuma, Sakurai et al. 2009; Radoshitzky, Dong et al. 
2010) and Herpesviruses (Mansouri, Viswanathan et al. 2009). There are 
conflicting data available for Filoviruses (Jouvenet, Neil et al. 2009) and 
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Paramyxoviruses, while BST-2 clearly does not block the exit of Poxviruses and 
Bunyaviruses (Radoshitzky, Dong et al. 2010).  
The proposed model of BST-2 restriction is summarised in Figure 15 and will be 
discussed in more detail in Chapter 4. 
 
 
Figure 15. Schematic diagram illustrating the 'tethering' viral restriction model induced by 
BST-2. 
BST-2 is highlighted in blue. Adapted from (Evans, Serra-Moreno et al. 2010). Viral particles can 
be retained individually or in aggregates, reducing dissemination of virions within the host. 
 
 
1.6.4  Conserved features of BST-2 
 
A comparison of human, rhesus, rat and murine BST-2 orthologs revealed four 
major conserved features (Kupzig, Korolchuk et al. 2003). BST-2 is composed of 
a short N terminal cytoplasmic region preceding a transmembrane region and an 
ectodomain, followed by C terminal GPI anchor. The ectodomain has several 
features including glycosylation sites and cysteine residues involved with 
dimerization and a coiled-coil motif.  
The hydrophobic transmembrane region and C terminal GPI anchor create two 
points of contact with the plasma membrane. The only other protein to share 
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this unique topology is the PrP (prion) protein. This unusual topology supports 
the hypothesis that BST-2 tethers fully formed infectious viral particles to the 
plasma membrane of host cells, ultimately by creating a bridge between the 
plasma membrane and virion. In other words, BST-2 can ‘crosslink’ both the 
plasma membrane and virion creating a stable bridge resulting in the retention 
of the tethered particles at the plasma membrane. 
Interestingly, Paul Bienasz and colleagues (Perez-Caballero, Zang et al. 2009) 
demonstrated that the configuration of BST-2 has more importance than the 
primary sequence for efficient restriction. An artificial ‘art tetherin’ with no 
sequence homology to BST-2 and yet still maintaining the configuration of BST-2 
is still capable of restricting the release of enveloped viral particles. This is 
significant evidence supporting the notion that it is the configuration of BST-2 
which leads to the efficient ‘tethering’ of viral particles on the cell surface. 
Whilst there are clear conserved features across BST-2 orthologs, there are 
contrasting views on the importance of these different regions on the antiviral 
restriction mechanism (Andrew and Strebel 2011). It has been suggested that the 
discrepancies which have arisen in the literature may be due to the different 
experimental settings used in different laboratories. For example, (Andrew, 
Miyagi et al. 2009) describe the necessity of glycosylation for the BST-2 
mechanism, whereas it was reported as dispensable for its action in the study of 
(Perez-Caballero, Zang et al. 2009). The key difference between these studies is 
the location of the tag used for detection within the protein (Andrew and 
Strebel 2011). The major structural features and the predicted topology of hBST-
2 are summarised in Fig 14. 
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Figure 16. The four major conserved regions and membrane topology of BST-2. 
 
 
 
 
1.6.5  N-terminal Cytoplasmic tail  
The N-terminal cytoplasmic tail of BST-2 is important for the internalisation 
from the plasma membrane surface via the clathrin mediated pathway. Two 
tyrosine residues are conserved in BST-2 orthologs that may contribute to an 
internalisation motif influencing the intracellular localisation (see below) 
(Kupzig, Korolchuk et al. 2003; Rollason, Korolchuk et al. 2007). 
 
1.6.6  Transmembrane region & C terminal GPI anchorage 
The model of BST-2 restriction predicts the formation of a bridge between the 
viral envelope and the plasma membrane (Neil, Zang et al. 2008). Based upon 
the distinctive topology of BST-2, it is logical to assume that the bridge is 
provided by the N terminal transmembrane region and the C terminal GPI 
anchorage. Indeed, mutagenesis experiments have found the transmembrane 
region to be essential for the structure and restriction (Hinz 2010). In addition, 
the mere presence of a GPI anchor is a strong indicator of a protein with a 
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plasma membrane association (Paulick and Bertozzi 2008). Introduction of a GPI 
anchor into a protein not of plasma membrane origin has been shown to result in 
its redistribution to the plasma membrane (Brown, Cowen et al. 2000). A BST-
2∆GPI mutant localises to the ER and it appears that the GPI anchor is an 
essential factor for the correct folding and export of the BST-2 protein to the 
plasma membrane (Kupzig, Korolchuk et al. 2003). However, upon cleavage and 
disruption of the GPI anchor by the enzyme PI-PLC, BST-2 still maintains its 
membrane association, confirming the presence of an additional transmembrane 
domain (Kupzig, Korolchuk et al. 2003). Cleavage of the GPI anchor of BST-2 
during viral ‘tethering’ does not release viral particles attached to the plasma 
membrane, presumably because of the terminal transmembrane domain and 
BST-2 dimers (Fitzpatrick, Skasko et al. 2010). Together, these data are highly 
supportive of the predicted mechanism of BST-2 restriction suggested by (Neil, 
Zang et al. 2008).  
 
1.6.7  Ectodomain- Glycosylation 
 
N-linked glycosylation is feature of BST-2 that appears to be conserved. 
Glycosylation results in three isoforms of BST-2, (ranging from approximately 25-
35kDa) commonly observed following transient transfection and western blot 
analysis with BST-2 expression plasmids. These were confirmed as di- and 
monoglycosylated forms following incubation with PNGase F, an enzyme which 
removes N-linked sugars from glycol proteins (Kupzig, Korolchuk et al. 2003). 
When human BST-2 was compared with isolates from rhesus, rat and mouse BST-
2, two similarly positioned N glycosylation sites could be found within the 
extracellular domain. Glycosylation has not been considered an important factor 
of function as studies with hBST-2 have demonstrated that altering the 
glycosylation status does not alter the distribution or impact upon the ability of 
BST-2 to restrict viral particle exit (Andrew, Miyagi et al. 2009; Sakuma, Sakurai 
et al. 2009). In contrast, others have reported that unglycosylated BST-2 is void 
of restrictive properties and suggests that this is likely as a result of trafficking 
defects (Perez-Caballero, Zang et al. 2009).  
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1.6.8  Ectodomain - Disulphide bond formation 
 
Human, rhesus, rat and murine orthologs of BST-2 all share three cysteine 
residues, which can mediate the potential dimer formation induced by 
disulphide bonds (Ohtomo, Sugamata et al. 1999; Kupzig, Korolchuk et al. 2003). 
Interestingly, BST-2 dimerization has been shown to be essential in the block of 
HIV release induced by human BST-2 (Andrew, Miyagi et al. 2009) and yet it is 
dispensable for the restriction of Lassa or Marburg viruses (Sakuma, Sakurai et 
al. 2009).  
1.6.9  Ectodomain - Coiled-coil motif 
 
A comparison of murine and human BST-2 appears to suggest that the coiled-coil 
motif of the ectodomain is an evolutionary conserved feature (Swiecki, Scheaffer 
et al. 2011). This motif is essential for virion retention and it provides the 
flexibility required for the two point contact model envisaged for BST-2 
restriction (Hinz, Miguet et al. 2010; Yang, Lopez et al. 2010). The ectodomain 
region of tetherin forms a single α-helix which assists in the formation of parallel 
BST-2 homodimers (Yang, Lopez et al. 2010), as previously described (Ohtomo, 
Sugamata et al. 1999). The observation of BST-2 tetramers has been excluded 
from having any functional role in viral restriction and it is most probably the 
result of non-specific interactions. While there is the suggestion that tetramers 
may confer stability to BST-2, it appears clear that dimerization alone is 
sufficient for viral particle retention (Schubert, Zhai et al. 2010).  
1.6.10 Bst-2 intracellular localisation and expression 
BST-2 is found to be expressed to varying degrees within a range of tissues in the 
absence of other IFN induced proteins (Erikson, Adam et al. 2011). BST-2 is 
constitutively expressed on the plasma membrane of cells which are targeted by 
retroviruses e.g. T cells. BST-2 can be induced on the surface of many other 
cells in response to IFN (Blasius, Giurisato et al. 2006). BST-2 is found 
concentrated within lipid rafts of the plasma membrane (Kupzig 2003). Indeed, 
plasma membrane based localisation of BST-2 is crucial for the ‘tethering’ 
antiviral effect to take place. BST-2 is then internalised from the plasma 
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membrane via clathrin mediated endocytosis (Rollason, Korolchuk et al. 2007; 
Masuyama, Kuronita et al. 2009) before being passed to the Golgi where an 
independent pool of BST-2 has been identified (Kupzig, Korolchuk et al. 2003). 
The localisation of BST-2 is summarized in Figure 17 and will be discussed in 
more detail in Chapter 3. 
 
 
 
Figure 17. Illustration detailing the processing and localisation of BST-2. 
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1.6.11 Viral evasion of BST-2 restriction  
 
The search for a restriction factor blocking HIV exit was stimulated by the 
observation that the accessory protein Vpu was required for successful viral exit 
in certain cell lines (Van Damme, Goff et al. 2008). In addition to 
downregulating CD4 from the cell surface, Vpu actively engages BST-2 and 
downregulates it from the plasma membrane (Iwabu, Fujita et al. 2009; Iwabu, 
Fujita et al. 2010; Ruiz, Guatelli et al. 2010). Vpu directs CD4 to the E3 ubiquitin 
ligase complex driven by a signal within the cytoplasmic domain (Andrew and 
Strebel 2010; Goffinet, Homann et al. 2010). Depletion of BST-2 by Vpu has been 
suggested to occur via proteosome degradation, (Goffinet, Allespach et al. 2009) 
also as a result of a combination of late endosomal targeting and degradation by 
lysosomes (Mitchell, Katsura et al. 2009). Many studies have considered the 
interaction of BST-2 and Vpu in vitro with contrasting results. Vpu affects BST-2 
expression in HeLa cells and macrophages while BST-2 levels in H9 and CEMx174 
cells are unaffected (Andrew, Miyagi et al. 2009). The specificity of Vpu for BST-
2 is linked to three amino acid residues in the transmembrane domain of BST-2 
(Kobayashi, Ode et al. 2011; Lv, Wang et al. 2011). There is evidence that Vpu 
promotes release of HIV without affecting the turnover of BST-2. However, Vpu 
appears to slow down its transport to the plasma membrane and redistributes 
BST-2 to the intracellular pool located within the trans-Golgi network (TGN) 
compartment by the recycling pathway common to BST-2 (Dube, Roy et al. 2010; 
Schmidt, Fritz et al. 2011). The antagonism Vpu provides is specific to human 
BST-2 and it does not antagonise simian BST-2 orthologs. Indeed Vpu is not 
present in many simian lentiviruses. Gain of function studies, which swapped 
domains between human and simian BST-2, concluded that the transmembrane 
region of BST-2 was responsible for the antagonism elicited by Vpu (Yoshida, Kao 
et al. 2011). Interestingly, SIVtan (but not SIVmac) and HIV-2 utilise Env to 
overcome human BST-2 restriction by sequestering it within the TGN (Gupta, 
Mlcochova et al. 2009; Le Tortorec and Neil 2009). The inability of SIVmac Env to 
overcome human BST-2 is an elegant demonstration of the species specific 
nature of virus and host factor co-evolution. SIVagm/blu/cpz/mac utilise the 
accessory protein Nef in a species-specific manner to counteract BST-2 
restriction by the recruitment of the AP2 adaptor complex to downregulate BST-
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2 (Jia, Serra-Moreno et al. 2009; Zhang, Wilson et al. 2009; Zhang, Landford et 
al. 2011). In addition, the Ebola virus glycoprotein and the K5 protein of Kaposi’s 
sarcoma associated herpesvirus also facilitates escape from BST-2 restriction by 
mechanisms that have not been completely clarified (Lopez, Yang et al. 2010) 
(Mansouri, Viswanathan et al. 2009). 
The accessory proteins acquired by viruses to overcome BST-2 restriction have 
led in turn to the selection of proteins that escape virus blockage. This is 
particularly prominent for human BST-2. There is evidence to suggest that 
deletion of 5 amino acid residues in the cytoplasmic tail of hBST-2 (when 
compared with other simian primates) allows it to avoid the counteracting action 
of Nef. This is considered an important factor in preventing transmission of SIV 
to humans (Sauter, Vogl et al. 2011). In response, HIV-1 Vpu has developed a 
series of modifications within the N terminal region which account for the nature 
of its specifc interaction with hBST-2 (Lim, Malik et al. 2010). In a manner 
similar to human BST-2, both murine and rodent orthologs were capable of 
restricting the release of Vpu deficient HIV-1 when expressed in 293T cells, 
although this restriction was not overcome in the presence of the accessory 
protein Vpu. Murine and rodent BST-2 share 71% homology with each other but 
only 41% and 36% homology respectively with human BST-2 The critical regions of 
BST-2 for the evasion of Vpu are spread across the structural domains (Goffinet, 
Allespach et al. 2009). Sheep Betaretroviruses, have no accessory proteins to 
overcome the antiviral action of the ovine BST-2 (Arnaud, Black et al. 2010). The 
interaction of both exogenous and endogenous JSRVs with oBST-2 is the subject 
of this thesis. In addition, there are data suggesting that BST-2 is unable to block 
cell to cell transmission by retroviruses. This will also be discussed as part of this 
thesis. 
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2 Chapter 2 - Material and Methods 
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2.1 Cells  
 
 
HEK-293T cells are immortalized human embryonic kidney cells (referred 
throughout the text simply as 293T cells) and were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) Glutamax (Gibco), supplemented with 10% 
fetal bovine serum (FBS, Hyclone) and 1% Penicillin-Streptomycin (Gibco). CPT-
tert cells (ovine choroid plexus cells immortalised with h-tert, a gift from David 
Griffiths, Moredun) were maintained in Iscove’s modified Dulbecco’s medium 
(IMDM Glutamax, Gibco) supplemented with 10% FBS + 1% Pen-Step. Cells were 
incubated at 37oC, with 5% CO2 in 95% humidity. Cells were routinely cultured in 
10cm diameter tissue culture dishes and were passaged when monolayers 
reached ~95% confluency. All adherent cells were rinsed three times with 
phosphate buffered saline (PBS) pH7.4 (Gibco), once with trypsin (Gibco) and 
then incubated with 1 millilitre (ml) of trypsin at 37oC until detachment of the 
monolayer from the dish. Cells were resuspended in 10ml of the appropriate 
growth medium and pelleted by low speed centrifugation (Eppendorf Centrifuge 
5810) at 1000g for 5 minutes (mins). Cells were then washed twice in PBS, 
resuspended in 10ml of fresh growth media and seeded at the required density 
into a new 10cm Petri culture dish.  
For the long term storage, cells were resuspended in 1ml of 90% FBS/10% 
Dimethyl sulfoxide (DMSO, Sigma Aldrich) and aliquoted into fully labelled 
cryovials (Nunc). Vials were frozen at -80 oC in a cryofreezer (Mr Frosty, 
Nalgene) before being transferred into liquid nitrogen storage 24h later. The 
recovery of cells stored in liquid nitrogen was initiated by thawing vials for the 
minimum time necessary at 37oC. Cells were then added drop wise into 10 ml of 
suitable growth medium and pelleted by low speed centrifugation 1000g for 5 
mins. The resulting pellet was resuspended in 10mls of appropriate growth 
medium and seeded into either a 6 cm or 10 cm tissue culture dish as 
appropriate. 
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2.2 Plasmids  
 
JSRV plasmids 
 
Table 1. Summary of the main JSRV and enJSRV expression plasmids employed in this 
study. 
 
Name Description Source/ 
reference 
pCMV2JSRV21 full length molecular clone of JSRV21 Palmarini 1999 
pCmv435024 full length molecular clone of 
enJSRV7 
Arnaud, 
Caporale et al. 
2007 
pCmv457M3 full length molecular clone of 
enJSRV15 
Arnaud, 
Caporale et al. 
2007 
pCmv46F9 full length molecular clone of 
enJSRV18 
Arnaud, 
Caporale et al. 
2007 
pCmv4102B15 full length molecular clone of 
enJSRV26 
Arnaud, 
Caporale et al. 
2007 
pCMV2JSRV21FLAG pCMV2JSRV21 with HA tag between 
signal peptide and SU of Env 
This thesis 
pCMV5a-JS21Flag JSRV Env with C terminal FLAG 
epitope 
Varela, 2008 
pCMV3DGPP2NFlag JSRV Env with N terminal FLAG 
epitope 
Varela, 2008 
pCMVN-
FLAG57m4Env 
enJSRV18 Env tagged at the N 
terminal 
Dr. F Arnaud 
pCmv4js21XSstoM3 full length molecular clone of JSRV 
provirus with 2 stop codons before 
Env 
Dr. M. Caporale 
pCmv467f9ds full length molecular clone of 
enJSRV-18 provirus with 2 stop 
codons before Env 
Dr. M. Caporale 
 
pCMV2JSRV21 is a full length molecular clone of JSRV driven by the 
Cytomegalovirus (CMV) immediate early promoter and has been described 
previously (Palmarini, Sharp et al. 1999). Similarly, full length proviral clones of 
enJSRV-7, 15, 18 & 26 (pCmv435024, pCmv457M3, pCmv46F9, pCmv4102B15), 
driven by the CMV promoter, have also been described (Arnaud, Caporale et al. 
2007). pCMV2JSRV21HA is a construct generated from pCMV2JSRV21 which 
contains the haemagglutinin (HA) epitope inserted within the Env protein of 
Chapter 2  82 
JSRV, preceding the SU and after the signal peptide in the context of the full 
length proviral clone. This epitope was inserted by site directed mutagenesis 
using Fw 5‘-CCAGACTACGCTGCGGCTTTTTGGGCGTACATTCCTGATCC-3’ and Rw 
5‘-GACGTCGTATGGGTAAGCTGCCCCATTTTGTACCCGCTGTAAC-3’ primers.  
pCMV5a-JS21Flag and pCMV3DGPP2NFlag express the JSRV Env protein tagged  
with the FLAG epitope at either the C or N terminus respectively, and have been 
described previously (Varela 2007). pCMVN-FLAG57m4Env (enJSRV-18 Env tagged 
at the N terminal) was provided by Dr. F. Arnaud. pCmv4js21XSstoM3 and 
pCmv467f9ds express the full length exogenous JSRV and enJSRV-18 proviruses 
respectively but contain two stop codons preceding the envelope open reading 
frame (provided by Dr. M Caporale).  
BST-2 plasmids 
Two ovine Bst-2 genes (designated oBST-2A and -2B) were isolated and cloned 
into the pCI mammalian expression vector (Promega) to obtain pCI-oBST2A and 
pCI-oBST2B respectively as already described (Arnaud, Black et al. 2010). 
pCIoBST2AHa and pCIoBST2BHa express oBST-2A and -2B containing an HA 
epitope tag  prior to the predicted ω site for GPI cleavage. 
The Vpu gene of HIV-1 within a mammalian expression vector was provided by 
Dr. S.J. Neil (Kings College). The empty pCI-DNA mammalian expression plasmid 
was used as a control for transfection to equilibrate DNA volumes. In addition, 
peGFP-C1, which expresses the enhanced green fluorescent protein (eGFP), was 
used as a control for transfection efficiency. Cav-1GFP is an expression plasmid 
for Caveolin-1, a plasma membrane based protein, fused with GFP at the C 
terminus (Addgene plasmid 14433). E-Cad-GFP–c1 is an expression plasmid for 
Cadherin-1, a plasma membrane based protein fused with GFP and was kindly 
provided by Dr. K. Anderson. 
oBST-2B mutants were generated by site directed mutagenesis (Figure 18 and 
Table 2). 
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Figure 18. Illustration of the oBST-2B mutants employed in this thesis 
 
 
 
 
Table 2. Summary of the primers employed for the construction of the oBST-2B mutants 
employed in this thesis 
 
Plasmid Primers  5’-3’ 
oBST-2BGPIc-28  Fw  
gactacgctgctaggtccTGAttgttcgacgtgttcctc  
Rw  
gaggaacacgtcgaacaaTCAggacctagcagcgtagtc 
oBST-2Bc-25   Fw  
gctaggtccagcttgttcTAGgtgttcctctcctttttc 
Rw 
gaaaaaggagaggaacacCTAgaacaagctggacctagc 
oBST-2Bc-20  Fw 
tgttcgacgtgttcctctGATttttcgggggtgtggtga 
Rw 
tcaccacacccccgaaaaaTCAgaggaacacgtcgaaca 
oBST-2Bc-9 -  Fw 
cgggttgtgtccatcaccTGAaagtgtctgaagaaatga 
Rw 
tcatttcttcagacacttTCAggtgatggacacaacccg 
oBST-2Bc-6   Fw 
cgggttgtgtccatcaccTGAaagtgtctgaagaaatga 
Rw 
tcatttcttcagacacttTCAggtgatggacacaacccg 
oBST-2Bc-5  Fw 
gttgtgtccatcacccgcTAGtgtctgaagaaatgag 
Rw 
ctcatttcttcagacaCTAgcgggtgatggacacaac 
 
 
All PCR primers were purchased from MWG Biotech. For cloning purposes, all 
PCR reactions were performed using Hotstar Hifidelity (Qiagen) according to the 
manufacturer’s protocol.  
PCR purification and Gel extraction was performed with the QIAquick PCR 
purification kit (Qiagen) or QIAquick Gel extraction kit (Qiagen) respectively. 
Ligations were performed using the Rapid DNA Ligation Kit (Roche). Plasmids 
were transformed into either DH5α or TOP10 strains of E.Coli (Invitrogen). 
Minipreps of plasmid were prepared using the QIAprep Miniprep kit (Qiagen), and 
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Maxipreps with Purelink HiPure Plasmid Maxiprep kit (Invitrogen). DNA 
concentrations and quality were measured and verified using a Nanodrop 2000 
spectrometer. 
The authenticity of each plasmid was verified first by restriction digestion with 
appropriate restriction enzymes (Roche) and subsequently by DNA sequencing 
(Dundee Sequencing Service). 
All sequence predictions for oBST-2A/ -2B were made by submitting sequences to 
programs available on the Expasy Proteomics server http://expasy.org/tools. 
TMHMM Server v2 predicted potential transmembrane regions, NetNGly 1.0 
Server sites for possible N-linked glycosylation, and GPI-SOM for residues 
targeted for cleavage and GPI anchor addition. 
For site directed mutagenesis, PCR reactions were performed using the 
Quikchange II site directed mutagenesis kit (Agilent Technologies) according to 
the manufacturer’s protocol. When necessary, PCR products were precipitated 
at -20oC with isopropanol in the presence of 3M Sodium Acetate pH5.5 (Ambion). 
The DNA was precipitated by centrifugation at 20,000g for 30mins at 4 oC 
(Eppendorf Centrifuge 5810-R) and resuspended in double deionized water 
(ddH2O) (Millipore) prior to transformation into competent cells. 
 
2.3 Transient transfections 
 
Transient transfections for western blot analysis were performed using the 
CalPhos™ mammalian transfection kit (Clontech) adhering to manufacturer’s 
protocol. 293T cells were plated 24 hours prior to transfection in 10cm plates so 
that 80% confluency was achieved prior to transfection. An hour prior to 
transfection the cells were washed with 1X PBS and maintained in media 
containing no antibiotics. Transfection complexes were formed by first mixing 
appropriate amounts of plasmid DNA (0.25-4µg) with 2M Calcium phosphate. This 
mixture was then added dropwise to a 2X Hepes-buffered saline solution and 
incubated for 20 mins at room temperature. Transfection complexes were then 
added to cells and incubated overnight at 37oC. Following overnight incubation, 
the cells were washed with 1X PBS and fresh medium containing antibiotics was 
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added. Cells were incubated for a further 24 hours before cell 
supernatant/lysates were harvested. 
 
 
2.4 Cell lysates 
 
Cells lysates were harvested in general 24 hours post transfection for protein 
analysis by standard molecular techniques. Briefly, cells were rinsed with cold 
PBS and lysed on ice for 10 minutes with modified RIPA buffer ((15mM Tris-HCl, 
pH 7.4; 1% NP-40; 1mM EDTA; 150mM NaCl, 1mM PMSF; 1mM NaF; protease 
inhibitors cocktail (COMPLETE-Roche)). Cells were collected by scraping and 
subsequently sonicated on ice. Protein concentration was measured using the 
BioRad protein assay kit according to manufacturer’s protocol.  
 
2.5 PNGaseF treatment of lysates 
 
Peptide N-Glycosidase F (PNGaseF, Sigma-Aldrich) is commonly used to study the 
glycosylation status of proteins as it removes N-linked carbohydrate chains 
added during the process of post translation modification. 293T cells were 
transfected as previously described using CalPhos with 1µg of pCI-oBST2A or -2B. 
24 h post-transfection, cell lysates were harvested in 1% NP-40 (Fisher). 200µg of 
the appropriate cell lysate (mock transfected, or transfected with expression 
plasmids for oBST-2A and oBST-2B) was aliquoted in duplicate. The samples were 
diluted to a final volume of 35µl before adding 10µl of 250mM PBS pH7.5, 2.5µl 
of 2% Sodium Dodecyl Sulphate, 1M 2-mercaptoethanol. The samples were then 
boiled at 100 oC for 5 min and cooled on ice. 2.5µl of 15% Triton X100/PBS (v/v) 
was added before the addition of 2µl of PNGaseF solution, or PBS as a mock 
control. All samples were then incubated at 37oC for 6h. Reactions were stopped 
by adding 4µl of 4x SDS-PAGE reducing buffer (250mM Tris-HCl pH6.8, 8% SDS, 
40% Glycerol (v/v), 0.008% Bromophenol Blue, 20% 2-Mercaptoethanol) and 
boiling for 5 min prior to SDS-PAGE/western blot analysis. 
 
 
Chapter 2  87 
 
2.6 Cell lysate fraction preparation 
 
293T cells were transfected as described above with expression plasmids for 
oBST-2A or -2B. The cells were then washed with PBS and treated for 30 min at 
room temperature with 3,3’-dithiobis sulfosuccinumidylpropionate (DTSSP) 
(Thermo Scientific). DTSSP crosslinks cellular proteins to membranes and this 
treatment was used in an attempt to preserve oBST-2A/-2B in their native 
environment during the fractionation process. DTSSP treatment was stopped by 
the addition of 1M Tris (pH7.5) prior to harvesting the lysates.  The cells were 
then scraped from the Petri dish and washed with PBS. The cells were sheared 
using a 21G needle (BD Microlance) with 30 strokes per sample. Lysates were 
then processed using the Plasma Membrane Protein Extraction Kit (Biovision) as 
suggested by the manufacturer. Cytosolic fractions and plasma membrane 
fractions were retained for western blot analysis. 
2.7 Viral particle preparations 
 
Cell culture supernatants were collected 24 hours after transfection with the 
appropriate plasmid. The viral particles were concentrated by 
ultracentrifugation at 35,000rpm (SW41 rotor Beckmann) for 60 minutes at 4oC 
on a 29% sucrose cushion. Viral pellets were resuspended in 1x TNE buffer 
(diluted from 10X stock, 1M NaCl; 0.1M Tris; EDTA final solution pH 7.5) at a 
final volume 200x concentrated compared to the initial volume of the 
centrifuged supernatants.  The viral pellets were resuspended overnight at 4oC 
in 4µl of 4x SDS-PAGE reducing buffer (250mM Tris-HCl, pH 6.8; 8% Sodium 
Dodecyl Sulphate; 40% glycerol (v/v); 0.008% Bromophenol Blue; 5% β-
Mecarptoethanol) and boiled for 5 minutes prior to SDS-PAGE western blot 
analysis, or storage at -80oC for subsequent use. 
In some cases, viral pellets were purified by isopycnic centrifugation on 20 to 
55% (w/w) sucrose gradients (25,000 rpm (SW41 rotor Beckmann) for 16h at 4oC). 
Fractions of approximately 500 µl were then collected and the virus 
concentrated by ultracentrifugation prior to further analysis.  
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2.8 SDS-PAGE and western blotting 
 
200µg of cell lysate or an appropriate volume of viral pellet material was 
separated by SDS-PAGE before transferring to a Polyvinylidene Fluoride (PVDF) 
membrane (GE Healthcare). Membranes were then incubated in blocking buffer 
(5% milk in TBS-Tween (ddH2O, 10% Tris Buffered Saline (TBS) 10x, 0.1% Tween 
20)) for 1h at room temperature prior to incubation overnight at 4oC with 
primary antibodies. The primary antibodies used were anti JSRV/enJSRVs Gag 
(used at either 1:3000 dilution for lysates or 1:300,000 for viral pellet detection) 
and anti-HA (1:500) in blocking buffer, or anti-JSRV TM (1:500) in BSA blocking 
buffer (5% BSA, 5% milk, ddH2O, 10% TBS 10x, 0.1% Tween 20). Membranes were 
then washed three times with TBS-TWEEN solution and incubated with a species-
specific horseradish peroxidise-conjugated secondary antibody diluted in 
blocking buffer for 1h at room temperature. The secondary antibodies used were 
donkey anti rabbit F(ab’)2 fragment (1:30,000; GE Healthcare) or an anti mouse 
F(ab’)2 (1:30,000; AbD Serotec). Detection was performed by 
chemiluminescence (ECL, GE Healthcare). When redetection was necessary, the 
membranes were stripped with Restore Western Blot Stripping Buffer (Thermo 
Scientific) at 37oC for one hour and washed with TBS-TWEEN solution. The 
stripped membranes were then used as before to blot using the required primary 
antibody. Whenever necessary, the band strength in western blots was 
quantified using a Storm 640 (Molecular Dynamics) using ImageQUANT software 
(GE healthcare). 
2.9 Reverse Transcriptase Activity assay 
 
Reverse transcriptase (RT) activity from concentrated viral pellet/virus isolated 
on sucrose gradient was detected and quantified using the HS-Mg RT Activity Kit 
(Cavidi) according to the manufacturer’s protocol. Positive RT activity was 
determined with values representing more than twice the negative controls. A 
rRT of HIV-1 was used to derive a standard curve.  
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2.10 Dynamic Light Scattering 
 
Dynamic Light Scattering (DLS) was used to estimate the size of viral particles 
released by enJSRV-18 and JSRV in the presence and absence of oBST-2A/-2B. All 
samples were checked by western blot prior to DLS analysis and all 
measurements were made using the Zetasizer Nano zs90 (Malvern). Viral pellets 
produced following Calphos™ transfection of the appropriate plasmid(s) were 
diluted to a final volume of 500µl in 1x TNE buffer. Samples were loaded into 
the cuvette provided with the apparatus, inserted into the Zetasizer Nano zs90 
and a run was initiated. All of the measurements were made at 37οC. The 
Zetasizer Nano zs90 software compiled the data and generated a Z average and 
count rate. The Z average is representative of the predicted hydrophobic 
diameter and the count rate is indicative of sample quality, respectively. An 
average value and standard error was calculated from three individual 
measurements per sample. 
 
2.11 Nanoparticle Tracking Analysis 
 
Nanoparticle tracking analysis (NTA) was performed with a Nanosight (LM-20). 
NTA was used to estimate the size of viral particles released by enJSRV-18 and 
JSRV in the presence and absence of oBST-2B. All samples were checked by 
western blotting prior to NTA analysis. Three measurements of each sample 
were made and the results captured and analyzed with the NTA 2.0 Build 
software (Nanosight). Mean values and standard errors for the average size of all 
particles within the sample were calculated. 
 
2.12 Confocal microscopy 
 
CPT-tert cells were plated 24 hours prior to transfection on 2-chamber slides 
(Cornell) in IMDM-Glutamax media (Invitrogen) supplemented with 10% FBS + 1% 
Penicillin-Streptomycin.  Cells were transfected with the appropriate plasmids 
using Lipofectamine 2000 as recommended by the manufacturer. Transfection 
mixtures were incubated at room temperature for 20 minutes to allow 
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Lipofectamine 2000 complexes to form before each reaction was added dropwise 
to the chamber. The cells were incubated for 5 h at 37oC before replacing the 
media containing transfection mixture with fresh complete media. 18h post-
transfection the cell monolayer was washed twice with cold PBS, fixed with 5% 
formaldehyde in PBS at 4oC for 20 min, and quenched in 10mM ammonium 
chloride.  
For the analysis of intracellular protein distribution, the cells were 
permeabilised with PBT (PBS + 0.5% Trition X-100; Sigma-Aldrich) for 10 min at 
room temperature and then blocked with solutions 1 and 2 (Table 3) 
consecutively for 5 minutes each to minimise non-specific antibody binding. The 
appropriate primary antibodies (Table 4) were then diluted in solution 2 and 
incubated overnight at 4oC in a lightproof container.  
Table 3.  Composition of blocking solutions used for confocal microscopy. 
 
Solution 1 Solution 2 
200µl Fish Gelatin (Sigma-Aldrich ) 
+ 50mls 1%PBS + 2% Tween20 
1250 µl Goat Serum (Biosera)             
+ 50mls 1%PBS + 2% Tween20 
 
 
 
Table 4. Primary and secondary antibodies used in this thesis. 
 
Primary Antibody Antibody species and 
type 
Dilution 
p23 GAG polyclonal anti-rabbit 1:200 
FLAG polyclonal anti-rabbit 
(Sigma) 
1:750 
HA monoclonal anti-mouse 
(Covance) 
1:100 
TGN46 polyclonal anti-rabbit 
(Abcam) 
1:1000 
Golgi -Giantin polyclonal anti-rabbit 
(Abcam) 
1:100 
Golgi - p115 anti-rabbit (Abcam) 1:100 
Rab7 Polyclonal anti-rabbit 
(Abcam) 
1:100 
GFP polyclonal anti rabbit 
(Abcam) 
1:500 
Secondary Antibody   
Alexa Fluor 488 goat anti-rabbit 
(Invitrogen) 
1:3000 
Alexa Fluro 594 donkey anti-mouse 
(Invitrogen) 
1:3000 
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The next day, the cells were washed three times in PBS-T (PBS + 2% Tween20) 
before repeating the blocking step with solutions 1 and 2. The cells were then 
incubated with the appropriate secondary antibodies in Solution 2 (as indicated 
below) at 37oC for 30 min and then washed again three times with PBS-T 
solution. Finally, the chamber walls and adhesive were removed from slides 
before adding one drop of Vectashield with 4’, 6-diamidino-2-phenylindole 
dihydrochloride DAPI (Vector Laboratories). Coverslips (22x22mm, BDH 
Laboratory Supplies) were then applied and sealed with nail varnish. Cells were 
examined and imaged with a Leica TCS SP2 confocal microscope. Image analysis 
was performed with Image Pro Analyzer 7.0 (Media Cybernetics). 
Colocalisation was measured using Pearson’s Correlation (a value reflecting the 
degree of overlap between two channels) calculated by Image Pro Plus software 
(Media Cybernetics). The value ranges from -1 to 1. Anything below 0.5 was 
considered non-significant and anything above as a significant degree of 
colocalisation. At least fifty cells were measured for each experiment. All values 
presented represent an average percent and include standard error values. 
 
 
2.13 Brefeldin A treatment 
Whenever necessary cells were treated with Brefeldin-A, a fungal metabolite 
which fragments the Golgi stacks leading to the concentration of proteins within 
the endoplasmic reticulum and redistribution of Golgi based proteins. Brefeldin-
A was used at a concentration of 200ng/ml. Transient transfections were 
performed as described in section 2.12. At the point where the medium was 
changed, the replacement media was either serum free medium (SFM) alone 
(control), or SFM containing 200ng/ml Brefeldin A. The cells were incubated for 
90mins before fixation and immunolabelling for confocal microscopy (see 2.12 
Confocal microscopy). 
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3 Chapter 3 - Investigating the intracellular 
distribution of the oBST-2 paralogs 
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3.1 Summary 
In this chapter, we defined their intracellular distribution of the oBST-2 
paralogs. We also highlight key differences between the oBST-2A/ -2B proteins 
which may contribute to the difference in intracellular localisation observed.  
 
3.2 Introduction 
3.2.1 BST-2 localisation and intracellular trafficking.  
 
As discussed in Chapter 1, BST-2 is a cellular restriction factor with a broad 
antiviral activity. To date, the majority of knowledge of BST-2 expression and 
mode of action has been derived from studies involving the human ortholog. In 
vivo, human BST-2 is found constitutively expressed to varying degrees on the 
surface of a range of cells including hepatocytes, pneumocytes, Leydig cells, 
plasma cells and bone marrow stromal cells (Erikson, Adam et al. 2011). This is 
in direct contrast to the original reports following its discovery when it was 
considered a surface marker of terminally differentiated human B cells (Goto, 
Kennel et al. 1994). It is not found to be constitutively expressed on the surface 
of T cells, B cells, macrophages, monocytes or plasmacytoid dendritic cells (pDC) 
in humans. There is strong evidence to suggest that constitutive expression is 
species specific as it is found expressed on the surface of murine pDCs (Swiecki 
and Colonna 2010), but is absent from human pDCs (Erikson, Adam et al. 2011). 
BST-2 is found expressed in a wide variety of cells including pDCs following 
treatment with IFN (Kupzig, Korolchuk et al. 2003; Blasius, Giurisato et al. 
2006), although in vivo it may only partially regulate expression (Erikson, Adam 
et al. 2011). In vitro studies have shown that BST-2 is constitutively expressed in 
HeLa and Jurkat cells but its expression can also be induced in 293T and HT1080 
cells following IFN treatment.  
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BST-2 appears to reside specifically within the lipid rafts of the plasma 
membrane (Kupzig, Korolchuk et al. 2003). Lipid rafts or ‘membrane rafts’ are 
small heterogenous regions of the plasma membrane (10-200 nm in diameter) 
with a high content of sterol and sphingolipids. They are essential for efficient 
membrane segregation, protein trafficking and signalling (Viola and Gupta 2007). 
Interestingly, lipid rafts are considered hotspots for viral particle release during 
the retroviral replication cycle (Nguyen and Hildreth 2000). The localisation of 
BST-2 at the plasma membrane is fundamental for the ‘tethering’ antiviral 
mechanism.  
As previously mentioned, BST-2 is composed of a short N terminal cytoplasmic 
region preceding a transmembrane domain and an ectodomain followed by a C-
terminal GPI anchor (Kupzig, Korolchuk et al. 2003). GPI anchorage is a major 
determinant of BST-2 localisation. BST-2 mutants with the GPI signal deleted 
localise to the ER. Thus, the GPI signal is essential for the correct export of BST-
2 to the plasma membrane and for its restriction capability. The property of 
BST-2 to make two connections with the plasma membrane, provided by the N-
terminal transmembrane region and GPI anchorage, forms the basis of the 
‘tethering’ restriction mechanism. BST-2 inserts one end of the protein within 
the host plasma membrane and the other within the virion envelope, in this way 
creating a bridge of retention (Neil, Zang et al. 2008).  
BST-2 has been shown to be internalised via clathrin-mediated endocytosis into 
early recycling endosomes (not late) before passing to the trans-Golgi network 
(TGN). The N-terminal region of BST-2 contains two conserved tyrosine residues 
that likely form part of an internalisation motif (Rollason, Korolchuk et al. 
2007). Pull down experiments demonstrated the specific interaction of the N-
terminal cytosolic region of BST-2 with the µ2 subunit of the adaptor protein AP2 
(Masuyama, Kuronita et al. 2009). Adaptor protein complexes are cytosolic 
heterodimers that regulate protein sorting in the post Golgi network. AP2 
mediates endocytosis from the plasma membrane whilst AP1/2 and 4 are 
involved in endosomal/lysosomal pathways (Nakatsu and Ohno 2003). Disruption 
of the GPI anchor alters the internalisation pathway of BST-2, demonstrating 
that the GPI/lipid raft association is an important and established factor for 
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successful internalisation (Rollason, Korolchuk et al. 2007; Masuyama, Kuronita 
et al. 2009).  
As mentioned above, BST-2 has been found to localise also at the TGN, an 
unusual property for a GPI anchored protein. The localisation of a second pool of 
BST-2 to the TGN raises the question of whether this pool is independent from 
the one recycling from the plasma membrane and TGN. 
 
 
 
3.2.2 The Golgi and Trans Golgi Network 
 
The Golgi is formed by several layers of membranous stacks arranged in ribbon 
like structures juxtaposed to the centrosome (cis and medial cisternae) in 
eukaryotic cells (Sengupta and Linstedt 2011). Newly synthesized membrane 
proteins bud from the ER and concentrate within COP II vesicles. The COP II 
vesicles bud directly from the ER and target the Golgi for cargo delivery (Haucke 
2003). Upon arrival at the Golgi, proteins undergo post-translational 
modification, progressing through the cis and medial Golgi via COP I vesicles 
before finally entering the trans-Golgi network (TGN). Arrangement of the Golgi 
as stacked cisternae is an important feature of its function, promoting an 
optimum environment for sequential post-transcriptional processing events such 
as glycosylation and sorting of cargo (Sengupta and Linstedt 2011). The Golgi 
contains numerous resident proteins (Golgins) which provide structural support 
and function. For example, p115 is localised to the cis Golgi stack and is a 
vesicle docking protein assisting COP I cargo entering the Golgi. In addition, p115 
also plays a role as a Golgin protein for mitosis and apoptosis (Radulescu, 
Mukherjee et al. 2011). Giantin is also a Golgin but is found within COP I vesicles 
moving cargo between Golgi stacks and is involved in vesicles docking to Golgi 
membranes (Sonnichsen, Lowe et al. 1998), whilst TGN46 is an example of a 
resident TGN protein.  
The TGN is the final sorting compartment which determines the final 
intracellular location of membrane proteins. The Golgi and TGN should be 
considered as separate structural entities which perform unique functions, 
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although they are closely associated (Sengupta and Linstedt 2011). This is 
emphasised by the differences observed following treatment with Brefeldin-A a 
fungal metabolite which fragments the Golgi. Upon treatment with Brefeldin-A, 
the Golgi stacks form tubules that fuse with the ER resulting in the redistribution 
of all Golgi based proteins to the ER. Similarly, the TGN is also fragmented by 
Brefeldin A but the resulting tubules fuse with the endosomal network and all 
TGN based proteins are redistributed to the MTOC (Gu, Crump et al. 2001).  
The TGN forms the sorting station for newly synthesized membrane proteins. It 
differs from the Golgi stacks in that it is a structure with an extensive series of 
membranes rather than organized stacks and varies in size and structure 
depending on the cell type. Like the Golgi, it is a highly diverse, mobile element 
with a high level of protein renewal and not a static structure of the cell. It is 
absent altogether from cells which have a high turnover of very large secretory 
granules but it does form extensive multilayer interconnecting stacks in cell 
types which have a more moderate level of granules for secretion (Sengupta and 
Linstedt 2011). Once located within the TGN, proteins will be sorted for delivery 
to their final destination based on protein binding domains and motifs. This 
results in them either being retained as TGN proteins, trafficked back to the 
Golgi stacks/E.R./nucleus or onwards to endosomes, ubiquitin proteosome or the 
plasma membrane (Tekirian 2002). The TGN is also the receiving centre for a 
select set of proteins (approximately 5%) via retrograde transport from the 
plasma membrane (Chege and Pfeffer 1990) 
 
3.2.3 Interplay between ovine BST-2 and sheep Betaretroviruses 
 
The enJSRVs are abundantly expressed within the reproductive tract of sheep 
and have a prominent role in placental morphogenesis (see Chapter 1.4.8). 
enJSRV expression during pregnancy coincides with that of IFNtau, a type I IFN 
which, as well as having antiviral activity, is the pregnancy recognition signal in 
ruminants. Previously, a study conducted by Frederick Arnaud in our laboratory, 
showed that IFNtau upregulates the expression of BST-2 both in vitro and in vivo 
(Arnaud, Black et al. 2010). Interestingly, he also found that the BST-2 gene is 
duplicated in ruminants and designated these paralogs oBST-2A and -2B. 
Duplication of an IFN-induced BST-2 has not been reported for any other 
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ortholog to date (although splice variants have been identified for human and 
canine orthologs). The date of this duplication event is unknown but as it is 
present in both cows and sheep it has occurred prior to their speciation. Both 
paralogs block JSRV/enJSRVs viral exit, although oBST-2A appears to be more 
efficient than oBST-2B based on Gag exit (Arnaud, Black et al. 2010). In vivo, the 
expression of oBST-2 and enJSRVs was found to be mutually exclusive leading to 
the speculation that the interplay between the host restriction factors such as 
oBST-2 and enJSRVs may have influenced the tropism of these viruses. 
 
3.3 Results 
 
3.3.1 Sheep Betaretroviruses are restricted by human BST-2 
(hBST-2)  
 
Betaretroviruses, including sheep Betaretroviruses, assemble in the cytoplasm in 
the vicinity of the MTOC, and not at the cell membrane like the great majority 
of retroviruses. In order to investigate the relationship between ovine BST-2 and 
sheep Betaretroviruses we first assessed whether the human ortholog (hBST-2) is 
able to block these viruses. Studies were conducted with the exogenous JSRV 
and one of its endogenous counterparts, enJSRV-18. As mentioned in Chapter 1, 
enJSRV-18 has intact open reading frames and is abundantly expressed in 
transfected cells in vitro (Chessa, Pereira et al. 2009). 
We transiently transfected 293T cells with expression plasmids for either 
enJSRV-18 or JSRV in the presence and absence of hBST-2 (Figure 19). We 
observed that hBST-2 induced an efficient block on virion release based on the 
presence of pelletable Gag in the supernatants of transfected cells.  
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Figure 19. JSRV and enJSRV-18 viral exit is blocked by hBST-2 but rescued by the addition 
of Vpu in trans. 
Western blot analysis on concentrated supernatants of 293T co-transfected with expression 
plasmids for viruses and BST-2/Vpu proteins as indicated in each panel. Cells were transfected in 
a 6 well plate with 0.5µg of JSRV (panel A) / enJSRV-18 (panel B) and 0.1µg of HA tagged 
expression plasmids for hBST-2 and Vpu. Blots were incubated with the Gag antisera against the 
CA domain, indicated in each panel. Viral particle release based on CA release was quantified, and 
values represent arbitrary units relative to the values of each virus transfected in the absence of 
BST-2 (which was assigned a value of 100). Representative experiments are shown and were 
repeated at least three times independently. 
 
 
 
 
In order to determine the specificity of the BST-2 restriction, we also confirmed 
a similar level of efficiency of restriction for several other insertionally 
polymorphic, replication competent enJSRVs, including enJSRV-7, 15 and 26, by 
hBST-2 (Figure 20). As expected based upon previously published data (Neil, 
Zang et al. 2008), in all cases the provision of the HIV accessory protein Vpu in 
trans efficiently counteracted the restriction by hBST-2. 
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Figure 20. Viral exit of enJSRV-7, 15 and 26 is blocked by hBST-2 but rescued by the 
addition of Vpu in trans. 
Western blot analysis on concentrated supernatants of 293T cells cotransfected with expression 
plasmids for viruses and BST-2/Vpu proteins as indicated in each panel. Cells were transfected in 
a 6 well plate with 1.5, 0.5 and 4 µg of enJSRV-7, 15 and 26 respectively, and 0.1µg of HA tagged 
expression plasmids for hBST-2 and Vpu. Blots were incubated with the Gag antisera against the 
CA domain, indicated in each panel. Viral particle release was quantified based on CA release, and 
values represent arbitrary units relative to the values of each virus transfected in the absence of 
BST-2 (which was assigned a value of 100). Representative experiments are shown and were 
repeated at least three times independently. 
 
 
 
 
As mentioned previously, studies conducted by Frederick Arnaud in our 
laboratory showed that the BST-2 gene is duplicated in ruminants. oBST-2A 
blocks JSRV/enJSRVs viral particle exit more efficiently than oBST-2B (Arnaud, 
Black et al. 2010). In concordance with these data, enJSRV-18 exit was found to 
be blocked very efficiently in the presence of both oBST-2A and -2B (Figure 21). 
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Figure 21. enJSRV-18 viral exit is blocked by oBST-2A/ -2B. 
(A) Cells were transfected in 10cm diameter Petri dishes with 1µg of a plasmid expressing 
enJSRV-18  and a gradient of HA tagged expression plasmids for oBST-2A and -2B ranging from 
0.1- 1.4 µg. A ratio of 3:1 for oBST-2A/ -2B respectively was transfected to reflect the expression 
pattern previously identified in vivo (Arnaud, Black et al. 2010). Blots were incubated with the 
appropriate antisera, indicated in each panel. (B) Quantification of western blotting of concentrated 
viral particles from supernatants of 293T co-transfected with expression plasmids for enJSRV-18 
and oBST-2A/ -2B. Viral particle release was quantified, and values represent arbitrary units 
relative to the values of each virus transfected in the absence of BST-2 (which was assigned a 
value of 100). 
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3.3.2 oBST-2A and -2B proteins have different glycosylation 
patterns 
Next, we compared the structural features between the ovine BST-2 paralogs 
and human BST-2. oBST-2A retains many of the structural features typical of the 
BST-2 proteins including a predicted N-terminal transmembrane region, a C-
terminal coiled coil domain, a GPI-Signal Peptide (SP, for cleavage and GPI 
anchor addition within the ER), as well as N-linked glycosylation sites similarly to 
hBST-2. In contrast, oBST-2B possesses only an N-terminal transmembrane region 
and a C-terminal coiled coil region like oBST-2A and hBST-2, and does not appear 
to contain a GPI-SP. In addition, oBST-2B appears to contain a putative ER 
retention motif at the C-terminal. Interestingly, no glycosylation sites are 
predicted in oBST-2B (Figure 22). 
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Figure 22. The main features of the BST-2 proteins. 
(A) A sequence alignment of oBST-2A/-2B where X depicts non conserved residues. oBST-2B 
does not contain N-linked glycosylation sites and lacks a GPI-SP yet maintains the omega site for 
GPI anchorage. (B) A schematic diagram illustrating the main structural features and post-
translational modification of hBST-2 and those predicted for oBST-2A/ -2B.  
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We next experimentally addressed whether the ovine BST-2 paralogs possess a 
different glycosylation pattern as suggested by the lack of predicted N-
glycosylation sites in the latter. Previously, it was observed that oBST-2A and -2B 
display a different migration pattern by western blotting (Arnaud, Black et al. 
2010). oBST-2A appears as a triple band whilst oBST-2B shows a single band 
(Figure 23).  
To establish whether oBST-2A and -2B are glycosylated we transiently 
transfected 293T cells with expression plasmids for oBST-2A/ -2B (tagged with an 
HA epitope) and cell lysates were harvested in 1% NP-40 prior to incubation in 
the presence or absence of PNGaseF (peptide N-glycosidase F), an amidase that 
removes carbohydrate side chains from N-linked glycosylated proteins. Following 
overnight incubation, proteins were separated by SDS-PAGE and analysed by 
western blotting, using an anti-HA antibody for oBST-2A/ -2B detection. The 
migration patterns of oBST-2A/ -2B in the presence and absence of PNGaseF 
confirmed a different glycosylation pattern. We found that oBST-2A migrated as 
a triple band and was reduced to a single band in the presence of PNGaseF, 
confirming that the observed isoforms were a result of glycosylation as reported 
for other orthologs (Kupzig, Korolchuk et al. 2003) (Figure 23). In contrast, we 
observed no difference in the migration pattern of oBST-2B following PNGaseF 
treatment. Therefore, these data confirm the hypothesis that oBST-2A is a 
glycosylated protein whilst oBST-2B remains unglycosylated.  
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Figure 23. Ovine Bst-2 paralogs show a different glycosylation pattern. 
293T cells were transiently transfected with expression plasmids for oBST-2A or -2B. Cell lysates 
were harvested and incubated in the presence and absence of PNGaseF overnight. Proteins were 
then separated by SDS-PAGE and visualized by western blotting. Migration patterns indicate that 
oBST-2A is a glycosylated protein as it is reduced to a single band by PNGaseF. oBST-2B appears 
to be unaffected by PNGaseF treatment. γ-tubulin was used as a sample quality and loading 
control.  
 
 
 
 
3.3.3 The oBST-2A and -2B paralogs display a different 
intracellular localisation 
 
The presence of BST-2 at the plasma membrane is a key factor for the antiviral 
restriction mechanism displayed by this protein (Neil, Zang et al. 2008; Van 
Damme, Goff et al. 2008). Although GPI anchorage is a determinant of protein 
localisation to the lipid rafts of the plasma membrane, we predicted that only 
oBST-2A has a functional GPI-SP (Figure 22). 
We next investigated the intracellular localisation of both oBST-2A and -2B to 
assess the importance of GPI anchorage for oBST-2. Experiments were performed 
in sheep CPT-tert cells transiently transfected with oBST-2A or -2B expression 
plasmids (Arnaud, Black et al. 2010) and analysed by confocal microscopy.  
The detection of the BST-2 paralogs with an HA antibody revealed two different 
staining patterns: (i) a "dispersed", broad based internal and plasma membrane 
localisation and (ii) a "concentrated" perinuclear staining pattern (Figure 24 (A)). 
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We noticed that oBST-2A existed primarily as a dispersed localisation whilst in 
contrast oBST-2B appeared mainly as a significantly concentrated, perinuclear 
form. We quantified the data by randomly counting the oBST-2A/ -2B staining 
pattern in 100 cells in two independent experiments (Figure 24 (B)). The results 
were very consistent in both experiments with more than 90% of the cells 
transfected with oBST-2A displaying a dispersed phenotype while 90% of the cells 
transfected with oBST-2B displayed a concentrated phenotype (Figure 24, (B)). 
 
 
Figure 24. Ovine BST-2 paralogs display a different intracellular localisation. 
(A) Confocal microscopy of oBST-2A / -2B in CPT-tert cells transiently transfected with either 
oBST-2A or -2B expressing plasmids display two different staining patterns: (i) dispersed within the 
cytoplasm and cell membrane and (ii) concentrated in a perinuclear region. (B) Data were 
quantified by counting the staining phenotype of 100 cells in random fields. More than 90% of 
oBST-2A positive cells have a significant dispersed localisation whilst oBST-2B transfected cells 
display mostly a concentrated, perinuclear association. 
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3.3.4 oBST-2B has remnants of a once functional GPI anchorage 
 
GPI anchorage ensures protein incorporation within the lipid rafts of the plasma 
membrane by post translational modification within the ER involving protein 
cleavage and addition of a GPI anchor at the omega site. Sequence analyses 
show that oBST-2A has a predicted GPI-SP. oBST-2B lacks a GPI-SP but it has a 
conserved serine residue. This residue, in the presence of a functional signal 
peptide, would constitute the ‘omega’ cleavage site (ω) similar to oBST-2A 
where cleavage and addition of the GPI anchor would typically occur. To confirm 
if the presence of a serine omega cleavage site is indicative of a functional site 
for GPI anchorage addition, we designed an oBST-2B mutant (termed oBST-
2BGPIc-28) possessing a premature stop codon in place of the second serine 
following the omega site (Figure 25). We predicted that insertion of a stop codon 
at this site would mimic cleavage that would ordinarily occur in the presence of 
a functional GPI-SP within the ER facilitating GPI anchor addition and 
consequently modify the oBST-2B protein trafficking patterns.  
 
 
Figure 25. Schematic diagram of the oBST-2B truncated mutant where a stop codon was 
inserted at ω site . 
In order to assess the impact of introducing the premature stop codon, we first transfected CPT-tert 
cells with oBST-2B (control) or oBST-2BGPIc-28 expression plasmids. Subsequently, we quantified 
the phenotype of oBST-2B localisation (or the truncation mutant) by confocal microscopy as either 
concentrated or dispersed (Figure 26A). We found that oBST-2BGPIc-28 had a significant 
dispersed localisation in comparison to the concentrated perinuclear localisation characteristic of 
oBST-2B (Figure 26 (B)).  
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Figure 26. Ovine BST-2GPIc-28 displays an intracellular localisation different to that of 
oBST-2B. 
(A) Confocal microscopy of CPT-tert cells transiently transfected with oBST-2B/oBST-2BGPIc-28 
revealed two different staining patterns: (i) dispersed within the cytoplasm and cell membrane and 
(ii) concentrated in a perinuclear region. (B) Data were quantified by counting the staining 
phenotype of 100 cells in random fields. oBST-2B transfected cells display mostly a concentrated, 
perinuclear association whilst oBST-2BGPIc-28 is found as both dispersed and concentrated in 
roughly equal amounts. 
 
We found that oBST-2GPIc-28 displays an intracellular localisation different to 
that of oBST-2B, switching from a concentrated to a dispersed phenotype (Figure 
26). During the course of these experiments, we also found evidence suggesting 
that oBST-2BGPIc-28 was able to accumulate at the plasma membrane (Figure 27 
(a) and (d)). Thus, oBST-2BGPIc-28 shows a similar phenotype to oBST-2A. 
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Figure 27. oBST-2B truncation mutants display a distinct localization pattern from oBST-2B 
CPT-tert cells transfected with oBST-2BGPIc-28 were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against the HA epitope and appropriate secondary 
conjugated antibodies. In addition to the ‘wild-type’ oBST-2B concentrated perinuclear distribution, 
oBST-2BGPIc-28 also shows a dispersed intracellular localisation (B and C) with plasma 
membrane association noted (A and D). 
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3.3.5 oBST-2B has an ER retention motif  
 
Above, we showed that truncation of the last 28 amino acid residues of oBST-2B 
result in its re-distribution within the cell and the switch from a concentrated to 
a dispersed phenotype. Perinuclear localization of oBST-2B might be due to a 
dysfunctional GPI-SP and/or to a predicted ER retention motif (KLCKK) that is 
present in the C terminal region. In order to test this point we made multiple 
truncated mutants in oBST-2B after the predicted omega site, as illustrated 
schematically in Figure 28.  
 
 
Figure 28. Schematic diagram of the oBST-2B C truncation mutants generated in this study.  
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To assess the influence of the differing truncations upon oBST-2B distribution, 
we transfected each mutant into CPT-tert cells and assessed their intracellular 
localisation as described above. We found that all of the C-terminal truncated 
mutants, with the exception of oBST-2Bc-5, had a dispersed intracellular 
localisation whereas oBST-2Bc-5 maintained the localisation typical of the native 
oBST-2B, predominately concentrated and perinuclear (Figure 29).  
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Figure 29. Ovine BST-2 C truncation mutants display a different intracellular localisation 
from oBST-2B. 
Confocal microscopy of CPT-tert transiently transfected with oBST -2B and C terminal mutants 
display two different staining patterns: A(i) dispersed within the cytoplasm and cell membrane and 
A(ii) concentrated in a perinuclear region. (B) Data were quantified by counting the staining 
phenotype of 100 cells in random fields. oBST-2Bc-25, 20, 9 and 6 positive cells have a significant 
dispersed localisation whilst oBST-2Bc-5 transfected cells display mostly a concentrated, 
perinuclear association typical of the native oBST-2B protein. 
 
Interestingly, we also observed that, although oBST-2Bc-5 (deleted of the KLCKK 
motif) maintains a predominantly perinuclear localisation, it appears to have a 
more punctuated distribution surrounding the nucleus (Figure 30 panels E and F) 
rather than the tightly concentrated mass characteristic of oBST-2B (Figure 30, 
panels A and B). Nevertheless, oBST-2Bc-5, like oBST-2B, could be found in a 
dispersed form (Figure 30 C and D). It was frequently observed that the 
punctuated distribution of oBST-2Bc-5 was observed as small individual spherical 
aggregates, O-rings, around the nucleus (Figure 30, panels G and H). We 
currently have no explanation as to why this occurs. We conclude that the KLCKK 
motif is functional and likely represents one of the K(X)KXX retention motifs 
previously described (Teasdale and Jackson 1996).  
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Figure 30. oBST-2Bc-5 truncation mutant displays a similar intracellular localisation pattern with oBST-2B. 
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Figure 30. oBST-2Bc-5 truncation mutant displays a similar intracellular localisation 
pattern with oBST-2B. 
CP tert cells transfected oBST-2Bc-5 and oBST-2B were fixed 18h after transfection and 
analyzed by confocal microscopy using antibodies against the HA epitopes and appropriate 
secondary conjugated antibodies. oBST-2Bc-5 shows a concentrated intracellular localisation 
(e and f) similar to oBST-2B (a and b) but with a more punctuate appearance around the 
nucleus. oBST-2Bc-5 is frequently observed with small circular aggregates, O rings (g and h). 
A small proportion of cells transfected with oBST-2Bc-5 show a dispersed localisation (c and 
d). 
 
 
3.3.6 oBST-2B co-localises with Golgi based markers  
 
We have established above that oBST-2B has no functional GPI-SP, it is not 
glycosylated and displays mostly a perinuclear concentrated intracellular 
distribution, primarily due to a KLCKK ER retention motif at the C-terminal 
of the protein. Next, using confocal microscopy we assessed whether oBST-
2B localises in the Golgi using different cellular markers: p115, Giantin and 
TGN46; that localise in the cis, medial and trans-Golgi network respectively 
(Figure. 31, 32, 33, 34, 35, 36, 37).  
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Figure 31. Schematic representation of the Golgi and the cellular markers used in this 
study. 
We transfected CPT-tert cells with  expression plasmids for either oBST-2A or -2B and 24h 
post-transfection cells were fixed and analysed by confocal microscopy using antibodies 
against the HA epitope (detecting oBST-2A and -2B) and p115 (Figures 32 and 33), Giantin 
(Figures 34 and 35) or TGN46 (Figures 36 and 37). The extent of co-localisation between 
oBST-2 and each of the Golgi markers indicated above was performed by calculating the 
Pearson’s correlation coefficient using Image-Pro software (Media Cybernetics).  
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Figure 32. oBST-2A does not co-localise significantly with p115 
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Figure 33. oBST-2B co-localises with p115 
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Figure 34. oBST-2A does not co-localise with Giantin 
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Figure 35. oBST-2B co-localises with Giantin 
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Figure 36. oBST-2A does not co-localise with TGN46 
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Figure 37. oBST-2B co-localises with TGN46 
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Figure 32. oBST-2A does not c-localise significantly with p115. 
CPT-tert cells transfected with oBST-2A were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based p115 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation between p115 and oBST-2A was 
observed. Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) the absence of white areas indicates there is no significant 
colocalisation between oBST-2A and p115. 
 
 
Figure 33. oBST-2B co-localises with p115. 
CPT-tert cells transfected with oBST-2B were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based p115 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and the yellow areas indicate significant colocalisation between 
p115 and oBST-2B. Co-localisation can also be assessed visually for images with a greyscale 
merge of individual images (d, h and l) with white areas indicating significant association. 
 
 
Figure 34 oBST-2A does not co-localise with Giantin. 
CPT-tert cells transfected with oBST-2A were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based Giantin (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation was observed between Giantin and 
oBST-2A.,Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) with the absence of white areas indicating there is no significant 
colocalisation between Giantin and oBST-2A. 
 
 
Figure 35 oBST-2B co-localises with Giantin. 
CP tert cells transfected with oBST-2B were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against Golgi based Giantin (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and yellow indicates areas of significant colocalisation between 
Giantin and oBST-2B. Co-localisation can also be assessed visually for images with a 
greyscale merge of individual images (d, h and l) with white indicating areas of significant 
association Giantin and oBST-2B. 
 
 
Figure 36 oBST-2A does not co-localise with TGN46. 
CP tert cells transfected with oBST-2A were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against TGN based TGN46 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and no significant colocalisation was observed between TGN46 and 
oBST-2A. Co-localisation can also be assessed visually for images with a greyscale merge of 
individual images (d, h and l) the absence of white areas indicates no significant association 
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Figure 37 oBST-2B colocalises with TGN46 
CP tert cells transfected with oBST-2B were fixed 18h after transfection and analyzed by 
confocal microscopy using antibodies against TGN based TGN46 (green- a, e and i) and the 
HA epitopes (red- b, f and j) and appropriate secondary conjugated antibodies. These images 
were merged (c, g and k) and yellow indicates areas of significant colocalisation between 
TGN46 and oBST-2B. Co-localisation can also be assessed visually for images with a 
greyscale merge of individual images (d, h and l) with white indicating areas of significant 
association. 
 
Data are shown in Figure 38 as the average Pearson’s correlation values 
obtained in 50 random images representative of cells expressing oBST-2A or 
-2B and incubated with antibodies towards each of the Golgi markers. The 
Pearson’s correlation is a value ranging from -1 to 1, which in this case 
indicates the degree of co-localisation between the Golgi marker in question 
and oBST-2A/ -2B. We considered 0.5 as our threshold for significant 
association. oBST-2B, and not oBST-2A, displayed a significant degree of co-
localisation with all three Golgi-based markers (Fig. 38). 
 
Figure 38. oBST-2B co-localises with Golgi based markers 
This figure displays the quantification of the data shown in Figures 32-37. The values 
represent the average of the Pearson’s correlation coefficient. Any values obtained above 0.5 
were regarded as representing significant co-localisation.  
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Next, we used confocal microscopy to assess the localisation of oBST-2B in 
the presence or absence of Brefeldin-A, a drug which fragments the Golgi 
apparatus. We observed that oBST-2B behaved in a similar manner to 
Giantin in the presence of Brefeldin-A as its distribution pattern was 
redistributed from a predominantly concentrated form (Figure 39) to that of 
a more dispersed one (Figure 40) results are summarised in Figure 41. 
Collectively, the data obtained suggest that oBST-2B is a Golgi based 
protein. 
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Figure 39. Giantin and oBST-2B have a concentrated, perinuclear distribution 
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Figure 40. Giantin and oBST-2B localisation is altered by treatment with Brefeldin A 
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Figure 39. Giantin and oBST-2B have a concentrated, perinuclear 
distribution.  
CPT-tert cells were transfected with the oBST-2B expression plasmid. The cells were fixed and 
analysed by confocal microscopy using antibodies towards the Giantin Golgi marker and HA 
epitope as indicated. These images were also merged. oBST-2B and Giantin display a 
concentrated localisation with a high degree of colocalisation as shown in the merge indicated by 
yellow and within the Image-Pro greyscale images indicated in white. 
 
Figure 40. Giantin and oBST-2B localisation is altered by treatment with 
Brefeldin-A. 
CPT-tert cells were transfected with either oBST-2A or -2B expression plasmids. Eighteen hours 
after transfection, the cells were treated in the presence and absence of 200ng/ml of Brefeldin-A for 
90mins, fixed and analysed by confocal microscopy using antibodies towards the Giantin Golgi 
marker and HA epitope as indicated. These images were also merged. Both Giantin and oBST-2B 
localisation is altered by treatment with Brefeldin-A. 
 
 
 
 
Figure 41. Brefeldin-A treatment leads to an intracellular redistribution of oBST-2B. 
This figure displays the quantification data for the images shown in Figures 39 and 40. Data were 
quantified by counting the staining phenotype of 100 cells in random fields. Cells were grouped as 
(i) dispersed within the cytoplasm and cell membrane and (ii) concentrated in a perinuclear region. 
In the absence of Brefeldin-A both Giantin and oBST-2B have a predominantly concentrated 
localisation. Following treatment with 200ng/ml of Brefeldin-A for 90 mins post transfection the 
localisation of both Giantin and oBST-2B is altered to be predominantly dispersed pattern. 
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3.4 Discussion 
 
The Bst-2 gene is an IFN inducible gene with a broad antiviral activity. 
Interestingly, the Bst-2 gene is duplicated in sheep and in cattle, suggesting that 
duplication occurred more than 25 million years ago before speciation within the 
Bovinae subfamily. The fixation and maintenance of oBST-2B in the ruminant 
genome suggests a biological function for this gene. However, in a previous 
study, we found oBST-2B to have only a moderate antiviral activity compared to 
oBST-2A (Arnaud, Black et al. 2010). In this chapter, we aimed to characterise 
key differences between the ovine BST-2 paralogs, and in particular we 
investigated their intracellular distribution.  
Although oBST-2B appears to have a limited antiviral activity, in co-transfection 
assays we ruled out that it acts as a negative regulator of oBST-2A. Indeed, 
sheep Betaretroviruses were efficiently inhibited in the presence of oBST-2A and 
oBST-2B. 
We revealed several properties that are unique to oBST-2B and that might be at 
the basis of the different biological properties observed in the ovine paralogs. 
We found oBST-2B not to be glycosylated, to lack a predicted GPI anchor 
attachment signal and to possess an ER retention motif (KLCKK) at its C-terminal 
portion.  
A lack of glycosylation alone would not seem to be the main reason underlining 
the different biological properties of oBST-2A and -2B. Mutation of the 
glycosylation sites in hBST-2 did not affect its distribution nor its common 
‘tethering’ antiviral function (Perez-Caballero, Zang et al. 2009). N-linked 
glycosylation is a common form of protein modification, predicted for more than 
half of all eukaryotic proteins. It is reported to be involved in a number of 
processes including protein orientation relative to membranes, protein turnover 
and regulation of stabilisation against denaturation/proteolysis, enhanced 
solubility and modulation of immune responses (Helenius and Aebi 2004). Thus, a 
lack of glycosylation may have a profound impact on BST-2B structure and in 
turn function.  
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We found that oBST-2B is present mainly in a concentrated form in a 
perinucleolar region while oBST-2A is dispersed throughout the cytoplasm and 
the cell membrane. oBST-2A, similarly to other BST-2 orthologs, appears to 
maintain a functional GPI-SP and adopt the current “tethering” model where 
BST-2 is directed via its GPI anchorage to the plasma membrane. However, oBST-
2B does not seem to possess a canonical GPI-SP (or at least it is not predicted by 
current bioinformatic tools), and does not localise to the cell membrane. 
Consequently, it is difficult to envisage how this protein could restrict viral exit 
by the classic ‘tethering’ mechanism.  
Despite the importance of GPI anchorage for the BST-2 membrane localisation, 
this can only account for its absence from the plasma membrane and does not 
fully explain the differing patterns of intracellular localization that we observed. 
oBST-2A and -2B share a transmembrane domain but the latter contains a non-
canonical ER retention motif (KLCKK). Deletion of this region (e.g. mutant oBST-
2Bc-6) resulted in the redistribution of oBST-2B from the characteristic 
concentrated form to that of a more dispersed form. The KLCKK motif of oBST-
2B is similar to the classic K(X)KXX motif, one of several C-terminal ER retention 
motifs identified. It differs slightly from the standard consensus sequence 
described which has three lysine residues found at positions -1/-2 and -5 relative 
to the C-terminus. Therefore, the lack of the KLCKK retention motif may explain 
the potential redistribution to the plasma membrane rather than the possibility 
of GPI anchorage. 
Proteins with ER retention motifs often require post translational modifications 
carried out at the Golgi, where they traffic before feeding back to the ER where 
they are based. ER retention motifs allow re-circulation to the ER from the Golgi 
and TGN (Jackson, Nilsson et al. 1993). It was puzzling that mutant oBST-2Bc-5 
(with a premature termination codon replacing the K residue in position -5) had 
an apparently concentrated localisation. However, the distribution pattern of 
oBST-2c-5 was notably different from wild type oBST-2B. Wild type oBST-2B was 
usually localised mainly in a single perinuclear region while oBST-2c-5 had a 
series of punctuate dots surrounding the nucleus which may indicate that it 
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remains trapped within the ER, although further studies will be needed to 
confirm this point.  
Using confocal microscopy, we established that oBST-2B localises in the Golgi 
stacks. This is not a novel concept for BST-2 as an independent intracellular pool 
localising at the TGN for hBST-2 has already been described (Kupzig, Korolchuk 
et al. 2003) and, interestingly, a Golgi based localisation has also recently been 
described for a BST-2 homolog (GREG) derived from CHO cells (Li, Kaloyanova et 
al. 2007). oBST-2B localisation was also confirmed by a functional assay. In the 
presence of Brefeldin-A, oBST-2B is redistributed in the same manner as the 
Golgi based protein Giantin. Therefore, we conclude from these data that oBST-
2B does not progress beyond the Golgi and behaves as a resident Golgin closely 
associated with the cis/medial cisternae of this organelle. oBST-2A showed a 
distinct localisation from oBST-2B. 
As mentioned above, we noticed a similar intracellular localisation between 
oBST-2B and GREG (Li, Kaloyanova et al. 2007) However, we find that 
intracellular localisation is the only feature that these two proteins share. GREG 
is a constitutively expressed protein which appears to be important for 
maintaining Golgi structure, while oBST-2B is induced by IFN and displays some 
antiviral activity (see also Chapter 4). Structurally, GREG and oBST-2B do not 
share many features. GREG has GPI anchorage like all other BST-2 orthologs and 
several sites for N-linked glycosylation, but neither of these features are found 
in oBST-2B. GREG and oBST-2B share a predicted coiled coil region linked to 
functionality and retention motifs which determine intracellular localisation 
patterns. GREG possesses a central EQ tandem repeat that is essential for Golgi 
localisation. oBST-2B has a C-terminal retention motif which we have shown is 
the determinant of perinuclear localisation. 
Therefore we conclude that oBST-2B has some but not all the features conserved 
for most BST-2 orthologs. oBST-2A is clearly a plasma membrane based protein 
bearing many of the features of other classical ‘tethering’ BST-2 proteins. If 
oBST-2B is absent from the plasma membrane, then we expect that it would be 
difficult to understand how it can contribute to the traditional mode of 
tethering viral particles to the plasma membrane. However, (Arnaud, Black et 
Chapter 3  130 
 
130 
al. 2010) have shown oBST-2B to possess only limited antiviral activity, 
prompting us to question how oBST-2B can block viral particle release. 
A limitation of our studies is that they are conducted by transient transfections. 
Unfortunately, there is no cell culture system for the propagation of sheep 
Betaretroviruses.  
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4 Chapter 4 - Investigating the antiviral restriction 
mechanism of the oBST-2 paralogs 
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4.1 Summary 
In this chapter we aimed to identify the antiviral mechanism of the ovine BST-2 
paralogs to determine if oBST-2B shared the classical ‘tethering’ antiviral 
restriction common to other BST-2 orthologs. 
 
4.2 Introduction 
4.2.1 Overview of BST-2 induced antiviral restriction.  
 
The discovery of BST-2 as a restriction factor was inspired by the observations 
that Vpu was mandatory for HIV viral particle release in certain cell lines while it 
was dispensable in others. These data suggested the presence of a host cellular 
factor which prevented viral particle release (Smith, Thresher et al. 1991). BST-
2 restricts viral replication by ‘tethering’ HIV (and other enveloped viruses) viral 
particles at the cell membrane, preventing their final release (Van Damme, Goff 
et al. 2008), (Neil, Zang et al. 2008). Fully formed viral particles are tethered to 
the cell membrane by BST-2, which creates a bridge of retention between the 
plasma membrane and virions exiting the cell (Neil, Zang et al. 2008). BST-2 
restriction is essentially independent from the cell line in which the assays are 
carried out, thus ruling out the involvement of essential cofactors for its 
function (Sato, Yamamoto et al. 2009). There is also evidence to indicate that 
BST-2 reduces infectivity of the small number of virions released in its presence 
potentially by interfering with the maturation process (Zhang and Liang 2010). 
There are conflicting observations regarding the importance of conserved BST-2 
structural elements in the tethering mechanism (reviewed by (Andrew and 
Strebel 2011)). However, it has been demonstrated by mutational analysis of 
BST-2 with ‘art-tetherin’ (a protein which bears no sequence homology to 
tetherin but maintains the structural arrangement conserved within BST-2 
homologs) that protein configuration is more important than the primary 
sequence for efficient restriction (Perez-Caballero, Zang et al. 2009).  
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Human BST-2 possesses a broad antiviral activity extending beyond HIV-1. Human 
BST-2 has been shown to block the exit of a range of diverse retroviral genera 
including alpharetroviruses, Betaretroviruses, deltaretroviruses and 
spumaviruses (Jouvenet, Neil et al. 2009). Further evidence of the restriction of 
enveloped arenaviruses (Sakuma, Sakurai et al. 2009; Radoshitzky, Dong et al. 
2010), herpesviruses (Mansouri, Viswanathan et al. 2009), filoviruses (Jouvenet, 
Neil et al. 2009) and paramyxoviruses (Radoshitzky, Dong et al. 2010) by human 
BST-2 has also been demonstrated, although conflicting results have been 
published in the case of filoviruses (Jouvenet, Neil et al. 2009; Kaletsky, 
Francica et al. 2009; Radoshitzky, Dong et al. 2010).  
Although BST-2 is very efficient in blocking viral exit, some doubts have been 
cast as to whether this protein can efficiently block viral dissemination within a 
host. In addition to the ability of BST-2 to ‘tether’ viral particles to the plasma 
membrane and thus inhibit cell-free virus transmission, there is also evidence 
which supports the idea that BST-2 efficiently restricts cell-to-cell virus 
transmission (Casartelli, Sourisseau et al. 2010). However, it is intriguing that, in 
contrast to idea that BST-2 may reduce the formation of virological synapses and 
therefore reduce cell-to-cell transfer, BST-2 does not appear to inhibit their 
formation and may even promote them (Jolly, Booth et al. 2010). Furthermore, 
the transfer of virions from an infected to an uninfected cell via a synapse has 
been observed (Jolly, Booth et al. 2010), although virions that successfully pass 
through the virological synapses in the presence of BST-2 appear to be heavily 
aggregated (Casartelli, Sourisseau et al. 2010). The efficient restriction of cell-
to-cell transmission by BST-2 has been further disputed by the evidence that 
∆Vpu HIV-1 mutant viruses switch from cell free to a cell-to-cell transmission 
mode in the presence of BST-2 (Jolly, Booth et al. 2010). Thus, BST-2 may even 
promote cell-to-cell virus transmission. An increase in the formation of the 
virological synapse and cell-to-cell transmission is possibly linked to an increase 
of virus at the plasma membrane in the presence of BST-2 compared to wild type 
virus (Jolly, Booth et al. 2010). However, BST-2 restriction may also result in 
positive selection for viral variants which can spread more efficiently by cell-to-
cell transmission, as shown for FIV (Dietrich, McMonagle et al. 2011). Overall, it 
is important to stress that the antiviral action promoted by BST-2 occurs in vivo 
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in parallel with a range of antiviral factors which target various stages of the 
replication cycle (Neil and Bieniasz 2009).  
Different studies have provided evidence for the positive selection of BST-2 and 
other restriction factors such as APOBEC-3G and TRIM5α (Sawyer, Emerman et 
al. 2004; McNatt, Zang et al. 2009). However, these studies have also highlighted 
the fact that BST-2 does not appear to be as strongly selected as other host 
restriction factors (Bozek and Lengauer 2010). 
 
 
 
 
4.3 Results 
 
 
4.3.1 oBST-2A and –2B both redistribute intracellular viral Gag 
localisation. 
 
In Chapter 3 we established the intracellular localisation of oBST-2B while here 
we wanted to investigate specifically the effect that they exerted over viral 
structural proteins. Firstly, using confocal microscopy we looked at the effects 
of oBST-2A/ -2B on the localisation of enJSRV Gag. Expression plasmids for 
enJSRV-18 were co-transfected with expression plasmids for either oBST-2A or -
2B. Cells were then fixed, permeabilised and subsequently analysed for Gag 
localisation with a rabbit polyclonal antisera against the capsid (CA) protein. The 
intracellular distribution pattern of exogenous JSRV and enJSRV-18 Gag proteins, 
in the presence and absence of oBST-2A and -2B, was based on three previously 
established distributions: concentrated, dispersed and dispersed with plasma 
membrane association (Arnaud, Black et al. 2010). We found that both oBST-2A 
and -2B influence the distribution of intracellular viral Gag proteins, although in 
apparently different ways. We found a clear redistribution of enJSRV Gag to the 
plasma membrane in the presence of oBST-2A (Figure 42). These data are in 
accordance with the ‘tethering’ mechanism of action displayed by BST-2 
orthologs. However, we found that a significant proportion of enJSRV Gag 
displayed a concentrated distribution in the perinuclear region in the presence 
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of oBST-2B compared to cells expressing enJSRV-18 alone. This concentrated 
perinuclear distribution observed for Gag is reminiscent of the Golgi-based 
localisation defined for oBST-2B in Chapter 3. 
 
 
Figure 42. The ovine BST-2 paralogs redistribute enJSRV-18 Gag in different ways. 
CPT-tert cells were transfected with expression plasmids for enJSRV-18 alone or with either oBST-
2A or -2B (0.25µg of each plasmid). A. The intracellular distribution of Gag (green) was categorised 
as either concentrated, dispersed or reaching the plasma membrane by confocal microscopy. 
(Please note the picture representing plasma membrane based distribution was provided by Dr. 
Frederick Arnaud). B. The phenotype of intracellular gag distribution was counted in 100 cells 
randomly including blind counts. In the presence of oBST-2A, enJSRV-18 Gag appears to 
accumulate at the plasma membrane. In the presence of oBST-2B, more than 80% of transfected 
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cells display enJSRV-18 with a concentrated phenotype. Western blotting of ultracentrifuged 
supernatants (virus) confirms that oBST-2A/ -2B is actively  restricting the release of enJSRV-18 
viral particles in those cells counted. 
 
 
 
4.3.2 oBST-2B redistributes intracellular Env  
Next we sought to determine if oBST-2A/ -2B were also capable of affecting the 
intracellular distribution of the viral Env protein. This was done by transiently 
transfecting CPT-tert cells with an expression plasmid for the exogenous JSRV 
Env (tagged with a Flag epitope at the C-terminus) in the presence or absence of 
oBST-2A or -2B expression plasmids. The cells were fixed and analysed by 
confocal microscopy using an anti-Flag antibody to detect Env. The localisation 
of Env was quantified by confocal microscopy by counting its distribution as 
‘concentrated’, ‘dispersed’ or ‘reaching the plasma membrane’ (Figure 43 (A)). 
This time we found that oBST-2A had no influence over the distribution of viral 
Env compared to Env alone. However, in the presence of oBST-2B we again 
observed a notable redistribution of viral Env to the perinuclear region as 
summarized in Figure 43 (B). We also noted that Env that is localised in the 
perinuclear region co-localises with oBST-2B, as determined by Pearson’s 
correlation 0.62 (+/- 0.02), illustrated in Figure 44. 
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Figure 43. oBST-2B redistributes the intracellular distribution of Env. 
CPT-tert cells were transfected with 1µg of JSRV Env in the presence or absence of oBST-2A/ -2B 
(0.25µg). A. The intracellular pattern of Env (green) was classed and counted as concentrated, 
dispersed or plasma membrane associated by confocal microscopy. B. oBST-2A had no influence 
over Env distribution. However, oBST-2B holds a significant proportion of Env in a concentrated 
form upon comparison to the Env counted alone 
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Figure 44. Env held in a perinuclear localisation shows a significant degree of co-localisation with oBST-2B. 
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Figure 44. Env held in a perinuclear localisation shows a significant degree of co-
localisation with oBST-2B. 
CPT-tert cells were transfected with 1µg of JSRV Env in the presence or absence of 
oBST-2B (0.25µg). Eighteen hours after transfection the cells were fixed and analysed by 
confocal microscopy using antibodies against the Flag (a, e and i) and HA (b, f and j) 
epitopes. These images were also merged. Env and oBST-2B display a concentrated 
localisation with a high degree of colocalisation as shown in the merge indicated by 
yellow (c, g and k) and within the Image-Pro greyscale images indicated in white (d, h 
and l). The Pearson’s correlation value of 0.62 is above the 0.5 threshold and is therefore 
considered to confirm a significant degree of co-localisation between Env and oBST-2B. 
 
 
 
 
4.3.3 oBST-2B potentially exerts not just an effect over viral 
proteins but creates a general inhibition of intracellular 
trafficking  
 
Thus far we have shown that oBST-2B had a significant effect on the 
trafficking/intracellular localisation of the Gag and Env proteins of both 
an exogenous and an endogenous sheep Betaretrovirus. Next, we sought 
to confirm if the influence on protein distribution due to oBST-2B was 
confined specifically to viral proteins or if it extended to cellular 
membrane proteins. This would determine if the mode of restriction was 
virus specific or reflected a more general control over intracellular 
trafficking of membrane proteins exerted by oBST-2B. We used a GFP 
tagged form of Caveolin-1 expressed from a plasmid transfected in the 
presence or absence of either oBST-2A /-2B expression plasmids. Once 
again, quantification of the intracellular protein localisation was made 
by confocal microscopy by grouping the expressed proteins as either 
concentrated, dispersed or based at the plasma membrane (Figure 45 
(A)). Caveolin-1 proteins in isolation were found to traffic to the plasma 
membrane. We found no significant difference in the intracellular 
distribution of Caveolin-1 in the presence or absence of oBST-2A. 
Interestingly, the presence of oBST-2B resulted in a greater proportion 
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of Caveolin-1 being retained in a more concentrated form, as illustrated 
in Figure 45 (B). 
 
 
 
Figure 45. oBST-2B redistributes the intracellular localisation of non viral proteins. 
CPT-tert cells were transfected with 1µg of a Caveolin-1-GFP expression plasmid in the 
presence and absence of oBST-2A/ -2B (0.25µg of each plasmid). A. Internalisation was 
classed and counted as ‘concentrated’, ‘dispersed’ or ‘plasma membrane based’. B. No 
significant redistribution of Caveolin-1 in the presence of oBST-2A was observed. 
However in the presence of oBST-2B we found an increased proportion of Caveolin-1 to 
be in a concentrated form. 
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4.3.4 oBST-2B reduces the incorporation of Env into viral 
particles  
oBST-2A was found to redistribute intracellular Gag to the plasma 
membrane, supporting the "tethering" restriction model. However, we 
found that oBST-2B blocked intracellular trafficking of both 
Betaretrovirus Gag and Env proteins by retaining them within a 
perinuclear area which is highly likely to impact viral particle assembly. 
Given this observation, we next investigated the ratio of Gag and Env 
being incorporated into the small number of viral particles released in 
the presence of the oBST-2A or -2B. We performed transient 
transfections of 293T cells with an expression plasmid for enJSRV-18 in 
the presence or absence of different amounts of oBST-2A or -2B 
expression plasmids. 24 hours post-transfection, cell supernatants were 
collected and concentrated by ultracentrifugation. Viral pellets were 
separated by SDS-PAGE and both Gag and Env were detected by western 
blotting using appropriate antibodies.  
There are wide differences in the stoichiometry of Gag and Env in a 
retroviral particle. Each virion contains far more Gag than Env. 
Consequently, we took great care in optimising the dilutions of anti-Gag 
and Env antibodies to be used in western blotting so that we could be 
confident that these proteins were detected with similar sensitivity in 
our assays. Figure 46 (A) shows that serial dilutions of enJSRV-18 viral 
particles are detected with similar sensitivity by both anti-Gag and anti-
Env antibodies. As expected, in the presence of oBST-2A enJSRV-18 viral 
particle release is greatly inhibited (Figure 46 (B)). On the other hand, 
inhibition of enJSRV-18 particle release appears to be only moderately 
affected by oBST-2B (Figure 46 (C)). However, each experiment was 
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performed independently three times and the blots shown are 
representative of the trend observed. A comparison of Env incorporation 
of into enJSRV-18 viral particles is based on a visual reading from the 
blots. It may be suggested in Figure 46 that, in the presence of oBST-2B, 
Env incorporation into viral particles is reduced compared to viral 
particles expressed in the absence of oBST-2B. Similar data were also 
obtained with exogenous JSRV in the presence or absence of oBST-2A 
and -2B and is shown in Figure 47. We attempted to confirm this data 
using standard DLS technology and Nanoparticle tracking analysis (NTA) 
to estimate the size (diameter) of virions released by JSRV/ enJSRV-18 
in the presence and absence of oBST-2A/ -2B. To do this we first 
estimated the size of virions released following transfection of 293T cells 
with JSRV/ enJSRV-18 and JSRV∆Env/ enJSRV-18∆Env. Each experiment 
was performed independently three times and an average result 
representative of the trend observed is shown in Figure 48. We found 
that standard DLS technology did not produce accurate or reproducible 
results for the size of JSRV/enJSRV-18 particles (data not shown). NTA 
was able to detect particles at the 100nm size predicted for JSRV (but 
not enJSRV-18). No difference was observed between ‘complete’ 
JSRV/enJSRV-18 virions and those devoid of Env.  
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Figure 46. oBST-2B blocks Env incorporation by enJSRV-18 viral particles. 
A. Western blotting of serial dilutions of concentrated supernatants of 293T cells 
transfected with an expression plasmid for enJSRV-18. Dilutions of anti-Gag (CA) and 
anti-Env (TM) sera used in this series of experiments were pre-determined in order to 
obtain approximately the same levels of sensitivity. B-C. Western blotting of 
ultracentrifuged supernatants (virus) from 293T cells cotransfected with 1 µg of an 
expression plasmid for enJSRV-18 and variable amounts (0.25 – 1 µg) of expression 
plasmids for either oBST-2A or oBST-2B. Blots were incubated with the appropriate 
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antisera as indicated beside each panel. Gag associated with the viral particles was 
quantified by chemifluorescence using a Molecular Dynamics Storm 840 imaging system 
using ImageQuant TL software (Molecular Dynamics). The numbers indicated below 
each panel quantify Gag release in the presence of oBST-2A/ -2B compared to the 
standard virus transfected alone (100). Each experiment was repeated at least three 
times. D-E The corresponding cell lysates are also shown γ-tubulin was used as loading 
control while a cotransfected plasmid expressing GFP was used as transfection control.  
 
 
 
 
Figure 47. oBST-2B reduces envelope incorporation by JSRV viral particles. 
A. Western blotting of serial dilutions of concentrated supernatants of 293T cells 
transfected with an expression plasmid for JSRV. Dilutions of anti-Gag (CA) and anti-Env 
(SU) sera used in these series of experiments where pre-determined in order to obtain 
approximately the same levels of sensitivity. B-C. Western blotting of ultracentrifuged 
supernatants (virus) of 293T cells co-transfected with 4 µg of an expression plasmid for 
JSRV, and variable amounts (0.05 – 0.5 µg) of expression plasmids for either oBST-2A 
or oBST-2B. Blots were incubated with the appropriate antisera as indicated beside each 
panel. Gag and Env associated with viral particles was quantified by chemifluorescence 
using a Molecular Dynamics Storm 840 imaging system using ImageQuant TL software 
(Molecular Dynamics) and numbers are indicated below each relevant panel. The 
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numbers indicated below each panel quantify Gag and Env release in the presence of 
oBST-2A/ -2B compared to the standard virus transfected alone (100).  
 
 
 
 
 
Figure 48. NTA analysis of exogenous and endogenous JSRV virions and those 
released devoid of Env. 
Nanoparticle Tracking Analysis (NTA) was employed to measure the hydrophobic 
diameter of ultracentrifuged supernatants of 293T cells transfected with 1 µg of 
expression plasmid for enJSRV-18/enJSRV∆Env, or 4 µg of JSRV/ JSRV∆Env. NTA of 
JSRV virions revealed an average particle size of 96.7nm while JSRV∆Env virions were 
smaller at 82.7nm (red) with a background reading of particles averaging at 75nm (grey). 
For enJSRV-18 the average particle size was larger at 95nm and enJSRV∆Env virions 
were 92nm (red) with a background reading of particles averaging at 119nm (grey). 
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4.3.5 oBST-2B C-terminal truncated mutants do not affect 
the incorporation of Env into sheep Betaretrovirus viral 
particles.  
 
Having confirmed the effects of oBST-2A/ -2B on Gag and Env, we then 
focused on determining whether the function of oBST-2B relied on its 
localisation in the Golgi. In order to experimentally address this point we 
used the previously described truncation mutant oBST-2BGPIc-28, which 
no longer retained the predominately concentrated localisation exclusive 
to oBST-2B and displayed instead a more dispersed localisation (Figure 
25 from Chapter 3). We performed transient transfections of the enJSRV-
18 expression plasmid in the presence of variable amounts of oBST-
2BGPIc-28 as described above and once again assessed the incorporation 
of Gag and Env into viral particles by western blotting. We found that, 
unlike wild type oBST-2B, oBST-2GPIc-28 was not able to deplete Env 
incorporation into enJSRV-18 viral particles (Figure 49). We conclude 
that the C-terminal portion of oBST-2B and its characteristic 
concentrated perinuclear localisation appear to be essential for its 
antiviral function.  
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Figure 49. The C terminal portion of oBST-2B is essential for inhibiting Env 
incorporation. 
 
A. Western blotting of ultracentrifuged supernatants (virus) and cell extracts (B) of 293T 
cells co-transfected with 1 µg of an expression plasmid for enJSRV-18 and variable 
amounts (0.25 – 1 µg) of oBST-2BGPIc-28. Blots were incubated with the appropriate 
antisera as indicated beside each panel. Data show that the C-terminal truncation mutant 
has no effect on either Gag (CA) or Env (TM) release.  
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4.4 Discussion 
 
It is well established that BST-2 proteins directly antagonise the late 
phases of the retroviral lifecycle by engaging with viral particles as they 
exit from the cell and retain them by tethering them to the plasma 
membrane. BST-2 resides within the lipid rafts of the host membrane, 
which are known to be hotspots for viral release, and the various BST-2 
orthologs isolated from different animal species seem to restrict viral 
replication in a similar manner. 
Sheep (and other ruminants within the sub-family of the Bovinae) have a 
duplicated BST-2 gene (termed oBST-2B) that has been conserved 
throughout evolution. In a previous study, it has been shown that oBST-
2B blocks viral exit less efficiently than oBST-2A as judged by the 
relative amount of Gag released in the supernatants of cells transfected 
with plasmids expressing retroviral constructs (Arnaud, Black et al. 
2010). Indeed, in this current study we showed that oBST-2B localises 
mainly in the Golgi and possesses different structural characteristics 
from oBST2-A.  
Within this Chapter, we found that oBST-2A and -2B both redistribute 
ovine Betaretrovirus structural proteins, although in a different manner. 
oBST-2A increases the concentration of Gag at the plasma membrane, 
similarly to what has been observed for the classic ‘tethering’ model 
with other BST-2 orthologs that retain virions to the cell surface. In 
contrast, oBST-2B induces Gag accumulation in a concentrated form in a 
perinucleolar region. Furthermore, oBST-2B also co-localises with Env 
and induces accumulation of this protein in the same perinuclear region.  
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These data strongly suggested that oBST-2A and -2B acted in 
substantially different ways. Previous studies have shown that the Gag of 
Betaretroviruses, including Mason-Pfizer monkey retrovirus (M-PMV) and 
sheep Betaretroviruses (Sfakianos and Hunter 2003; Sfakianos, LaCasse 
et al. 2003; Arnaud, Murcia et al. 2007; Murcia, Arnaud et al. 2007) 
concentrate in the pericentrosomal area in a dynein and microtubule-
dependent fashion. The assembled viral particles then traffic to the cell 
membrane by a mechanism that is influenced by the pericentriolar 
recycling endosomes and by Env (Arnaud, Murcia et al. 2007). Thus, the 
data obtained in this chapter could be explained with a model whereby 
oBST-2B interacts (directly or indirectly) with the betaretroviral Env and 
inhibits its trafficking to the cell membrane. As the Env protein 
influences the assembly and trafficking of virions, inhibition of Env 
trafficking would in turn lead to the accumulation of Gag in a 
pericentrosomal area. Betaretroviral particles can exit transfected cells 
in the absence of viral Env although it is expected that this would occur 
in a slower manner than in the presence of Env. 
Consistent with this model, western blotting suggested that in the 
presence of oBST-2B there may be a reduction of Env protein 
incorporation into viral particles.  
The data obtained in this Chapter suggest that the antiviral action of 
oBST-2B might be based on a mechanism not previously reported for 
other BST-2 orthologs. In the presence of oBST-2B, Env appears to be 
sequestered in a cellular compartment (likely the Golgi, although we 
have not formally assessed this point) and does not reach the cell 
membrane and consequently reduces viral incorporation of Env. The 
retention of Caveolin-1 in a concentrated perinuclear region in the 
presence of oBST-2B suggests that BST-2B may have similar effects on 
other membrane proteins, suggesting that this paralog may have a global 
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effect on trafficking of certain proteins rather than target specifically 
the retroviral Env. oBST-2B may act indirectly by inhibiting a general 
cellular function which results in Env (and other proteins) being 
physically sequestered within the Golgi. These data suggest that oBST-2B 
interferes with a fundamental requirement for Golgi trafficking, rather 
than being based on any specific interaction/recognition event with viral 
proteins. However, in this Thesis we only tested Caveolin-1. Attempts 
were made with a Cadherin-GFP fused protein but the construct was 
considerably cytotoxic in CPT-tert cells. Further experiments are 
required with other host endogenous proteins which traffic and leave the 
Golgi.  
Previously, we observed close association of oBST-2B with p115 and 
Giantin (Chapter 3). Both p115 and Giantin have been linked with 
cargo/vesicle movement between stacks (Sonnichsen, Lowe et al. 1998; 
Sengupta and Linstedt 2011). We may speculate that it is possible for 
oBST-2B to interact with and disrupt the flow of protein cargo passing 
between the Golgi stacks and exiting the TGN, which could also explain 
the retention of Env within the Golgi. Co-immunoprecipatation studies 
followed by proteomic screens would be required to confirm particular 
associations of oBST-2B with Golgi-based proteins which could suggest 
particular modes of function. Although the exact nature of the oBST-2 
interaction within the Golgi was outside the scope of this study, we can 
conclude with confidence that the antiviral restriction induced by oBST-
2B does not follow the pattern of the classic ‘tethering’ mechanism.  
We tested the lack of Env incorporation into the sheep betaretroviral 
particles in the presence of oBST-2B by western blotting. As mentioned 
in the results section of this Chapter, we took care in optimising the 
dilutions of anti-Gag and anti-Env antibodies in order to equilibrate the 
sensitivity of detection of Gag and Env. We attempted to obtain more 
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detailed measurements of virion size and weight in the presence and 
absence of oBST-2B. Both dynamic light scattering and NTA were 
employed to measure virion size. Nanosight technology proved to be 
more sensitive at accurately measuring the virion size of JSRV/enJSRV-
18 than DLS, but did not reveal any significant, reproducible differences 
between the size of JSRV/enJSRV-18 virions and the VLPs produced by 
transfection of enJSRV-18/JSRV∆Env truncation mutants (Figure 48). This 
is likely due to the incorporation of plasma membrane proteins into VLPs 
during exit of viral particles from the cell (Hammarstedt, Wallengren et 
al. 2000; Hammarstedt and Garoff 2004; Cantin, Methot et al. 2005).  
There is some debate as to whether BST-2 is able to effectively restrict 
viral infection in vivo. While human BST-2 actively reduces cell free virus 
transmission, it appears to have little influence over cell-to-cell virus 
transmission (Jolly, Booth et al. 2010). The latter has been evolved by 
retroviruses as an efficient way to evade host defences. Thus, the 
different mechanism of antiviral restriction employed by oBST-2B may 
have an impact on cell-to-cell viral spread. There are different 
mechanisms that have been envisaged for cell-to-cell virus spread 
including plasma membrane based fusion, use of filopodia, nanotubules 
or formation of the virological synapse (Jolly and Sattentau 2004; 
Sherer, Lehmann et al. 2007). All of these mechanisms share the 
common feature of viral transfer directly from an infected to an 
uninfected cell largely driven by Env-receptor(s) interaction. We suspect 
oBST-2B would prevent cell-to-cell transmission by retaining Env within 
the Golgi. Thus, the unique duplication of BST-2 in ruminants potentially 
induces a novel and more stringent antiviral mechanism for 
Betaretroviruses. 
 
Chapter 4  152 
 
 
Figure 50. Models of oBST-2A and -2B viral restriction. 
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Figure 50. Models of oBST-2A (panel A) and oBST-2B viral restriction (panel B). 
We suspect that oBST-2A restricts virion release by the ‘classical tethering mechanism’. However, 
we predict that a different strategy is employed by BST-2. Betaretroviral particles assemble in the 
pericentrosomal area and exit through the recycling endosomes by a mechanism that is influenced 
by the pericentriolar recycling endosomes and Env. We predict that oBST-2B inhibits trafficking of 
the betaretroviral Env the cell membrane. As the Env protein influences the assembly and 
trafficking of virions, inhibition of Env trafficking would in turn lead to the accumulation of Gag in a 
pericentrosomal area. Betaretroviral particles in the presence of oBST-2B exit the cell void of Env 
are deemed non infectious VLPs. 
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5.1 General Discussion 
 
 
There is a delicate evolutionary balance between viruses and their hosts. The 
hosts have evolved innate, intrinsic and adaptive immunity in order to fight viral 
(including retroviral) invasion. At the same time, viruses have evolved 
counteracting measures in order to evade such host defences in order to survive 
and propagate.  
Betaretroviruses of sheep have represented a unique model to study virus-host 
over long evolutionary periods (Arnaud, Caporale et al. 2007; Arnaud, Murcia et 
al. 2007; Arnaud, Varela et al. 2008; Chessa, Pereira et al. 2009; Varela, Spencer 
et al. 2009). The sheep genome has been invaded by Betaretroviruses for at 
least the last 5-7 million years, before the divergence of the genera Ovis and 
Capra. During evolution, two enJSRV loci (enJS56A1 and enJSRV-20) have 
acquired a mutation in Gag (R21W) that renders them defective as they 
assemble viral particles that are not able to exit the cells (Mura, Murcia et al. 
2004). Interestingly, it has been shown that this mutation has been positively 
selected and is transdominant over other endogenous and exogenous 
Betaretroviruses with a process termed “JLR” for JSRV late restriction, and 
estimates based upon evolutionary rates suggest that these transdominant 
enJSRV proviruses became fixed in the genome of the host around the time of 
domestication (Arnaud, Murcia et al. 2007; Murcia, Arnaud et al. 2007; 
Armezzani, Arnaud et al. 2011). However, viruses always appear to possess an 
answer to the host defences and a recently integrated provirus, enJSRV-26, was 
found to be able to escape viral restriction due to a single point mutation in the 
signal peptide of the enJSRV-26 viral Env protein. Thus, sheep Betaretroviruses 
have left “fossils” that have allowed us to trace the evolutionary arms race 
between viruses and hosts.  
Cellular restriction factors have also been positively selected during evolution. 
In this thesis we have investigated the interplay between the two oBST-2 genes 
and sheep Betaretroviruses. BST-2 is an IFN-inducible restriction factor, with a 
broad antiviral activity targeting the late stages of viral replication. Curiously, in 
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ruminants BST-2 is duplicated, resulting in the paralogs oBST-2A and -2B 
(Arnaud, Black et al. 2010). Whilst oBST-2A possesses an antiviral activity similar 
to other BST-2 orthologs, we found oBST-2 B to possess distinct biological 
properties.  
Gene duplication offers the possibility to produce a large number of “novel” 
genes to bacteria, archaebacteria and eukaryotes and it is linked to the 
development of species-specific functions. Duplication of a gene is most often 
generated by unequal cross over, retroposition or chromosomal duplication 
events within the genome (Zhang 2003). In the majority of cases duplication 
creates an identical copy of the gene. This process is beneficial to the host for 
strongly expressed genes, but where there is no requirement for additional gene 
expression duplicated genes may undergo “subfunctionalization” or 
“neofunctionalization”. Subfunctionalization involves the original gene and its 
paralog sharing only small parts of the original gene function, resulting in two 
genes which perform individually refined functions in place of a previous gene. 
On the other hand, neofunctionalization involves the duplicated gene taking on 
an entirely novel function altogether. It is difficult to envisage how a gene could 
undergo rapid modification to adopt an entirely new function within the 
constraints of the host genome.  
Two models are suggested to explain how this may have arisen within the host. 
The first model proposes that extensive mutations may accumulate within the 
duplicated gene over time without the pressure of positive selection as it is 
functionally redundant. The second model suggests that the duplicated genes 
have been subject to positive selection where even a few mutations induce a 
weak but novel function, which is then positively selected or that the original 
gene had dual action which mutations followed by selection result in this action 
being shared and refined between the current paralogs (Zhang 2003). 
Recent analysis of the history of gene duplication and loss within fungi yielded 
important information with regard to the significance of duplication within the 
host (Wapinski, Pfeffer et al. 2007). It highlighted that there was little evidence 
of duplication of genes with a fundamental physiological importance to cell 
function. Those genes which were continually subjected to ‘environmental 
stress’ were found to be more frequently duplicated within the genome. 
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Interestingly, hosts which have undergone whole genome duplication appeared 
to favour the addition and loss of genes for the majority of gene duplications 
observed (Flintoft 2007). Gene duplication has been implicated in the 
development and function of major intracellular organelles such as the Golgi 
(Klute, Melancon et al. 2011). In addition it is considered to resolve intralocus 
sexually antagonistic variation. This is the presence of genes on the X 
chromosome shared in both males and females which are under selection in both 
species in opposing directions (Gibson, Chippindale et al. 2002; Gallach and 
Betran 2011). There is evidence to suggest that gene duplication has also 
contributed to the evolution of placental pregnancy (Hughes, Green et al. 2000).  
We suggest that oBST-2B could be seen as a rare example of 
neofunctionalization, a gene duplication event which occurred prior to the 
speciation of the bovinae and which has resulted in an entirely novel function for 
oBST-2. This is novel in that oBST-2B appears to restrict Betaretroviruses with a 
mechanism entirely different from oBST-2A.  
Genes involved in host immunity are among those under the most significant 
evolutionary pressure. We did not address in this thesis whether oBST-2B has or 
is under positive selection. The extensive lifespan of primates is at odds with the 
rapid turnover of retroviral populations and inevitably gives the virus the 
evolutionary advantage with more chances to generate ways to defeat the host 
immune system. Therefore, oBST-2B represents a rare example of the unique 
forms of positive selection occurring within the host in response to the continual 
challenge a particular retrovirus infecting a particular animal species. 
Betaretroviruses, unlike other retroviruses, assemble at the pericentrosomal 
area, a unique feature of the Betaretrovirus lifecycle. Viral particles then exit 
with a process that is influenced by Env and by the recycling endosomes. oBST-
2B appears to co-localise strongly with Env and in turn reduce Env incorporation 
into the envelope of nascent virions. In light of the BST-2 gene duplication event 
having occurred prior to divergence of cattle and sheep, the challenge posed by 
ancient betaretroviral ancestors to enJSRVs may have lead to the positive 
selection of a second oBST-2 gene. The cattle genome has been shown to contain 
Betaretroviruses that are distinct from enJSRVs. The pattern of restriction 
observed for oBST-2B is unique amongst all the BST-2 orthologs known. 
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As mentioned before, oBST-2A is a glycosylated protein with a broad based 
internal/plasma membrane based distribution while we found oBST-2B appears 
to be unglycosylated with a concentrated perinuclear localisation. The 
perinuclear accumulation of oBST-2B was shown to localise to the Golgi stacks 
and TGN. In addition, functional experiments with Brefeldin-A confirmed that 
oBST-2B is localised with the Golgi and behaved like a Golgin. Interestingly, this 
is the first description of a perinuclear based location for an IFN induced BST-2 
protein. Given the striking differences we observed between the oBST-2A and -
2B localisation, it was difficult to envisage how both paralogs were capable of 
restricting viral replication by the same mechanism. Furthermore, the classical 
tethering mechanism is dependent upon the residence of BST-2 within the lipid 
rafts of the plasma membrane where it engages with viral particles exiting the 
cell. The unusual location for oBST-2B did not fit with this model of restriction 
and led us to question if another mode of restriction was utilised by oBST-2B. 
In concurrence with the classical tethering model we found that oBST-2A 
redistributed Gag protein to the plasma membrane. This is consistent with the 
fundamental idea that viral particles are tethered to the plasma membrane in 
order to prevent exit (Neil, Zang et al. 2008). oBST-2A had no effect over Env 
distribution. However, oBST-2B redistributed both Gag and Env proteins in a 
concentrated perinuclear pattern. Previously, it was observed that oBST-2A was 
more efficient at blocking virion exit than oBST-2B based on viral Gag exit levels 
(Arnaud, Black et al. 2010). During this thesis we found that that oBST-2A is a 
highly efficient restriction factor for both Gag and Env. oBST-2B in contrast 
appears inefficient at blocking Gag exit but we obtained data suggesting that 
oBST-2B substantially reduced the presence of Env in the virions released into 
the supernatants. We suspect in the presence of oBST-2B uninfectious VLPs are 
released. 
Thus, in this thesis we suggest that oBST-2B is in fact, an efficient restriction 
factor which blocks Betaretroviruses by a unique method of restriction, different 
from oBST-2A and one not previously described for any other BST-2 protein. 
oBST-2B appears to exert its restriction by sequestering Env in a perinuclear 
compartment, most likely the Golgi, preventing trafficking and reducing the 
incorporation of Env into assembling virions. The virions released are devoid of 
Env and therefore we suspect are non-infectious VLPs. We speculate that oBST-
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2B, unlike oBST-2A, may provide an efficient restriction mechanism by 
preventing cell-to-cell transmission which is driven by the interaction between 
Env and the host receptor. This interaction would be unable to occur due the 
unique pattern of Env perinuclear localisation in the presence of oBST-2B.  
Unfortunately there are inherent difficulties in our experimental system that 
makes it difficult to firmly establish that indeed oBST-2B blocks Env 
incorporation. Because there is less Env than Gag in viral particles, western 
blotting could provide misleading results although (i) we carefully titrated anti-
Gag and anti-Env antibodies in order to obtain a similar sensitivity in this test 
and (ii) confocal microscopy also showed an accumulation of Env in the Golgi.  
It was assumed that viral particles devoid of Env would be a different diameter 
to wild type particles with a full complement of Env. We therefore attempted to 
measure the size of the viral particles in the presence or absence of oBST-2B by 
dynamic light-scattering methods. Our results revealed no difference in the size 
of sheep betaretroviral particles in the presence or absence of oBST-2B. 
However, using the same technique we could not detect a difference in size 
between our positive controls (wild type JSRV/enJSRV-18) and the respective 
Env truncation mutants. The reason for these data is that betaretoviral particles 
formed by Gag alone are still enveloped by the cell membrane. Consequently it 
is very difficult to resolve the size of a betaretroviral particle with Env from one 
without Env. An alternative approach would be to visualise intracellular or 
budding particles by transmission electron microscopy with immunogold labelling 
for Env detection.  
There is no tissue culture system for the propagation of JSRV/enJSRVs. During 
this thesis we also tried to develop infectious assays for JSRV/enJSRVs but 
without success and therefore it has proven difficult to corroborate oBST-2B 
restriction by infectious assays. 
Overall, we suggest that oBST-2B provides another example of a host restriction 
factor. Future experiments need to be directed to prove lack of Env 
incorporation with other techniques. Use of other Betaretroviruses, such as 
Mason-Pfizer monkey virus may help to develop infectious assays that could 
further corroborate our studies.  
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